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SUMMARY
Human cytomegalovirus (HCMV) origin-dependent DNA synthesis has not been as 
well studied as herpes simplex virus type 1 (HSV-1) DNA synthesis, partly due to the 
difficulty of manipulating HCMV permissive cell lines in tissue culture. Seven virus encoded 
proteins are required for HSV-1 origin-dependent DNA synthesis. Of the seven essential 
proteins, the six replication fork proteins, comprising the helicase/primase (UL5/UL8/UL52), 
the DNA polymerase (UL30/UL42) and a single stranded DNA binding protein (UL29), are 
conserved throughout the Herpesviridae. The seventh protein required for HSV-1 
origin-dependent DNA synthesis is the origin-binding protein, UL9, which is conserved 
among the alphaherpesviruses and the roseolovirus genus. HCMV origin-dependent DNA 
synthesis requires the six conserved replication fork proteins and five other HCMV encoded 
proteins. HCMV does not encode an obvious counterpart to UL9.
In this thesis, transient replication assays were used to further investigate the initiation 
of HCMV origin-dependent DNA synthesis. In order to simplify the transient transfection 
assay, alternatives to human fibroblast cell lines were tested for their ability to support 
HCMV DNA synthesis.
A transfected HCMV origin-containing plasmid was replicated by HCMV strain 
AD 169 infection in Vero cells which did not apparently support the replication of the 
infecting genomes. The replication of independent origin-containing plasmids, and the failure 
of control plasmids to be replicated, confirmed that replication was specific to the HCMV 
origin sequences and independent of the vector used. Replication of an unmethylated 
origin-containing plasmid confirmed that the bacterial methylation patterns on the plasmid 
DNA were not responsible for its aberrant replication. Inhibitors were used to demonstrate
that DNA synthesis was directed by the viral DNA polymerase. An assay exploiting the 
ability of simian virus 40 (SV40) T-antigen to recruit cellular DNA polymerases to direct 
SV40 origin-dependent DNA synthesis was used to confirm that the concentrations of 
inhibitors used did not abrogate the activity of the cellular (nuclear) replicative polymerases.
In contrast to previously published data, genomic DNA synthesis was observed in 
HCMV strain AD 169 infected 293 cells and in HCMV strain Towne infected 293 and Vero 
cells. Therefore, the ability of HCMV to replicate in 293 and Vero cells was examined by 
virus growth assay and electron microscopic examination of infected cells. Neither Vero 
cells infected with HCMV strain AD 169 or Towne, nor 293 cells infected with HCMV strain 
AD 169, supported the production of HCMV progeny as measured by plaque formation or by 
electron microscopy (E.M.). HCMV particles were observed by E.M. at 140 h p.i. in 10% 
of 293 cells infected with HCMV strain Towne.
An HCMV origin-containing plasmid was replicated by the HSV-1 replication fork 
proteins in the presence of the HCMV auxiliary proteins (TRS1, UL36-38, UL84, 
UL112-113 and UL122-123). Replication was dependent on intact origin sequences and was 
directed by the HSV-1 DNA polymerase. The HCMV major immediate early proteins 
(IE 1/2) were sufficient to mediate replication of an HCMV origin-containing plasmid by the 
HSV-1 replication fork proteins, addition of UL36-38 significantly increased the efficiency of 
replication. Stop mutants in pSVH (expressing the major immediate early proteins) and 
pZP8 (expressing UL36-38) and a deletion mutant in pZP8 were used to demonstrate that 
IE2-86 and UL38 likely provided functions important for origin-dependent DNA synthesis. 
UL84, which specifies a putative origin-specific function (Sarisky & Hayward, 1996), was 
not required for HCMV origin-containing plasmid replication in this assay.
Simian cytomegalovirus (SCMV) strain Colburn is more closely related to HCMV 
than HCMV is to HSV-1, therefore, the ability of SCMV superinfection to replicate an 
HCMV origin-containing plasmid was examined. SCMV infection directed the replication of 
an HCMV origin-containing plasmid in the absence of any HCMV proteins, addition of 
plasmids expressing UL84 did not increase the replication efficiency. The model system of 
replication of a varicella-zoster virus (VZV) origin-containing plasmid by HSV-1 
superinfection was used to demonstrate that the addition of a cognate origin-binding protein 
to such “cross-complementation” assays increased replication efficiency. In an experiment in 
which the level replication of an HCMV origin-containing plasmid by SCMV strain Colburn 
was below the limits of detection, addition of HCMV IE1/IE2 and UL36-38 increased the 
efficiency of replication to a detectable level.
The results of experiments using HSV-1 plasmids or SCMV virus to provide 
replication fork proteins to replicate an HCMV origin containing plasmid indicate that 
proteins provided by the IE1/IE2 locus and the UL36-38 locus, but not UL84, perform 
important origin specific roles in these assays.
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Chapter 1: Introduction
This thesis is concerned with origin-dependent DNA synthesis in the herpesvirus, 
human cytomegalovirus (HCMV). I will first provide a general introduction to the 
Herpesviridae, noting the characteristics which are common to all members of the family 
and describing the human herpesviruses identified thus far. This will be followed by a brief 
overview of the lytic cycle of HCMV.
Much of our knowledge of HCMV DNA synthesis has come from our knowledge 
of herpes simplex virus 1 (HSV-1), so DNA synthesis in HSV-1 will be reviewed, followed 
by a description of DNA synthesis in Epstein-Barr virus (EBV) and HCMV. In part, 
studies into HCMV replication have been hampered by its restricted growth in tissue 
culture and therefore I will briefly review HCMV replication in cultured cells.
1.1 Characteristics of the Herpesviridae
The general characteristics of the Herpesviridae have been reviewed in the recent 
report of the International Committee on the Taxonomy of Viruses (ICTV) (Minson et al., 
2000), and by Davison and Clements (1998). The Herpesviridae are a large family of 
enveloped viruses with double-stranded DNA genomes packaged within an icosahedral 
capsid. The Herpesviridae encode most of the proteins required to direct origin-dependent 
viral genomic DNA synthesis in the nuclei of infected cells. Viral DNA is packaged into a 
preformed proteinaceous capsid which is surrounded in turn by a tegument layer and a lipid 
envelope containing viral glycoproteins. Release of virus from infected cells results in cell 
death. The Herpesviridae are also characterised by their ability to establish latent infections 
following a primary infection.
Classification
There are three subfamilies within the Herpesviridae: the Alpha, Beta, and
Gammaherpesvirinae. Classification into a subfamily of the Herpesviridae was originally
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on the basis of the biological properties of the virus. However, as more sequence data is 
produced, classification will ultimately be on the basis of DNA sequence. The 
classification of the Herpesviridae has recently been presented in the ICTV report (Minson 
et al., 2000).
The Alphaherpesvirinae tend to be fast growing viruses able to infect a wide range 
of cell types in tissue culture and to establish latent infections primarily in sensory ganglia. 
Betaherpesvirinae are generally the slowest growing and most host restricted of the 
Herpesviridae in tissue culture, infection is usually associated with the formation of large 
cells with intranuclear inclusions. Betaherpesvirinae are maintained in latent form in spleen 
cells, monocytes and possibly other cell types. Gammaherpesvirinae are slightly less host 
restricted in vitro and are able to establish latent infections in lymphoid cells. Subfamilies 
of the Herpesviridae may be subdivided into genera; Cytomegalovirus, Muromegalovirus 
and Roseolovirus are the three genera of the Betaherpesvirinae.
Human herpesviruses flTHVsl
Eight herpesviruses of man have been isolated to date, including members of all 
three subfamilies, reviewed in Fields Virology by Roizman and Sears (1996), Mocarski 
(1996), Kieff (1996), Cohen and Straus (1996), Pellett and Black (1996) and Frenkel and 
Roffinan (1996).
HSV-1 (HHV-1) is an alphaherpesvirus of the Simplexvirus genus. HSV-1 
commonly causes cold sores and may rarely be responsible for encephalitis. Following 
primary infection, HSV-1 can establish a latent infection in sensory ganglia from which the 
virus can reactivate. Herpes simplex virus 2 (HSV-2 or HHV-2) is a Simplexvirus, closely 
related to HSV-1, which is also able to establish a latent infection in sensory ganglia, but 
which manifests a productive infection in the form of genital lesions. The third human 
alphaherpesvirus is varicella-zoster virus (VZV or HHV-3) which is the prototype 
Varicellovirus. Primary infection with VZV causes chicken pox, following which the virus
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maintains a latent infection in sensory neurones. Reactivation from latency can cause a 
more severe illness known as shingles.
Three members of the Betaherpesvirinae are human herpesviruses. HCMV 
(HHV-5) is the most intensively studied member of the Cytomegalovirus genus of the 
Betaherpesvirinae. HCMV infection is usually asymptomatic in immune-competent 
individuals but can cause severe neurological damage in congenitally infected infants. 
HCMV infection in immuno-suppressed individuals, such as individuals infected with 
human immunodeficiency virus (HIV) and transplant recipients, can cause HCMV retinitis 
and other complications. HCMV infection is probably responsible for nearly 10% of cases 
of infectious mononucleosis with possible complications of this including pneumonia, 
hepatitis and aseptic meningitis. Human herpesvirus type 6 (HHV-6) is a Roseolovirus 
causing exanthem subitum in children. HHV-6 has also been associated with multiple 
sclerosis. Human herpesvirus type 7 (HHV-7) is the second member of the Roseolovirus 
genus. Similarly to HCMV, both HHV-6 and HHV-7 may reactivate in patients following 
organ transplantation.
Two gammaherpesviruses of humans have been isolated. EBV (HHV-4) is a 
Lymphocryptovirus which establishes a latent infection in B-lymphocytes. EBV is the 
common cause of infectious mononucleosis, and is associated with Burkitts lymphoma, 
Hodgkins disease and nasopharyngeal carcinoma. Human herpesvirus type 8 (HHV-8 or 
Kapsosi’s sarcoma associated herpesvirus) is a Rhadinovirus which may establish latency in 
T or B lymphocytes. HHV-8 is associated with Kaposi’s sarcoma, normally manifesting as 
skin lesions but which is a severe complication in individuals infected with HIV. HHV-8 
infection may be associated with the progression of HIV infection to AIDS.
Genome arrangement
The genomes of the Herpesviridae are linear double-stranded DNA molecules 
ranging in size from 125 to over 240 kbp, containing from 70 to over 200 open reading
frames. Herpesvirus genomes contain various arrangements of unique sequences and 
repeated elements, giving rise to seven distinct genome types which are represented 
schematically in figure 1.1 and have been described by Roizman (1996) and by McGeoch 
and Davison, (1995). There is no correlation between the type of genome arrangement and 
the subfamily to which a virus belongs. HCMV has a 230 to 240 kbp genome which, like 
HSV-1 and HSV-2, falls into a group 6 arrangement. Group 6 genomes have two
stretches of unique sequences (U l and Us), each flanked by inverted repeats (IRL and TRL 
flanking Ul, and IRS and TRS flanking Us). The long (TRL + U l + IRL) and short (IRS +
Us + TRS) segments of group 6 genomes are able to invert relative to each other so that an
HCMV genome can exist in one of four possible isomeric forms. An additional repeated 
element, the ‘a’-sequence, is found at the genomic termini and the junction between the 
long and short segments.
Gene expression
Gene expression in the Herpesviridae is strictly controlled. The three temporal 
classes of genes expressed during infection are immediate early (a), early (pi and p2), and 
late (yl and y2). Genes are transcribed in the infected cell nucleus by cellular RNA 
polymerase II.
Particle structure
Herpesvirus particles consist of a core composed of the viral genome 
packaged in a liquid-crystalline array within a twenty faced (icosahedral) capsid assembled 
from virus encoded proteins. The capsid is surrounded by an amorphous tegument layer, 
also composed of virus proteins. Tegumented virus is enclosed in a host-cell derived lipid 
envelope containing virus glycoproteins. A cryo-electron micrograph showing an HCMV 
particle is shown with a schematic representation of the particle (figure 1.2).
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Figure 1.1 Genome arrangements in the Herpesviridae, (Davison & McGeoch, 1995; Roizman, 1996). 
Group 0 genomes have a single unique region, e.g. tree-shrew herpesvirus.
Group 1 genomes have a single unique region flanked by a direct, terminal repeat, e.g. channel catfish 
herpesvirus, HHV6 and HHV7.
Group 2 genomes have a single unique region flanked by a group o f direct terminal repeats, e.g. 
herpesvirus saimiri.
Group 3 genomes have two unique regions separated by and flanked by a group o f direct repeats, e.g. 
cottontail rabbit herpesvirus.
Group 4 genomes have two unique regions separated by a group of internal repeats. At each end o f the 
genome is a group o f  direct terminal repeats unrelated to the internal repeats, e.g. Epstein-Barr virus. 
Group 5 genomes have two unique regions, each unique region is Banked by an inverted repeat. The 
repeat regions Banking the long and short unique regions (Us and U ,) are not related. The repeats 
Banking U, are quite short, and only the S segment has a high frequency o f  inversion. A virus with this 
genome arrangement is varicella-zoster virus.
Group 6 genomes have two unique regions, each unique region is Banked by an inverted repeat. The 
repeat regions, I/TR, and 1/TRs Banking Ul and Us respectively, are not related. An additional repeat, 
the'a' sequence, is found at the genomic termini and at the junction between the internal repeats (IR, and 
IRs). Both the L and S segments show high frequency inversion. Herpes simplex virus type 1 and type 
2 as well as human cytomegalovirus have this type o f genome arrangement.
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1.2 The lytic cycle of HCMV
Herpesvirus replication has been reviewed by Mocarski, (1993), Roizman and Sears 
(1993), Liebowitz and Kieff (1993) and Davison and Clements (1998). The HCMV lytic 
cycle will be described here, and differences between HCMV replication and HSV-1 
replication will be noted.
HCMV genome
The HCMV genome was represented in figure 1.1. HCMV genes have been named 
according to their position within the genome. The TRL region o f the HCMV strain 
AD 169 genome (GenBank accession number X I7403) spans approximately 11.2 kbp
containing fourteen loci. The genes in the 167 kbp Ul region are named UL1 to UL132.
The IRS region is approximately 2.5 kbp long and contains one open reading frame. The 
US region contains 36 genes in 35.4 kbp of DNA. Usually the protein product of an open 
reading frame is named after the gene that encodes it, so the protein product of the UL84 
gene is known as UL84. Several proteins are additionally named on the basis of their size 
or function, for example, the protein product of the UL83 gene is also known as pp65 or 
the lower matrix protein. The HCMV genome potentially encodes over 200 proteins and 
contains one copy of an origin of lytic phase DNA synthesis, oriLyt.
The published HCMV genome sequence is that of HCMV strain AD 169 (Chee, 
1989). It has since been shown that the genomes of the HCMV Towne laboratory strain 
and the HCMV Toledo clinical isolate differ from that of HCMV strain AD 169. In fact, the 
AD 169 genome possibly lacks open reading frames found in the Towne genome, and both 
laboratory strains have lost open reading frames (up to nineteen) found in more recent 
clinical isolates (Cha et al., 1996). Another indication of the heterogeneity of HCMV is the 
finding that the virus genome used to produce the AD 169 genomic sequence lacks DNA 
(approximately 1 kbp) found in most stocks of HCMV strain AD 169 (Dargan et al., 1997).
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Attachment
The first events in the HCMV lytic cycle in vitro involve binding of the virus to the 
target cell, and its penetration. As has been demonstrated for other herpesviruses, initial 
interactions of HCMV with the cell surface may involve interactions with heparin, probably 
mediated by viral glycoprotein B (Compton et al., 1993).
Virus adsorption also involves the binding of a viral glycoprotein to a specific cell 
surface receptor(s). HCMV has been shown to bind to some cellular membrane proteins of 
30 to 34 kDa, and the presence of these proteins in cell membranes has been shown to be 
indicative of the ability of HCMV to be internalised (Nowlin et al., 1991). Unlike HSV-1, 
for which cellular receptors have been identified (reviewed by Campadelli-Fiume et al., 
2000), the identity of the HCMV cellular receptor(s) remains unknown. HCMV replication 
in tissue culture is quite cell type restricted, and the lack of a suitable cell surface receptor 
is one point at which the virus life cycle may be blocked.
Internalisation and uncoating
Following attachment, HCMV is internalised by membrane fusion. Binding of 
glycoprotein H (gH), in complex with glycoprotein L, to a 92.5 kDa phosphorylated 
cellular glycoprotein may be involved in the fusion mechanism (Keay et al., 1989). HSV-1 
penetration into a target cell involves gH and other virus glycoproteins (reviewed by 
Rajcani & Vojvodova, 1998). Attachment of HCMV to the cell surface has been shown to 
induce transcription of several cellular mRNAs and to increase detectable NF-kB binding 
activity (Boldogh et al., 1991; Yurochko et al., 1995). This latter response can be 
stimulated on addition of purified HCMV gB to cells (Yurochko et al., 1997).
After internalisation, capsids migrate to the nucleus by an unknown mechanism.
DNA is released into the nucleus, and the genome circularises and is replicated (McVoy &
Adler, 1994). HCMV genomes, like those of other herpesviruses, localise adjacent to
pre-existing nuclear structures known as promyelocytic leukaemia (PML) oncogenic
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domains (PODs), which are thought to be the site of viral gene expression (Ishov & Maul, 
1996). Some tegument proteins migrate to the nucleus with the capsid, and the upper 
matrix protein, pp71, can increase expression from promoters containing ATF and AP-1 
sites, including the HCMV major immediate early promoter (Liu & Stinski, 1992).
Temporal pattern of HCMV gene expression
HCMV mRNAs are transcribed in the nucleus by the cellular transcription 
machinery, then translated in the cytoplasm, also using the host-cell machinery. Gene 
expression in the herpesviruses is strictly controlled in three temporal classes; immediate 
early, early and late (Roizman, 1996; Mocarski, 1996).
The herpesvirus immediate early gene products are the first to be synthesised in 
infected cells, and most of these are involved in the expression of subsequent classes of 
genes. HCMV immediate early gene expression is mainly confined to four loci; IE1/IE2 
(UL122-123), IRS1/TRS1, UL36-38, and US3 (reviewed by Fortunato & Spector, 1999). 
At least one product of the US3 locus is thought to play a role in immune evasion by 
sequestration of some MHC class I molecules in the endoplasmic reticulum of the infected 
cell (Jones et al., 1996; Ahn et al., 1996). US3 is non-essential for virus growth in tissue 
culture (Jones & Muzithras, 1992). IE1 and IE2 together are able to activate expression of 
some early genes, while expression from other early promoters may require cooperation 
with other immediate early gene products (Stenberg et al., 1990; Pizzomo et al., 1998). 
Expression of the HCMV major immediate early proteins (IE1/IE2), as well as expression 
of some HCMV early genes, has been shown to be enhanced by the HCMV tegument 
proteins pp71 and UL69 (homologue of the HSV-1 IE63 post-transcriptional activator) 
(Liu & Stinski, 1992; Winkler et a l , 1994).
Following immediate early protein synthesis, the early genes are expressed. Early 
genes are mainly involved, directly or indirectly, in DNA metabolism and in the modulation 
of host cell metabolism. Efficient expression of the HCMV encoded proteins required for
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origin-dependent DNA replication requires the immediate early products of IE1/IE2, 
UL36-38, IRS 1/TRS 1 and at least one of the early gene products of the UL112-113 locus 
(Iskenderian et al., 1996).
Finally, expression of late genes is either greatly stimulated by, or dependent upon, 
viral DNA synthesis. Most late proteins are structural or have some role in particle 
assembly or DNA packaging.
DNA replication
HCMV DNA replication is described in more detail in section 1.4. Briefly, HCMV 
DNA replication, as in other herpesviruses, is thought to be initiated at a specific region of 
the genome, the origin, known in HCMV as oriLyt. The virus replication fork proteins are 
recruited, and semi-conservative DNA synthesis is postulated to proceed via an initial 
amplification of a circular template by theta replication, followed by rolling circle 
replication to produce concatemeric products. HCMV DNA synthesis occurs in distinct 
virus replication compartments which are derived from cellular PODs.
Capsid assembly
Less is known about capsid assembly and DNA packaging in HCMV than in
HSV-1, and much of our knowledge of the processes in HCMV is inferred from our
knowledge of HSV-1 (Gibson, 1996). The HCMV structural proteins, MCP (major capsid
protein), mCP (minor capsid protein), mC-BP (minor capsid protein binding protein), AP
(uncleaved assembly proteins) and SCP (smallest capsid protein), localise to the nucleus.
The HCMV structural proteins are homologous to the HSV-1 proteins VP5, VP23, VP19c,
VP22a and VP26 respectively. MCP interacts with AP in hexamers and pentamers. mCP
interacts with mC-BP in a 2:1 ratio to form structures resembling HSV-1 triplexes.
MCP and the assembly proteins are organised into pentamers and hexamers which
may be linked through interactions with the triplexes in precursor capsids. The precursor
capsid (preB-capsid) contains the MCP, mCP, mC-BP and AP. The preB-capsid matures
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into a virion following self-cleavage of the assembly proteins, DNA packaging, and exit of 
the cleavage products of the assembly proteins. The smallest capsid protein (SCP) is 
probably added to the virus particle following DNA packaging.
DNA packaging
The mechanism of DNA packaging has not been elucidated. DNA packaging 
requires enzymes to specifically cleave one complete genome from replicated, concatemeric 
DNA, and to pump that DNA into a capsid. Seven HSV-1 encoded proteins involved in 
DNA packaging have been identified, these are UL6, UL15, UL25, UL28, UL32, UL33, 
and UL17 (reviewed in Homa & Brown, 1997). The HSV-1 proteins have been more 
intensively studied than the HCMV proteins. Viral mutants in UL15, UL28 and UL33 have 
been shown to be defective in DNA packaging (Poon & Roizman, 1993; Addison et al., 
1990; al-Kobaisi et al., 1991). UL15 and UL28 have been shown to interact, possibly to 
form a complex similar to the bacterial T4 terminase (Abbotts et al., 2000). UL25 has been 
shown to be non-essential for the cleavage of concatemeric DNA, but to be required for 
packaging (McNab et al., 1998). The remaining packaging proteins, including UL25, may 
be involved in the formation of a ‘portal’ on the capsid, facilitating the association of DNA 
with the capsid and the retention of packaged DNA within the particle.
Homologues of the HSV-1 proteins involved in DNA packaging have been 
identified in HCMV, these are UL104, UL89, UL77, UL56, UL52, UL51, and UL93 
respectively (Chee et al., 1990). HCMV UL89 has some sequence homology with the 
bacteriophage T4 terminase protein and can bind to HCMV packaging signals (Underwood 
et al., 1998; Wang & McVoy, 1999). UL56 has been shown to be a DNA binding protein 
specific for the HCMV packaging signals, which shows ATP-independent nuclease activity 
(Bogner et al., 1998). Furthermore, benzimidazole ribonucleotides, which inhibit 
packaging of viral DNA, act on UL56 and UL89. In HCMV infected cells treated with 
benzimidazole ribonucleotides, concatemeric DNA is not cleaved into individual genomes,
supporting the proposition that UL56 and UL89 are most likely involved in resolving 
concatemeric DNA into genome lengths (Krosky et al., 1998; Underwood et al., 1998). 
HCMV UL56 has also been shown to localise, in a phosphonoacetic acid sensitive manner, 
to viral replication compartments and to interact with the viral DNA polymerase (UL44), 
thus “implicating that DNA replication is coupled with packaging” (Giesen et al., 2000).
The electrostatic repulsions between closely packed DNA strands may be partially 
neutralised by the polyamines which are also packaged into HCMV capsids (Gibson et al., 
1984), and the DNA may adopt a partially liquid crystalline structure (Bhella et al., 2000). 
By analogy with HSV-1, capsid assembly may be completed when the smallest capsid 
protein (SCP) decorates the outside of mature capsids. SCP may interact with the 
tegument.
Virus maturation and egress
The tegument is an amorphous protein layer associated with the viral capsid. The 
HCMV tegument is predominantly composed of pp65, pp71, UL32, UL47, and UL48. It 
has been proposed (Gibson, 1996) that tegument may be added to HCMV particles at a 
distended region of the nuclear membrane known in HHV-6 infected cells as the 
‘tegusome’ (Roffinan et al., 1990). A more recent report suggests that tegumentation of 
HCMV particles may occur, at least in part, in a cytoplasmic compartment (Sanchez et al., 
2000). HCMV virions have been shown to contain phospholipids, and various 
non-structural proteins including a protein kinase, phosphatases and a DNA polymerase 
(reviewed in Gibson, 1996). Recently, specific viral RNA molecules have been reported to 
be packaged within HCMV particles, though the relevance of this is unclear (Bresnahan & 
Shenk, 2000).
HCMV particles acquire an envelope when crossing the inner nuclear membrane 
which may be lost on crossing the outer nuclear membrane (reviewed by Mocarski, 1996). 
Particles are probably re-enveloped following passage through the golgi apparatus, and
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virus likely exits the cell via exocytosis. The envelope contains most of the virus encoded 
glycoproteins and possibly some host-cell membrane proteins (reviewed by Gibson, 1996; 
Britt & Mach, 1996). In addition to infectious virus particles, HCMV infected cells also 
produce two major types of non-infectious particles, these are dense bodies and 
non-infectious enveloped particles (NIEPS) (Irmiere & Gibson, 1983). Dense bodies are 
composed mainly of pp65 surrounded by an envelope containing viral glycoproteins. 
NIEPS are less abundant than dense bodies and contain capsids lacking the densely staining 
DNA core.
1.3 Herpesvirus DNA replication
1.3.1 HSV-1 lytic-phase DNA replication
Lytic-phase DNA replication has been much more extensively studied in HSV-1 
than in any other herpesvirus, and investigations into DNA replication in the other 
herpesviruses have, to some extent, been directed by our knowledge of HSV-1 (reviewed in 
Boehmer & Lehman 1997).
HSV-1 origins
Early electron micrographs of replicating HSV-1 DNA provided evidence that 
HSV-1 DNA synthesis begins at defined regions within the genome. The locations of three 
origins of lytic-phase DNA synthesis were later identified by transient replication assays 
(Stow, 1982; Weller et al., 1985). The transient replication assays examined the replication 
of transfected plasmids containing fragments of HSV-1 DNA following superinfection with 
HSV-1. Total cellular DNA was digested with a restriction enzyme to linearise the 
origin-containing plasmid, and with Dpnl to degrade input plasmid DNA. The presence of 
an HSV-1 origin of replication within the insert allowed the amplification of the plasmid, 
and the generation of Dpnl resistant molecules which were detected by Southern blotting.
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The HSV-1 genome has three sequence blocks which contain all the ds-acting 
signals required to serve as origins for DNA replication; one origin, oriL, is represented in a 
single copy near the centre of the long unique region of the genome; the other origin, oriS, 
is in the short repeats of the genome and is thus present twice in inverted orientation 
(Weller et al., 1985; Stow, 1982). The HSV-1 origins consist of an essential core region 
flanked by sequences which augment origin activity and contain transcription factor binding 
sites (Stow & McMonagle, 1983; Wong & Schaffer, 1991). The core regions of oriL and 
oriS are closely related, although there are some size and sequence differences. The 
locations and compositions of the HSV-1 lytic origins are shown in figure 1.3. Neither oriS 
nor oriL is absolutely essential for virus growth in tissue culture (Polvino-Bodnar et al., 
1987; Igarashi et al., 1993). Because of a tendency for plasmids containing oriL to delete 
in bacteria, most studies have been performed on oriS, and it is oriS that will be described 
in more detail here.
HSV-1 oriS has a core region of approximately 80 bp containing an imperfect 
palindrome of 45 bp (Stow & McMonagle, 1983; Lockshon & Galloway, 1988). The 
palindrome is composed of an 18 bp A/T region flanked by inverted repeats (imperfect) 
which are binding sites for the UL9 protein (Elias & Lehman, 1988; Weir et al., 1989). 
The UL9 binding sites flanking the A/T palindrome are termed ‘box I’ and ‘box II’. Box I 
(CGTTCGCACT) is a very high affinity binding site for UL9 and box II (TGCTCGCACT) 
is a high affinity site; UL9 has approximately five times greater affinity for box I than box
II. Close to box I is another UL9 binding site, box III; UL9 has 1000 times lower affinity 
for box III than box I. oriL is more symmetrical than oriS- the central region of oriL is a 
perfect palindrome of 145 bp with the 20 bp A/T region flanked on both sides by a copy of 
box I. While these differences might possibly allow the two types of origin to function in 
the initiation of different stages of lytic-phase DNA replication, it is not known whether the 
two origins actually differ in their activity.
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Figure 1.3 HSV-1 origin structures.
A) The location o f the HSV-1 lytic origins o f DNA replication (oriL and oriS) within the 
HSV-1 genome.
B) The core o f  oriL is a 144 bp perfect palindrome. The main features o f the origin are the 
20 bp A/T sequence and boxes I and III.
C) The core o f oriS contains a 45 bp imperfect palindrome. The 18 bp A/T sequence is 
flanked by one copy and box I and one copy o f box II.
The palindromic sequences are denoted by arrows ( ----------------- ).
DNA replication proteins
Seven virus proteins were identified as having direct, essential roles in HSV-1 
origin-dependent genomic DNA replication (Challberg, 1986; Wu et al., 1988; Heilbronn & 
zur Hausen, 1989). Transient replication assays were used to identify UL5, UL8, UL9, 
UL29, UL30, UL42 and UL52 as having essential functions in HSV-1 origin-dependent 
DNA synthesis. Initially, the transient replication assays involved the cotransfection of 
cosmids containing fragments of HSV-1 DNA with a plasmid containing an HSV-1 origin. 
This assay identified six fragments of HSV-1 DNA which encoded functions required for 
HSV-1 origin-dependent DNA synthesis (Challberg, 1986). Systematic subcloning and 
mutagenesis allowed the identification of ten open reading frames, including those for three 
known immediate early activators of gene expression, which were required for optimal 
activity. None of the three transactivators was absolutely essential, thus it was 
hypothesised that only the seven early genes had direct and essential functions in HSV-1 
DNA synthesis (Wu et al., 1988). This was confirmed using temperature-sensitive viral 
mutants (reviewed by Weller, 1991 and Boehmer & Lehman, 1997) and in transient 
replication assays in which the proteins were expressed from plasmids with constitutive 
promoters and downstream regulatory regions (Heilbronn & zur Hausen, 1989).
UL9 is the HSV-1 origin-binding protein; it is essential for DNA replication and is 
presumed to have an obligatory role in initiation (described later). The remaining six 
proteins, often referred to as the replication fork proteins, are likely to function both in 
initiation and in elongation. The replication fork proteins comprise the DNA polymerase 
holoenzyme (UL30 and UL42), the single-stranded DNA binding protein (UL29) and the 
helicase/primase (UL5, UL8 and UL52). These six proteins are conserved throughout the 
Herpesviridae (table 1.1). In contrast to the replication fork proteins, homologues of the 
origin-binding protein, UL9, are only found in the Alphaherpesvirinae and the 
Roseolovirus genus of the Betaherpesvirinae.
HSV-1 EBV HCMV
Helicase UL5 BBLF4 UL105
Helicase / primase accessory factor UL8 BBLF2 / 3 UL102
Single-stranded DNA binding protein UL29 BALF2 UL57
DNA polymerase UL30 BALF5 UL54
DNA polymerase accessory factor UL42 BMRF1 UL44
Primase UL52 BSLF1 UL70
Table 1.1 Six replication fork proteins conserved throughout the Herpesviridae. 
Transient replication assays were used to determine the virus encoded proteins required for 
DNA synthesis in HSV-1, EBV and HCMV (Wu et al., 1988; Heilbronn & zur Hausen, 
1989; Fixman et al., 1992; Pari & Anders, 1993). In addition to the six replication fork 
proteins conserved throughout the herpesviruses, one or more other virus encoded proteins 
are required for virus origin dependent DNA synthesis.
The HSV-1 DNA polymerase consists of two subunits which can be co-purified 
(Gallo et al., 1989). UL30 is the catalytic subunit of the HSV-1 DNA polymerase and has 
some activity in the absence of the accessory protein (Marcy et al., 1990). As well as its 
DNA polymerase activity, UL30 has a proof-reading 3’-5’ exonuclease and RNase H 
activity (Crute & Lehman, 1989). The polymerase accessory protein, UL42, is a 
double-stranded DNA binding protein which increases the processivity of the polymerase 
(Gottlieb et al., 1990; Digard et al., 1993).
The helicase/primase is a heterotrimer composed of one copy of each of UL5, UL8, 
and UL52 (Crute & Lehman, 1991). Helicase/primase activity is specified by UL5 and 
UL52 (Calder & Stow, 1990; Dodson & Lehman, 1991). The third member of the 
helicase/primase complex is UL8, which interacts with and modulates the activity of 
UL5/UL52 (Crute et al., 1989; Tenney et al., 1994). UL8 also interacts with the DNA 
polymerase and the origin-binding protein (Marsden et al., 1997; McLean et al., 1994).
The origin-specific function in HSV-1 DNA replication is provided by UL9 (Elias & 
Lehman, 1988; Olivo et al., 1988). UL9 is a sequence specific DNA binding protein with 
helicase activity, which exists in solution as a homodimer (Bruckner et al., 1991). As well 
as an interaction with UL8, UL9 interacts with UL29 and UL42 (Boehmer & Lehman, 
1993; Monahan et al., 1998).
The single stranded DNA binding protein, UL29 (also known as ICP8), 
cooperatively binds to single stranded DNA (Boehmer & Lehman, 1993). UL29 probably 
interacts with the polymerase accessory protein, and is required for optimum polymerase 
activity (Vaughan et al., 1984; Ruyechan & Weir, 1984). It also stimulates the 
helicase/primase, and the helicase activity of the origin-binding protein (Hamatake et al., 
1997; Boehmer et al., 1993).
The sites and significance of the interactions amongst the replication proteins, and 
with HSV-1 DNA, have been extensively investigated and the findings have been recently
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reviewed, (Stow, 2000)
Host cell encoded functions
Some essential host cell enzymes are presumed to be required in herpesvirus DNA 
replication. For example, HSV-1 does not encode a topoisomerase and would therefore 
require a host-cell topoisomerase to remove supercoils from the replicating circular DNA. 
As HSV-1 does not encode a DNA ligase, the host cell enzyme must be used to ligate 
Okazaki fragments on the lagging strand. In a temperature-sensitive baby hamster kidney 
(BHK) cell line with a mutant in the regulator of chromosome condensation (Reel), HSV-1 
failed to replicate and infecting genomes remained linear, implicating a requirement for 
circularisation prior to viral DNA replication, and an essential role for Reel in HSV-1 
infection in BHK cells (Umene & Nishimoto, 1996).
Non-essential enzymes involved in DNA metabolism
HSV-1 also encodes several proteins involved in nucleotide metabolism which are 
non-essential in tissue culture but may play more important roles during an in vivo infection 
(reviewed by Boehmer & Lehman, 1997). A ribonucleotide reductase, composed of UL39 
and UL40 subunits, converts ribonucleotide diphosphates to the corresponding 
deoxyribonucleotide diphosphates. Thymidine kinase, a homodimer of UL23, is able to 
phosphorylate thymidine and deoxycytidine. Thymidine kinase also activates the antiviral 
drug acyclovir. A uracil N-glycosylase, encoded by UL2, is involved in DNA repair. The 
HSV-1 dUTPase, UL50, converts dUTP to dUMP. The thymidine kinase, uracil 
N-glycosylase and the dUTPase may all be required for efficient reactivation from latency 
(Coen et al., 1989; Pyles & Thomsen, 1994; Pyles et al., 1992). An alkaline exonuclease, 
UL12, is non-essential for DNA replication or late gene expression, but may be involved in 
resolving branched DNA structures to facilitate DNA packaging (Shao et al., 1993).
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Pathway of HSV-1 DNA synthesis
While the HSV-1 DNA replication origins and the proteins required for 
origin-dependent DNA synthesis have been well studied, there are still very large gaps in 
our basic understanding of the mechanisms of genomic DNA replication.
HSV-1 DNA is thought to be replicated in two phases by two different mechanisms 
(reviewed by Boehmer & Lehman, 1997). Theta form replication is proposed to be 
employed in a first phase of replication, involving the amplification o f the circular template, 
because the initial accumulation of HSV-1 DNA proceeds more rapidly than would be 
predicted by single event rolling circle replication (Zhang et al., 1994). Ultimately, the 
products of HSV-1 DNA replication are head-to-tail concatemers, suggesting that a second 
phase o f DNA synthesis may be rolling circle replication.
Rolling circle replication has been reconstituted in vitro using a circular 
single-stranded DNA template partially annealed to a complementary strand with a free 
5’-poly-dT tail (Falkenberg et al., 2000). DNA synthesis required only the polymerase 
holoenzyme and the two catalytic subunits of the helicase/primase complex (UL5 and 
UL52). Replication products were double-stranded concatemeric DNA, and competition 
assays demonstrated that leading and lagging strand synthesis occurred concurrently. 
Clearly, the HSV-1 replicative machinery is capable of directing rolling circle DNA 
replication, but the use of such artificial templates cannot provide us with a model for 
initiation, or determine if this method of DNA replication actually occurs during HSV-1 
infection.
Initiation of HSV-1 DNA replication
UL9 is likely to provide the origin-specific function to initiate the formation of a
bi-directional replication fork, as required for theta replication. In the current model for the
origin-specific initiation of HSV-1 DNA synthesis, it is believed that dimeric UL9 binds
cooperatively to each of the two high affinity sites within the origin (boxl and boxl/boxll)
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(Fierer & Challberg, 1992). The two bound dimers are, by virtue of the spacing between 
the binding sites, located on the same side of the DNA helix (Lockshon & Galloway, 1988), 
and the cooperativity of binding of UL9 to the two sites suggests that the bound dimers 
may interact with each other (Fierer & Challberg, 1995). The A/T tract between the bound 
UL9 dimers is distorted and looped out (Koff et al., 1991). The distortion of the origin 
may expose single-stranded DNA which can be bound by UL29. Bound UL29 may interact 
with and stimulate the helicase activity of UL9 which can then unwind the DNA helix (Lee 
& Lehman, 1997), exposing more single-stranded DNA which can be coated with UL29.
Following unwinding of the origin by UL9, the DNA polymerase and the 
helicase/primase complex are probably recruited, possibly involving interactions of UL8 and 
UL42 with UL9 and/or between UL8 and UL30. Recruitment of the HSV-1 DNA 
polymerase to the replication fork may displace UL9 from the origin, allowing the 
helicase/primase to continue to unwind the origin and to lay down primers for DNA 
synthesis on the lagging strand. The interactions amongst the replication fork proteins 
presumably allow coordination of helicase and polymerase activity on the leading strand, 
and primase and polymerase activity on the leading and lagging strand. During theta 
replication, DNA synthesis would proceed in both directions around the circular HSV-1 
genome. UL9 can interact with the cellular polymerase a-primase, and it has been 
proposed that instead of the viral helicase/primase, this cellular enzyme may be responsible 
for synthesising the primer for leading strand DNA synthesis (Lee et al., 1995).
The mechanism for switching from theta to rolling circle replication is unknown, 
however, a late protein product of the UL9 gene, OBPC, may be involved. OBPC contains 
the C-terminal DNA binding domain of the full-length UL9 protein, but it lacks helicase 
activity and is unable to interact with the other HSV-1 replication proteins, thus OBPC can 
function as a potent inhibitor of origin-dependent HSV-1 DNA synthesis (Baradaran et al., 
1996). OBPC could thus enable a switch to rolling circle replication by preventing
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re-initiation of theta replication.
Model systems for rolling circle replication (reviewed by Komberg & Baker, 1992), 
are initiated at a free 3’-OH end on a DNA molecule, generated by cleavage, or ‘nicking’, 
of one strand of a circular DNA duplex. The mechanism for the initiation of rolling circle 
replication in HSV-1 is unknown, however, UL9 may not be required. UL9 has not been 
reported to have any DNA nicking activity, and a virus containing a temperature sensitive 
mutation in UL9 can replicate to wild-type levels if infected cells are shifted to the 
non-permissive temperature late in infection (Blumel & Matz, 1995).
Elongation in rolling circle synthesis is probably similar to that described for theta 
replication, except that a circular DNA strand acts as the template for leading strand 
synthesis, while the displaced concatemeric, single-stranded product of leading strand 
synthesis acts as the template for lagging strand synthesis.
1.3.2 Other herpesviruses encode sequence-specific origin-binding proteins
Other alphaherpesviruses, e.g., VZV, pseudorabies virus, Marek’s disease virus and 
equine herpesvirus 1, encode UL9-like origin-binding proteins which are essential for 
origin-dependent DNA replication, and which have distinct binding sites within their origins 
(Elias et al., 1986; Martin & Deb, 1994; Wu et al., 1996; Dijkstra et al., 1997). The 
degree of similarity between the VZV origin-binding protein (product of gene 51) and the 
HSV-1 origin-binding protein (UL9) is such that the VZV origin-binding protein can 
functionally substitute for UL9 in a transient replication assay (Webster et al., 1995).
The UL9-like origin-binding protein seems to be unique to the Alphaherpesvirinae 
and the roseoloviruses. HHV-6B, a Roseolovirus, encodes an ‘alphaherpesvirus-like’ 
origin-binding protein, the product of the U73 gene (Inoue et al., 1994). The core 
HHV-6B lytic origin is approximately 400 bp in length and contains two binding sites for 
the origin-binding protein, separated by an A/T rich region (Dewhurst et al., 1994). The 
two HHV-6 origin-binding protein binding sites are similar sequences to box I and box II of
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HSV-1 oriS (Inoue et a l, 1994).
Epstein-Barr virus has two distinct origins, oriLyt and oriP. OriP is required to 
maintain a latent infection, during which viral DNA replication is coordinated with the cell 
cycle (Yates et al., 1985; Yates & Guan, 1991). OriP contains a central unwinding element 
flanked by EBNA-1 binding sites. In its ability to bind to specific sites within the origin and 
to facilitate recruitment of the DNA replicative machinery, EBNA-1 is functionally 
equivalent to UL9, although it lacks any intrinsic helicase activity. The replicated products 
of oriP dependent replication are circular molecules, so replication may be exclusively by 
the theta mechanism, (Yates et al., 2000; Ceccarelli & Frappier, 2000). EBV oriLyt and 
lytic-phase DNA replication are described below.
1.3.3 Epstein-Barr virus lytic-phase DNA replication
Lvtic origin
An EBV origin of lytic-phase DNA replication (oriLyt) was first identified in strain 
B95-8 (Hammerschmidt & Sugden, 1988). While in EBV strain B95-8, oriLyt is present 
only once, most other strains of EBV have two functional copies of the oriLyt. OriLyt in 
EBV is larger and more complex than the lytic origins of HSV-1. The core of oriLyt has 
two essential regions, separated by approximately 260 bp, flanked by auxiliary regions 
which contribute to replication efficiency. Part of the larger of the two essential regions of 
oriLyt can be substituted with the HCMV major immediate early promoter/enhancer 
(Hammerschmidt & Sugden, 1988). The minimal essential origin contains seven binding 
sites for the Zta transactivator and two binding sites for the Rta transactivator (Schepers et 
al., 1993a;b). The lytic origin of EBV is represented schematically in figure 1.4.
Lytic-phase DNA replication
Transient replication assays were used to define the EBV proteins required for EBV 
oriLyt dependent DNA replication. Originally, six potential homologues of the HSV-1
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Figure 1.4 Schematic representation o f EBV oriLyt.
A) The positions o f the latent origin o f DNA replication (oriP), the internal repeats (IR) and the 
origins o f lytic DNA replication (oriLyt) within the EBV strain M-ABA genome are shown. 
EBV strain B95-8 contains only the left-hand copy of oriLyt.
B) The EBV oriLyt has two essential regions separated by a dispensable region. The 321 bp 
essential region contains the BHLF1 promoter. The 374 bp essential region contains two short 
A/T rich palindromes and an enhancer element.
C) Notable features o f  the two essential regions include the TATA and CCAAT boxes o f  the 
BHLF1 promoter and binding sites for the viral Zta (ZRE) and Rta (R) transactivators.
These diagrams are adapted from Fixman et al., 1992 and Schepers et al., 1993 (a and b).
replication fork proteins, as well as the three lytic-phase transactivators (Zta, Mta and Rta), 
and a function supplied by the Sail-F fragment of EBV genomic DNA, were identified as 
being essential for oriLyt dependent DNA replication (Fixman et al., 1992). Subsequently, 
it was demonstrated that the function supplied by Sall-F was a uracil-DNA glycosylase 
which was not required when the other replication proteins were expressed constitutively 
(Fixman et al., 1995).
No sequence homologue of the HSV-1 origin-binding protein was identified, but 
when the HSV-1 replication fork proteins were tested for their ability to direct EBV oriLyt 
dependent DNA replication, Zta and Rta were the only EBV encoded proteins which were 
additionally required (Fixman et al., 1995). Mutations of the Zta binding sites within the 
origin prevent origin-dependent DNA replication. Replacing Zta binding sites in oriLyt, in 
an EBV origin-containing plasmid, with binding sites for the bovine papillomavirus-1 E2 
transactivator, abrogated origin function. Replication of this mutated EBV 
origin-containing plasmid was rescued when a chimeric protein consisting of the DNA 
binding and dimerization domain of E2 was fused to the transactivation domain of Zta, thus 
it is thought to be the transactivation domain of Zta which is required for efficient DNA 
replication (Schepers et al., 1993b). The transactivation domain of Zta has subsequently 
been shown to interact with the EBV helicase/primase complex, analogous to the 
interactions between the HSV-1 origin-binding protein and helicase/primase (Gao et al., 
1998).
While this evidence suggests an origin-specific role for Zta in EBV oriLyt 
dependent DNA replication, it is interesting to note that in an omission assay with 
expression plasmids for the six EBV replication fork proteins, the putative uracil DNA 
glycosylase, and the three lytic-phase transactivators, neither Zta nor Rta was absolutely 
essential for DNA replication (Fixman et al., 1995).
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1.4 Human cytomegalovirus DNA replication
In contrast to HSV-1, the mechanism for the initiation of HCMV lytic-phase DNA 
replication and the proteins which serve an origin-specific function remain poorly 
understood. Possible mechanisms for the initiation of oriLyt dependent DNA replication 
will be reviewed in section 1.4.5. Once an HCMV replication fork has been established, 
elongation is assumed to proceed in the same way for HCMV as described for HSV-1, 
utilising the six conserved replication fork proteins (table 1.1). The proteins in HCMV, 
however, have been much less well characterised than their HSV-1 counterparts.
1.4.1 Cytomegalovirus lytic origins of DNA replication
A region of the HCMV genome containing an origin of lytic-phase DNA replication 
was first proposed following the observation that limited DNA synthesis in HCMV infected 
cells treated with ganciclovir was confined to one region of the genome (Hamzeh et al.,
1990). Ganciclovir is active only in HCMV infected cells where it inhibits viral DNA 
synthesis by acting as a chain terminator when incorporated into DNA. Subsequent to the 
identification of the ganciclovir amplified region, lytic origins of DNA replication in murine 
(MCMV), simian (SCMV), rat (RCMV) and human cytomegaloviruses were identified by 
transient replication assays, (Masse et al., 1997; Anders & Punturieri, 1991; Vink et al., 
1997; Anders et al., 1992).
Like the EBV oriLyt, the cytomegalovirus lytic origins studied so far are much 
larger (>1 kbp) and more complex than the HSV-1 origins. All the cytomegalovirus origins 
sequenced to date lie directly upstream of the gene encoding the single-stranded DNA 
binding protein, but share little sequence homology. Several common features are present 
within the cytomegalovirus and roseolovirus (HHV-6) origins, as shown in figure 1.5. 
Although the core origin of HHV-6 is only approximately 400 bp in length, flanking regions 
contribute to origin activity (Dewhurst et al., 1994) and have been included in figure 1.5.
Figure 1.5 Comparisons o f the lytic origins o f the Betaherpesvirinae.
The lytic origins o f  rat cytomegalovirus (A), human cytomegalovirus (B), murine 
cytomegalovirus (C), simian cytomegalovirus (D), and human herpesvirus-6 (E). 
Approximately 1500 bp o f oriLyt is shown for the rat, murine and simian viruses. 
Approximately 2000 bp o f  oriLyt for human cytomegalovirus and 1000 bp o f  oriLyt for HH V6 
are shown.
Sequence blocks show n correspond to regions o f oriLyt which are mainly: 
direct repeats 
indirect repeats 
A/T rich 
G/C rich
as\m metric C rich 
origin-binding protein binding sites 
The structures o f these lytic origins have been described by Masse et al., (1997) and Vink et 
al., (1997).
There are distinct G+C and A+T rich elements and numerous sets of direct and indirect 
repeats, including multiple binding sites for a variety of cellular transcription factors, 
especially Spl binding sites in HCMV and RCMV or AP-2 binding sites in MCMV.
In contrast to the ability of HSV-1 superinfection to direct the replication of a 
transfected VZV origin-containing plasmid (Stow & Davison, 1986), the murine, simian 
and human cytomegalovirus lytic origins lack sufficient similarity to be functionally 
interchangeable (Anders & Punturieri, 1991; Masse et al., 1997).
1.4.2 HCMV oriLyt DNA requirements
As previously described, a region of HCMV containing a putative oriLyt was first 
identified following the observation that limited DNA synthesis was detectable in one 
genomic region in ganciclovir treated cells (Hamzeh et al., 1990). Ganciclovir is 
phosphorylated by HCMV UL97 phosphotransferase (Sullivan et al., 1992; Littler et al., 
1992) and can then be incorporated by the DNA polymerase into the replicating DNA, 
where it acts as a chain terminator. From the structure of the ganciclovir terminated 
DNAs, Hamzeh et al. (1990) were able to conclude that DNA synthesis proceeds 
bidirectionally away from oriLyt. Transient replication assays were subsequently used to 
show that plasmids containing sequences surrounding and including the ganciclovir 
amplified region were replicated in HCMV infected cells, and thus represented a true oriLyt 
(Anders & Punturieri, 1991; Anders et al., 1992). HCMV oriLyt has been examined in 
detail and the minimal core region of the origin was located to an approximately 1.5 kbp 
region between nt 91751 and nt 93299, (Zhu et al., 1998).
The core region of HCMV oriLyt consists of two essential regions (I and II) of 364 
bp and 166 bp separated by an approximately 400 bp non-essential sequence. The central 
non-essential segment and sequences upstream of essential region I contribute significantly 
to origin function, sequences downstream of essential region II contribute less. The 
essential regions of HCMV oriLyt as well as the smallest replicator transcript (SRT) and
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the virus-associated RNAs (vRNAs) are described below and in figure 1.6.
Essential region I (nt 92209 - 92573) contains the ‘Y-block’ element, a 
polypyrimidine tract (nt 92471 - 92501), which is immediately upstream of the region of 
termination of transcription of the SRT (Huang et al., 1996). Origin-containing plasmids 
with mutations in the ‘Y-block’, generated so as to conserve spacing of flanking regions, 
were used to confirm that this element is essential for origin function (Huang et al., 1996). 
Region I also contains numerous repeated sequences, of which a 29 bp repeat consisting of 
an inverted pair of ATF-CREB sites was reported to be the most important component in 
the left half of essential region I (Zhu et al., 1998).
Essential region II (nt 92979 - 93145) has been less intensively studied than region 
I. Region II contains Spl binding sites and has been shown to contribute to SRT promoter 
activity (Huang et al., 1996; Zhu et al., 1998). Region II also contains part of vRNA2 
(Prichard et al., 1998).
vRNAs are two small oriLyt derived RNAs reported to be covalently integrated into 
the origin regions of some packaged HCMV genomes (Prichard et al., 1998). Using the 
data provided for the sizes and spacing of the vRNAs, and the definition of DNA fragments 
which the vRNAs can hybridise to, it is suggested that the 500 nucleotide long vRNAl lies 
between nt 93799 - 94340, and that the 300 nucleotide long vRNA2 lies between nt 92949 
- 93290. vRNA2 is located approximately 250 bp upstream of the transcription start site 
for the smallest replicator transcript (SRT) at nt 92686. Both SRT and vRNA2 are 
complementary to the same strand (Prichard et al., 1998).
SRT refers to a series of non-polyadenylated early transcripts, with a common 5’ 
end and loosely defined 3’ ends, which are transcribed from HCMV oriLyt between nt 
92686 and 92431-92474 (Huang et al., 1996). SRT transcription is cycloheximide 
sensitive but PFA insensitive, and is probably directed by host cell RNA polymerase II, 
under the control of an HCMV activated promoter region between nt 92688 - 92786.
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Figure 1.6 Features o f HCMV oriLyt.
A) The location o f oriLyt within the HCMV genome.
B) The location o f the essential regions (ERI and ERII) (Zhu et al., 1998) and the positions o f  
stably incorporated viral RNA molecules (vRNAs) (Prichard et al., 1998) within HCMV oriLyt.
C) The core o f HCMV oriLyt lies between nt 91751 - 93299 (Zhu et al., 1998). The core o f  the 
origin overlaps both essential regions and vRNA2. The smallest replicator transcript (SRT) refers 
to a series o f RNA molecules transcribed from the origin under the control o f  the SRT promoter 
(Huang e/ al., 1996). The SRT molecules have a common 5' end but variable 3' ends, as 
represented by the arrowhead. Transcription o f SRT terminates at, or shortly downstream of, the 
’Y-block' (Y), a 45 nucleotide long polypyrimidine tract (Huang et al., 1996).
Regions further downstream of the minimal promoter were shown to augment promoter 
activity.
Models for initiation of HCMV oriLyt dependent DNA replication, and possible 
roles for the vRNAs and the SRT will be described later (section 1.4.5). However, it 
should be noted that a deletion (A92574 - 92979) which removed the SRT promoter and 
half of the SRT gene, replicated to 48% of the level achieved by the wild-type origin (Zhu 
et al., 1998). The fact that origin-containing plasmids propagated in bacteria, which 
presumably lack covalently incorporated vRNA sequences, can be replicated, suggests that 
vRNAs are also unlikely to serve an absolutely essential role in the initiation of HCMV 
origin-dependent DNA synthesis.
1.4.3 HCMV DNA replication protein requirements
Replication fork proteins
Pari and Anders (1993) described a set of eleven loci which encode functions 
sufficient (and essential) for HCMV origin-dependent DNA replication in a transient 
replication assay. As expected, the eleven loci included homologues of the six herpesvirus 
conserved replication fork proteins, a DNA polymerase (UL54) and polymerase accessory 
protein (UL44), a single-stranded DNA binding protein (UL57), and three putative subunits 
of a helicase/primase complex (UL70, UL102, and UL105).
The HCMV DNA polymerase and polymerase accessory subunit have sequence
homology with their HSV-1 counterparts (Ertl & Powell, 1992). The catalytic subunit,
UL54, is a 5’-3’ DNA polymerase with 3’-5’ exonuclease activity, and, on the basis of
sequence homology, a possible RNase H activity (Huang, 1975; Nishiyama et al., 1983;
Marcy et al., 1990; Anders & McCue, 1996). The polymerase accessory protein was
originally identified as an early-class DNA binding protein in SCMV infected cells (Gibson
et al., 1981). UL54 and UL44 were expressed in insect cells and were shown to form a
stable complex. Co-expression of UL54 with UL44 resulted in increased processivity
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compared with the activity of UL54 alone (Ertl & Powell, 1992).
Helicase activity is thought to be encoded by UL105 (Smith et al., 1996) and 
primase activity by UL70. These assignments are on the basis that the two loci contain 
conserved catalytic motifs and have extensive sequence homology with their proposed 
HSV-1 counterparts, UL5 and UL52 respectively (Chee et al., 1990; Martignetti et al.,
1991). The UL70 and UL105 proteins are essential for HCMV origin-dependent DNA 
replication, but do not activate expression of the remaining essential replication proteins 
(Anders & McCue, 1996). More recently, a heterotrimeric complex containing UL70, 
UL105 and UL102, analogous to the helicase/primase complex of HSV-1, has been 
purified (Anders & McCue, 1996). UL102 was also shown to be essential for HCMV 
origin-dependent DNA replication, and while the two proteins share obvious sequence 
similarity in only one region, UL102 is believed to be the HCMV helicase/primase 
accessory factor homologous to HSV-1 UL8 (Smith & Pari, 1995a). The HCMV 
single-stranded DNA binding protein homologous to HSV-1 UL29, is UL57 (Kemble et 
al., 1987; Anders, 1990).
Auxiliary loci
The remaining five loci, UL36-38, UL84, UL112-113, UL122-123, and 
IRS1/TRS1, were termed auxiliary loci. The known functions of the HCMV auxiliary 
proteins have been reviewed (Colberg-Poley, 1996; Stenberg, 1996). Four of the five 
auxiliary loci (UL36-38, UL112-113, UL122-123 and IRS1/TRS1) are thought to play key 
roles in transactivating the expression of the replication fork proteins (Iskenderian et al., 
1996). The HCMV auxiliary loci do not include an obvious sequence homologue of the 
HSV-1, HHV-6 or HHV-7 origin-binding proteins. The positions of the auxiliary loci in 
the HCMV genome, and a schematic diagram representing the well characterised 
immediate early and early spliced products of UL36-38 and UL 122-123 (IE 1/2), are shown 
in figure 1.7. The reported functions of the auxiliary loci are described below, and their
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requirements in transient replication assays will be described later (section 1.4.4).
UL36-38 is a complex spliced locus encoding at least four proteins; UL36, UL37, 
UL37xl and UL38 (Kouzarides et al., 1988; Tenney & Colberg-Poley, 1991). The protein 
product of UL36 is a member of the US22 gene family, but the protein has not been 
purified. Two contradictory reports have been published regarding the requirement UL36 
for HCMV growth in tissue culture. It was first shown, using antisense oligonucleotides to 
inhibit splicing of UL36 and UL37 transcripts, that both proteins are required for HCMV 
DNA replication in HF cells (Smith & Pari, 1995b). More recently, however, an HCMV 
recombinant lacking UL36 was shown to have wild-type growth kinetics in HF cells 
(Patterson & Shenk, 1999). UL37 is a transmembrane glycoprotein which shares an 
N-terminal acidic domain with UL37xl; the acidic domain is involved in transcriptional 
activation (Colberg-Poley et al., 1998). No function has yet been assigned to UL38, but 
one early (1.35 kb) and one earlyrlate transcript (2.5 kb) from UL38 have been detected 
(Tenney & Colberg-Poley, 1991).
UL84 is an early protein which has been shown to co-immunoprecipitate with 
IE2-86 from HCMV infected human fibroblast cells (Spector & Tevethia, 1994). More 
recently, purified UL84 has been shown to interact with purified IE2-86 (McCue & Anders,
1998). UL84 does not cooperate with the other auxiliary loci to transactivate expression of 
the replication fork proteins (Iskenderian et al., 1996), rather it has been shown to be a 
strong inhibitor of some IE2 mediated transcriptional activation (Gebert et al., 1997). 
UL84 has also been shown to be essential for the formation of HCMV DNA replication 
compartments (Sarisky & Hayward, 1996), and an abstract was presented at an 
International Herpesvirus Workshop reporting that UL84 could function as an RNA 
endonuclease (Sarisky & Hayward, 1996b), although these latter data have not been 
published.
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The UL112-113 locus encodes four known DNA binding nuclear phosphoproteins, 
some of which are capable of cooperating with IE1/2, UL36-38, and TRS1 to activate 
expression of some HCMV early genes (Iskenderian et al., 1996). At least one product of 
UL112-113 is required for recruiting the replication fork proteins to precursors o f viral 
DNA replication compartments (Ahn et al., 1999).
TRS1 is an immediate early gene, a member of the US22 gene family, mainly 
contained within the short repeat region (terminal) of the genome. IRS1 is mainly 
contained within the short repeat region (internal) of the genome and so is homologous to 
TRS1. The N-terminal 549 aa of IRS 1 (846 aa) and TRS1 (788 aa) are encoded by the 
short repeat regions of the genome. The unique sequences of the two proteins, encoded by 
the short unique region of the genome, retain 55% identity. TRS1 acts together with 
IE2-86 to activate expression of UL44, and can cooperate with other HCMV immediate 
early proteins to activate expression of proteins required for DNA replication (Stasiak & 
Mocarski, 1992; Iskenderian et al.9 1996).
The UL 122-123 locus (expressing the major immediate early proteins, IE 1/2) is the 
most extensively studied of the auxiliary loci. The region encodes at least four immediate 
early proteins and one late protein (Stinski et al., 1983; Jahn et al., 1984; Stenberg et al., 
1984). Major immediate early transcripts are spliced such that IE1 and IE2 have the same 
5’ exons and the proteins share the same 85 N-terminal amino acids. IE 1/2 are 
transcriptional activators which can interact with a number of cellular and viral proteins 
(reviewed by Fortunato & Spector, 1999). The only IE1 protein is IE 1-72, the major IE2 
protein is IE2-86, but mRNAs for IE2-55 and IE2-18 have been seen in infected HF cells 
treated with cycloheximide, and in the case of IE2-18, in infected monocytes (Stinski et al., 
1983; Kerry et al., 1995).
IE2-86 alone can modulate transcription, for example, in repressing expression from 
the major immediate early promoter. IE2 can also act in concert with IE1 to upregulate
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expression of certain viral genes, and can cooperate with other HCMV immediate early and 
early proteins to modulate gene expression (Pizzomo et al., 1988; Stenberg et al., 1990; 
Iskenderian et al., 1996; Gebert et al., 1997). Direct binding to DNA has been 
demonstrated for IE2-86 but not for IE1. However, no single, defined IE2-86 binding 
sequence has been identified (Pizzomo & Hayward, 1990; Arlt et al., 1994; Huang et al., 
1994; Huang & Stinski, 1995; Schwartz et al., 1994; Scully et al., 1995). A 14 bp element
(CGGNgCCG) within HCMV oriLyt is a potential binding site for IE2-86 (Huang et al., 
1996).
IE2-86 appears to have several modes of action. It can modulate expression in a 
promoter dependent fashion by direct DNA binding, by interaction with cellular 
transcription factors, or by interactions with components of the cellular transcriptional 
machinery (Hagemeier et al., 1992, 1994; Caswell et al., 1993; Chiou et al., 1993; Spector 
& Tevethia, 1994; Lang et al., 1995; Schwartz et al., 1996; Yoo et al., 1996). An HCMV 
vims lacking IE1 was shown to have normal growth when it was used to infect HF cells at 
a high multiplicity, showing that IE1 is non-essential for HCMV growth in tissue culture 
(Greaves & Mocarski, 1998). During low multiplicity infection of HF with the HCMV- 
IE1 mutant, there was delayed accumulation of the HCMV polymerase accessory protein 
(compared to wild-type infection) and HCMV replication compartments were not formed. 
It is not known how high multiplicity infection of HF with the HCMV-IE1 mutant 
compensates for the absence of IE1.
Some of the auxiliary loci are involved in modifying nuclear structures within
infected cells, and may therefore be required for the formation of HCMV DNA replication
compartments. Infecting viral DNA is targeted to the nucleus where it accumulates
adjacent to pre-existing nuclear structures called PODs, which are the site of HCMV
immediate early gene expression (Ishov et al., 1997; Ahn & Hayward, 1997). The
distribution of cellular proteins within the PODs is altered as a result of vims infection, and,
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following the dispersal of the PML antigen from the PODs by IE1 (Wilkinson et al., 1998), 
HCMV DNA replication compartments begin to form at the periphery of PODs.
The formation of viral DNA replication compartments has been reported to be 
dependent on the presence of UL84 (Sarisky & Hayward, 1996). Some product of the 
UL112-113 locus has subsequently been shown to cause the redistribution of the HCMV 
DNA polymerase from a diffuse nuclear distribution into distinct compartments (Ahn et al.,
1999). The UL112-113 directed redistribution of UL44 has been shown to be enhanced in 
the presence of the remaining replication fork proteins. Thus, UL112-113 has been 
proposed to function, in part, by recruiting the replication fork proteins to the replication 
compartments (Ahn et al., 1999). IE2 has been shown to become incorporated into 
HCMV DNA replication compartments after dispersal of IE1 (Ahn et al., 1999).
1.4.4 HCMV transient replication assay
Sarisky and Hayward (1996) used HCMV replication proteins supplied from 
plasmids under the control of constitutive promoters and downstream regulatory signals to 
further examine the trans-acting functions with a direct role in HCMV DNA replication. In 
order to further exclude the possibility that any of the auxiliary proteins were solely 
required for efficient gene expression, the UL69 post-transcriptional activator (homologous 
to HSV-1 IE63) was also tested in these assays. The authors examined the ability of 
different combinations of proteins to direct replication of an HCMV origin-containing 
plasmid in transient replication assays in either Vero or HF cells. The published results of 
the transient replication assays (Sarisky & Hayward, 1996) are summarised in table 1.2.
In “omission” assays, all eleven HCMV DNA replication loci and an HCMV 
origin-containing plasmid were transfected together in a transient replication assay, then the 
auxiliary loci were individually omitted from the transfection and the replication of the 
origin-containing plasmid was examined. “Omission” assays were also done in the 
additional presence of the UL69 post-transcriptional activator.
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A)
1. Omission assay in 
Vero cells (no UL69)
2. Omission assay in 
Vero cells (with UL69)
3. Omission assay in 
HF cells (no UL69)
UL84 Essential (1 %) Essential (4 %) Essential (1 %)
UL36- 38 Essential (1 %) 61 % Essential (1 %)
UL112- 113 31 % 29% 39%
IE1 / IE2 5% 77% Essential (1 %)
IRS1 / TRS1 63% 53% 93%
B)
1. Addition assay with 
EBV proteins in Vero
2. Addition assay with HCMV 
proteins and UL69 in Vero cells
UL84 Positive Essential
UL69 Negative Always included
UL36 - 38 Negative Not essential
UL112- 113 Not tested Essential
IE2 Not tested Essential
IRS1 / TRS1 Not tested Not essential
Table 1.2 Requirements for HCMV auxiliary loci in transient replication assays (Sarisky 
& Hayward, 1996). Different combinations o f the five HCMV auxiliary loci were tested for the 
ability to direct replication of a transfected HCMV origin-containing plasmid in Vero or HF cells, 
when all of the replication proteins were constitutively expressed. Replication fork functions were 
provided from expression plasmids specifying the six replication fork proteins o f either EBV or 
HCMV, and where indicated, an expression plasmid for HCMV UL69 was also present. For the 
omission assays (A), the amount of plasmid replicated following the individual omission of one of 
the HCMV auxiliary loci was expressed as a percentage of the amount o f plasmid replicated in 
presence o f all o f the expression plasmids. A plasmid is scored as essential if the signal obtained 
when the plasmid was omitted was less than (or equal to) the signal from the negative control, 
obtained when plasmids for all six replication fork proteins were omitted from the transfection. The 
addition assays (B) were performed in Vero cells using replication fork proteins from plasmids 
specifying the EBV or HCMV proteins. In the assay using EBV replication fork proteins (1), 
replication of the HCMV origin-containing plasmid was observed on addition o f UL84 alone. In the 
assay using the HCMV replication fork proteins (2), replication required other auxiliary loci in 
addition to UL84, so the minimal set o f auxiliary loci required for HCMV origin-containing plasmid 
replication is shown.
In Vero cells, without UL69, omission of UL84 or UL36-38 abrogated replication. 
Omission of IE 1/2 reduced replication efficiency to a very low level. In the presence of 
UL69 in Vero cells, omission of UL84 abolished replication, but none of the other auxiliary 
loci was absolutely essential. An “omission” assay done in HFFF2 cells, without UL69, 
showed that omission of UL84 or UL36-38 or IE 1/2 abrogated replication (table 1.2, panel
A).
An “addition” assay was carried out in Vero cells using the sue HCMV replication 
fork proteins and UL69. Various combinations of auxiliary loci were tested for their ability 
to mediate HCMV origin-containing plasmid replication. In this assay, the minimum 
requirement for replication was the addition of UL84, UL112-113 and IE2 (table 1.2 panel
B).
A third type of assay tested the ability of the constitutively expressed EBV 
replication fork proteins to direct replication of an HCMV origin-containing plasmid in 
Vero cells. Replication was observed on addition of UL84 alone (table 1.2 panel B).
Finally, the formation of HCMV DNA replication compartments by cotransfection 
in Vero cells was shown to be dependent on the presence of UL84. Replication 
compartments were observed following transfection of expression plasmids for the 
replication fork proteins with UL69, UL84, IE2 and UL112-113.
UL69 clearly modified the requirements for the auxiliary loci in these transient 
replication assays, possibly removing the requirement for UL36-38. However, it is 
important to note that it was not identified as one of the eleven loci required for HCMV 
origin-dependent DNA replication in the original transient replication assays (Pari & 
Anders, 1993).
1.4.5 Initiation of HCMV DNA synthesis
Prichard et al. (1998) proposed that HCMV DNA replication may proceed in two 
phases, suggesting that an initial round of amplification might take place in the subset of
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genomes containing covalently incorporated vRNAs. The authors propose that an RNase 
H like enzyme would specifically nick or degrade the RNA moiety of the persistent 
RNA:DNA hybrid, leaving a free 3’ end of RNA or DNA from which DNA synthesis could 
be initiated. The second round of replication is then proposed to be initiated by a 
transcriptional event, as described below, and may use genomes either with or without 
covalently incorporated RNA.
The results described above (section 1.4.4), regarding the absolute requirement for 
UL84 in HCMV oriLyt dependent DNA replication, the reported RNA endonuclease 
properties of UL84 protein, and the discovery of origin derived transcripts (SRT), have led 
to the proposal that UL84 may be involved in the initiation of the second phase of 
replication (Prichard et al., 1998) which might proceed by a mechanism similar to the 
initiation of mitochondrial heavy strand DNA replication.
The two strands of mitochondrial DNA are not replicated simultaneously. Initially, 
RNA synthesis proceeds from the light strand promoter located near the mitochondrial 
‘D-loop’ region. If transcription continues around the template, an RNA transcript is 
released. Alternatively, the transcript may be processed once it has crossed the origin of 
heavy strand DNA synthesis (O h ) within the ‘D-loop’. Cleavage of the RNA at Oh is 
carried out by a nuclear-encoded, site-specific mitochondrial RNA processing enzyme 
(reviewed in Komberg & Baker, 1992). A stable RNA.DNA hybrid can be formed 
between the primer RNA transcript and the GC rich sequence at O h, and DNA synthesis
can proceed. Hybrid formation is not only dependent on the GC rich sequence, but also on 
the mitochondrial RNA polymerase, as heterologous RNA polymerases can synthesise the 
transcript, but not promote hybrid formation (Xu & Clayton, 1995).
By analogy with mitochondrial heavy strand initiation, it is proposed that the SRTs 
form stable hybrids with the origin sequences at the ‘Y-block’, and that an RNA 
endonuclease, possibly encoded by UL84, cleaves the RNA strand of the hybrid leaving a
short RNA with a free 3’-OH which can be used to prime DNA synthesis.
In the initiation of mitochondrial heavy strand DNA synthesis, RNA:DNA hybrid 
formation is not simply a function of the RNA and DNA sequences (Xu & Clayton, 1995), 
it specifically requires transcription to be directed by the mitochondrial RNA polymerase. 
An alternative role for UL84 might therefore be to stabilise the HCMV RNA:DNA hybrid 
at oriLyt.
The differences in requirements for the remaining HCMV auxiliary loci in HF and 
Vero cells (Sarisky & Hayward, 1996) is possibly related to the presence of different host 
cell transcription factors being involved in SRT synthesis in the different cell lines. The 
requirement for IE1/IE2 in HF cells (Sarisky & Hayward, 1996) may be associated with the 
presence of potential IE2-86 binding sites in the origin (Huang et al., 1996).
With such a complex origin region, and differing requirements for trans-acting 
factors in different cell lines, as well as the cell type specific differences seen in IE gene 
expression, it seems possible that there may not be a single unique mechanism for the 
initiation of HCMV DNA replication. If the transcription of the SRT is involved in the 
priming of DNA synthesis, it is possible to envisage that the promoter can be activated by 
various combinations of cellular and/or viral proteins.
While the mechanism of initiation of HCMV origin-dependent DNA synthesis has 
not been identified, the evidence reviewed here strongly implicates UL84 as serving an 
essential origin-specific function. Four of the five HCMV auxiliary loci, but not UL84, are 
required for efficient early gene expression, and UL84 was the only auxiliary protein which 
was absolutely essential for HCMV origin-dependent DNA synthesis in transient replication 
assays. UL84 was the only HCMV protein tested which was able to direct replication of a 
transfected HCMV origin-containing plasmid by the EBV replication fork proteins. Sarisky 
and Hayward (1996), reported that UL84 was obligatory for origin-dependent DNA 
amplification and suggested that it was “a key viral component in promoting the initiation
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of HCMV oriLyt-directed DNA replication”.
1.5 Range of cells permissive for HCM V infection in vitro
HCMV DNA replication has been difficult to study partially due to the restricted 
range of easily manipulated, fully permissive cell lines available. While in vivo, HCMV can 
infect almost all organ systems, the virus can normally be propagated in vitro only in human 
fibroblast cell lines such as HFL1 (human foetal lung) and HFFF2 (human foetal foreskin 
fibroblast). HCMV has also been reported to infect a wide range of other cell types in 
vitro, although the infection tends to be abortive (reviewed by Sinzger & Jahn, 1996). It 
has been shown that the growth restrictions in tissue culture may be partly due to passaging 
laboratory stocks in fibroblast cells (Waldman et al., 1989; Brown et al., 1995; Sinzger et 
al., 1999). Passaging HCMV in tissue culture may be associated with gross changes, 
especially large-scale deletions, within the virus genome (Cha et al., 1996), and loss of 
certain genes may, as seen for MCMV (Cavanaugh et al., 1996) result in altered cell 
tropisms.
An early investigation into the range of cell types permissive for HCMV infection 
showed that three HCMV strains could abortively infect primary bovine embryonic 
fibroblasts, and productively infect Vero cells (Waner & Weller, 1974). Later it was 
demonstrated that only a small fraction of HCMV infected Vero cells supported 
immediate-early gene expression, but that no viral DNA replication was detected 
(LaFemina & Hayward, 1988). LaFemina and Hayward (1988) conducted a 
comprehensive investigation into cytomegalovirus immediate-early gene expression and 
DNA replication in a variety o f cell lines. Twenty-one cell lines were examined for their 
ability to support the replication of HCMV strain Towne, SCMV strain Colburn and 
MCMV strain Smith. The results of this investigation with respect to HCMV infection are 
summarised in table 1.3.
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Human
Simian
Murine
Table 1.3 IE gene expression and DNA replication in HCMV strain Towne infected 
cells. Adapted from LaFemina & Hayward, 1988.
(a) levels of IE gene expression determined by synthesis of35S-methionine labeled IE68 
after cycloheximide reversal in cells infected with 50 p.f.u./cell of HCMV.
(b) levels of DNA replication determined by synthesis of 32P-labelled HCMV genomic 
DNA in cells infected with 20 p.f.u./cell of HCMV
HCMV infection of HF cells defines the fully permissive ++++ level of synthesis.
+++ denotes a level of replication which is 30 - 70 % of the fully permissive level.
++ denotes a level of synthesis which is 10 - 30 % of the fully permissive level.
+ denotes a level of synthesis which is 3 - 10 % of the fully permissive level.
- denotes a level of synthesis which is less than 3 % of the fully permissive level.
ND, not done.
Cell type infected Characteristics_________________________ IE (a) DNA (b)
HF Diploid fibroblast i I I I ++++
NT2/D1 Teratocarcinoma - -
NT2/D1 +RA Retinoic acid differentiated NT2/D1 + + + + + +
143 Osteosarcoma, TK- -H-+ +
MG63 Osteosarcoma + + + +
PBL Peripheral blood lymphocytes - -
FOS Megakaryocyte-like - -
HL60 Premyelocytic leukaemia - -
NBE HF, SV40 T Ag+ - -
293 HEK, Adenovirus E1A+ - -
AGMKF African green monkey kidney fibroblasts ++ -
CyMF Cynomolgous monkey fibroblasts ++ -
RhMF Rhesus monkey fibroblasts ++ -
Vero AGMK, immortalised - -
CV1 AGMK, immortalised ND ND
MEF Mouse embryo fibroblasts ++ -
BALB/C-3T3 Mouse, immortalised t m -
F9 Mouse teratocarcinoma - -
PYS Parietal yolk sac, transformed - -
Ltk- Mouse, transformed TK- - -
Only four human cell lines; HF, two osteosarcoma cell lines (143 and MG63) and a 
retinoic acid-differentiated teratocarcinoma cell line (NT2/D1), supported HCMV DNA 
replication. Ten of the cell lines examined supported immediate-early gene expression. 
These include three murine and three simian cell lines in addition to the four human cell 
lines previously mentioned. The block to immediate early gene expression has not been 
clearly identified as, at least in ‘non-permissive’ 293 and Vero cells, immediate-early 
proteins were synthesised following transfection of a plasmid encoding the HCMV major 
immediate-early proteins under the control of the HCMV major immediate-early promoter 
and downstream regulatory signals (LaFemina & Hayward, 1988).
Interestingly, SCMV and MCMV were more promiscuous in their ability to 
replicate in cell lines of heterologous species than HCMV. Treatment of some cells in 
tissue culture, e.g., NT2 human teratocarcinoma, with retinoic acid or short chain fatty 
acids (e.g. sodium butyrate or sodium proprionate) sometimes rendered cells more 
permissive to infection with HCMV (LaFemina & Hayward, 1986; Wu et al., 1994)..
HCMV has been shown to productively infect primary chimpanzee skin fibroblasts 
(Perot et al., 1992), and human trophoblasts (Hemmings et al., 1998). HCMV can also 
infect bone marrow stem cells, although virus is only produced following cell differentiation 
(M intons al., 1994).
1.6 Aims of this project
My aim in this project was to investigate the initiation of HCMV origin-dependent 
lytic-phase DNA replication. Since, at the time I began this project, UL84 seemed the most 
likely HCMV product providing an origin-specific function, my initial objective was to 
investigate its role in the initiation of origin-dependent DNA synthesis. In order to have an 
assay for UL84 function, I first attempted to set up the assay of Pari and Anders (1993) 
using transient transfection of an HCMV origin-containing plasmid with plasmids 
expressing the six HCMV replication fork proteins and the five auxiliary loci in HF cells.
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My attempts to establish the Pari and Anders assay in HF cells were unsuccessful. I 
therefore tested the ability of other cell lines to support HCMV origin-dependent DNA 
synthesis. I also used heterologous replication fork proteins, supplied by HSV-1 plasmids 
or virus superinfection, or supplied by SCMV superinfection, to set up alternative assays to 
investigate the initiation of HCMV origin-dependent DNA synthesis.
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C hapter 2: M aterials and M ethods
2.1 Materials
2.1.1 Chemicals and reagents
Most chemicals were obtained from BDH Laboratory supplies, Poole, Dorset and 
were of AnalaR grade.
Other sources of chemicals and reagents are listed:
Boehringer Mannheim GmbH, Germany Tris base
Melford Laboratories Ltd., Suffolk caesium chloride
Prolabo, Fontenay Sur Bois boric acid, chloroform, glacial
acetic acid, glycerol, 
isopropanol, methanol, 
sodium chloride
Sigma Chemicals Company, St. Louis, Mo. bovine serum albumin,
chloramphenicol, deoxyribonucleic 
acid (calf thymus), ficoll, 
hepes, isoamyl alcohol, 
phosphonoformic acid, 
polyvinylpyrrolidone,
Triton X-100
2.1.2 Enzymes
Most restriction enzymes were obtained from Boehringer Mannheim. Other 
sources of enzymes are listed:
Boehringer Mannheim proteinase K
New England BioLabs (NEB) DNA polymerase I, T4 DNA ligase,
T4 DNA polymerase
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itoEII, Dpnll, Dpnl, SexAl, ScrFl 
Sigma deoxyribonuclease I (DNase I)
hen egg white lysozyme, protease XIV 
ribonuclease TI (RNase TI) 
ribonuclease A (RNase A)
2.1.3 Radiochemicals
a - 32P deoxyribonucleoside triphosphates (dNTPs) were obtained from Amersham 
at 3000 Ci m M ole1 (10 pCi p i_1)
2.1.4 Plasmids
The following plasmids were obtained from D Anders at the Department of 
Biomedical Sciences, SUNY, New York (Pari & Anders, 1992). The plasmids express the 
HCMV DNA replication proteins under the control of their native promoters and 
downstream signals, the HCMV strain AD 169 DNA fragments are cloned into pGEM7zf. 
pZP3 IRS 1 locus (nt 189500-193108)
pZP8 UL36-38 locus (nt 42045-53104)
pZP13 UL84 locus (nt 120505-123363)
pZP24 UL112-113 locus (nt 159699-163028 and 163950-164152)
pSVH UL122-123 major immediate early locus from HCMV strain Towne
pSP50 HCMV origin-containing plasmid (nt 89795-94860)
pZP7 UL44 Polymerase accessory protein (nt 54118-56701)
pZP18 UL102 Helicaserprimase accessory protein (nt 146036-151125)
pZP20 UL105 Helicase (nt 150312-155121)
pZP29 UL70 Primase (nt 99700-103827)
pZP33 UL54 DNA polymerase (nt 76642-81435)
pZP37 UL57 single-stranded DNA binding protein (nt 78262-92576)
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The nucleotide coordinates used here, and throughout this thesis, are from the 
published sequence for HCMV strain AD 169 in GenBank accession number X I7403, 
(http://www2.ncbi.nlm.nih.gov/irx/cgi-bin/birx_doc7genbankH-5340494), unless otherwise 
noted.
pMAl contains a 6.8 kbp oriLyt fragment of HCMV strain Towne in pUC18, this 
was obtained from M McVoy, Department of Pediatrics, Medical College of Virginia, 
Richmond Virginia.
pCMVIO is based on pUC19, and contains a multiple cloning site immediately 
downstream of the human cytomegalovirus major immediate early promoter, as well as 
simian virus 40 (SV40) splicing and polyadenylation signals (Stow et al., 1993). pElacZ 
contains a p-galactosidase open reading frame cloned into pCMVIO.
Plasmids expressing the HSV-1 core replication machinery were obtained from N 
Stow. The following HSV-1 replication plasmids consist of the open reading frame cloned 
from HSV-1 strain 17 +, into pCMVIO (Stow et al., 1993):
pE5 HSV-1 UL5 helicase
pE8 HSV-1 UL8 helicase-primase accessory factor
pE29 HSV-1 UL29 single stranded DNA binding protein
pE30 HSV-1 UL30 polymerase
pE42 HSV-1 UL42 polymerase accessory factor
pE52 HSV-1 UL52 primase
Plasmids containing fragments of VZV (Dumas strain) DNA were obtained from N 
Stow, Institute of Virology, Glasgow. pV02 containing a VZV lytic origin of DNA 
replication cloned into pAT153 has been previously described (Stow & Davison, 1986). 
pEV51 and pEV51R contain the open reading frame for the VZV origin binding protein in 
the forward or reverse (pEV51R) orientation expressed from pCMVIO.
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pCMVIO, pElacZ and pAT153 (derived from pBR322) were obtained from N 
Stow, Institute of Virology, Glasgow. A pAT153 derived plasmid containing the HindWl 
D fragment of HCMV DNA was obtained from D Dargan, Institute of Virology, Glasgow.
2.1.5 Eukaryotic cells and culture media
Tissue culture media, antibiotics and supplements were obtained from Gibco BRL 
unless stated otherwise. Foetal calf serum (catalogue number 10106-169) and new-born 
calf serum (catalogue number 16010-084) were obtained from Gibco BRL and are 
mycoplasma and virus free. Most cell lines were obtained from J Mitchell in the cytology 
department in the Institute of Virology.
The original source of the cells and the passage numbers at which they were used in 
experimental work are listed:
BHK 21 C13 Syrian hamster kidney fibroblasts
from N Stow, used at passage 25-50 
CV-1 African green monkey kidney fibroblasts
from EC ACC, used up to passage 30 from recovery 
HFL1 human embryonal lung fibroblasts
from Flow, used at passage 21-40 
HFFF2 human foetal foreskin fibroblasts
from ECACC, used at passage 15-40 
U-373 MG human glioblastoma astrocytoma
from ECACC, used up to passage 30 from recovery 
293 human embryonal kidney cells transformed with sheared Ad5 DNA
from G Brown, used at passage 10-30 
Vero African green monkey kidney fibroblasts
from ECACC, used at passage 20-40 
The ECACC is the European cell and culture collection at Porton Down, Salisbury.
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Wash (DPS) is Dulbecco’s modified Eagle’s medium supplemented with 100 U ml'1 
penicillin and 100 pg ml"1 streptomycin.
HFL1 and HFFF2 were cultured in DPS supplemented with 10% foetal calf serum 
and 2 mM L-glutamine (DC 10). U-373 MG were cultured in DC 10 medium supplemented 
with lmM sodium pyruvate MEM.
BHK 21 C l3, CV-1, Vero and 293 were cultured in BHK medium supplemented 
with 100 U ml'1 penicillin and 100 pg ml'1 streptomycin and 10% foetal calf serum (EC 10) 
or 5% foetal calf serum (EC5) during transfections.
Transfection medium is DPS supplemented with 5% foetal calf serum (DC5). 
Transfection medium was supplemented with lmM sodium pyruvate for U-373 MG cells.
Human fibroblast (HF) methyl-cellulose overlay is 0.9x Dulbecco’s modified 
Eagle’s medium containing 100 U ml'1 penicillin, 100 pg ml"1 streptomycin, 1.5 % 
carboxy-methyl-cellulose, 10 % foetal calf serum, 1 mM sodium pyruvate and lx 
non-essential amino acids. BHK 21 C l3 methyl-cellulose overlay is 0.9x Glasgow modified 
Eagle’s medium containing 100 U ml'1 penicillin, 100 pg ml'1 streptomycin, 1.5 % 
carboxy-methyl-cellulose, and 5 % new-born calf serum.
Trypsin is 0.25% trypsin in Tris-buffered saline (TS) supplemented with 100 U ml'1 
penicillin, 100 pg ml'1 streptomycin and 15 pg ml'1 phenol red. Versene is 0.02% EDTA 
and 15 pg ml'1 phenol red in phosphate-buffered saline A (PBS-A). Versene/trypsin is a 4:1 
(v/v) mixture.
Storage medium is Dulbecco’s modified Eagle’s medium (or Glasgow modified 
Eagle’s medium for BHK 21 C l3 cells) with foetal calf serum and glycerol in a 5:4:1 v/v 
ratio.
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2.1.6 Viruses
The following herpesvirus strains were used in the experimental work:
Herpes simplex virus type 1 strain 17+ was obtained from Institute of Virology
stocks.
Cytomegalovirus strains AD 169 and Towne were obtained from D Dargan. 
Cytomegalovirus strain Colburn was obtained from A S Tyms, London. Cytomegalovirus 
strain Colburn was originally isolated from a human brain (Huang et al., 1978). Despite its 
isolation from a human brain, the virus is most similar to an African green monkey 
cytomegalovirus and it is usually referred to as SCMV (Gibson, 1983).
2.1.7 Prokaryotic cells and culture media
Most plasmids were maintained in Escherichia coli strain DH5a. Bacteria used for 
the production of unmethylated plasmid DNAs were Escherichia coli strain SCSI 10 which 
has mutant alleles for DNA adenine methylase and DNA cytosine methylase. Competent 
SCS110 cells were obtained from Stratagene, UK.
L-broth is 1% w/v NaCl, 1% w/v Difco tryptone, 0.5% w/v Difco yeast extract in 
distilled water. LB agar is L-broth containing 1% w/v Difco bacto agar.
2.1.8 Solutions
The compositions of solutions in routine use are described:
blot wash 2x SSC, 0.1% w/v SDS
boiling mix 6% w/v SDS, 30% v/v stacking gel buffer,
30% v/v glycerol, 0.3% w/v bromophenol
blue, 210 mM p-mercaptoethanol
calf thymus DNA (blotting) 2 mg ml'1 in TE pH 8.0, denatured by
boiling for 20 minutes
calf thymus DNA (transfection) 3 mg ml'1 in TE pH 8.0, proteinase K treated
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2x cell lysis buffer (2x CLB)
Chloroform:isoamyl alcohol 
50x Denhardt’s solution
DNase dilution buffer 
5x DNA loading dyes
gel soak I 
gel soak II
hybridisation mix (final concentrations)
hepes buffered saline (HeBS)
IE1/IE2 wash (PBS-T) 
IE1/IE2 antibody diluent 
IE1/IE2 block 
IF fix
IF permeabilisation buffer 
lacZ fix
10 mM Tris-HCl (pH 7.5), 1.2% w/v SDS,
1 mM EDTA (pH 8.0)
24:1 chloroform: isoamyl alcohol 
1% w/v BSA, 1% w/v ficoll 400,
1% w/v polyvinylpyrrolidone
50% v/v glycerol, 50 mM NaCl
5x running buffer with 50% w/v sucrose,
0.25% w/v bromophenol blue
0.6 M NaCl, 0.2 M NaOH
0.6 M NaCl, 1.0 M Tris-HCl (pH8.0)
5x Denhardt’s solution, 0.05% w/v SDS,
1 mM EDTA (pH8.0), 6x SSC,
20 mMTris-HCl (pH7.5),
50 pg ml"1 calf thymus DNA (blotting)
21 mM hepes, 137 mM NaCl, 5 mM KC1,
0.7 mM Na2HP04, 5.5 mM D(+)glucose, 
adjusted to pH 6.95 -7.15 with NaOH 
0.005% Tween in PBS
1% (w/v) BSA in IE1/IE2 block 
5% (w/v) Marvel in PBS-T
2 % (v/v) formaldehyde, 2 % (v/v) sucrose in 
PBS
0.5 % NP40 (v/v), 10 % (w/v) sucrose in PBS 
2 % (v/v) formaldehyde, 0.2 % (v/v) 
glutaraldehyde in PBS
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lacZ stain
20x Loening’s buffer
lOx nick translation buffer (lOx NTB)
phosphate buffered saline A (PBS-A) 
phosphate buffered saline complete (PBS)
pre-hybridisation buffer
protease (Sigma XIV) 
proteinase K
reticulocyte standard buffer (RSB)
200x RNase
Resolving gel buffer (4x)
Sample buffer 
Stacking gel buffer (4x)
5 mM potassium ferricyanide, 5 mM 
potassium ferrocyanide, 2 mM MgCl2,
0.5 mg m l1 X-Gal in PBS 
815 mM NaH2P 04, 720 mM Tris,
20 mM EDTA
500 mM Tris-HCl (pH 7.5), 10 mM DTT 
100 mM MgS04, 0.1 mM dATP,
0.1 mM dTTP, 0.5 mg ml"1 BSA 
170 mM NaCl, 3.4 mM KC1,
10 mM Na2HP04, 1.8 mM KH2P 04 
170 mM NaCl, 3.4 mM KC1,
10 mM Na2HP04, 1.8 mM KH2P 0 4,
6.8 mM CaCl2, 4.9 mM MgCl2 
6x SSC, 5x Denhardt’s solution,
0.1% w/v SDS, 20 pg ml'1 calf thymus 
DNA (blotting)
20 mg ml'1 in TE (pH 7.5), pre-digested 
for 1 hour at 37°C 
20 mg ml'1 in TE (pH 7.5)
10 mM Tris-HCl (pH 7.5), 10 mM KC1,
1.5 mM MgCl2
10,000 U ml"1 ribonuclease TI,
1 mg ml'1 ribonuclease A in TE (pH 7.5)
1.5 M Tris-HCl (pH 8.9), 0.4% w/v SDS 
30% v/v boiling mix
488 mM Tris-HCl (pH 6.8), 0.4% w/v SDS
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3 M NaCl, 300 mM trisodium citrate 
8% w/v sucrose, 0.5% v/v Triton X-100,
10 mM Tris-HCl (pH8.0), 50 mM EDTA 
250 mM sucrose, 2 mM MgCl2,
50 mM Tris-HCl (pH 7.5)
2 M Tris-acetate, 100 mM EDTA 
52 mM Tris, 53 mM glycine, 0.1% w/v SDS 
890 mM Tris, lOmM EDTA,
890 mM boric acid 
10 mM Tris-HCl (pH 7.5),
1 mM EDTA 
10 mM Tris-HCl (pH8.0),
1 mM EDTA
10% w/v PEG 3350, 10 mM MgCl2,
10 mM MgSC>4 in L-broth 
137 mM NaCl, 5 mM KC1,
5.5 mM D(+)glucose, 0.7 mM Na2HP04,
25 mM Tris-HCl (pH 7.4)
0.5% v/v Triton X-100,
62.5 mM EDTA (pH 8.0),
50 mM Tris-HCl (pH 8.0)
2.1.9 Antibodies
The following antibodies and detection reagents were obtained from Sigma 
Immunochemicals (unless otherwise indicated) and were used at the stated dilutions.
A polyclonal antibody to the HCMV major immediate early proteins was obtained 
from D Dargan, Institute of Virology, Gasgow. This was used at a 1:5 dilution.
20x standard saline citrate (20x SSC) 
STET buffer
sucrose reagent
50xTAE 
Tank buffer 
lOx TBE
TE (pH 7.5)
TE (pH8.0)
transformation and storage buffer (TSB) 
Tris buffered saline (TS)
Triton reagent
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Protein-A peroxidase: 1:1000
Goat anti-mouse IgG (Whole molecule) Cy™3 conjugate from Amersham
Pharmacia Biotech: 1:500
D42 is a mouse monoclonal antibody to HCMV UL84 protein obtained from E S 
Huang, Department of Medicine, University of North Carolina at Chapel Hill, North 
Carolina (unpublished). This was used in immunofluorescence at a 1:500 dilution.
2.1.10 Miscellaneous materials
Hybond-N and sephadex G-50 were obtained from Amersham Pharmacia Biotech.
3 mm filter paper was obtained from Whatman International Limited.
The phosphorimaging screens and scanner system were from BioRad.
Dialysis tubing was obtained from Medicell International Limited.
BEEM capsules and reagents used in preparation of samples for electron 
microscopy were from TAAB laboratories.
2.2 Methods
2.2.1 Growth and maintenance of eukaryotic cells
Cell culture
Cells were grown in 175 cm2 flasks containing 50 ml of the appropriate medium. 
Unless otherwise stated, cells were maintained at 37°C in an atmosphere containing 5% 
C 02. Cells were harvested at 95-100% confluency by washing once with versene and once 
with versene/trypsin (293 cells were given two versene washes without trypsin) followed by 
resuspension in 9 ml of growth medium. Cells were split 1:8-1:6 for faster growing cells 
(BHK 21 C13 and Vero) or 1:6-1:4 for slower growing cells (CV-1, HFL1, HFFF2, U-373 
MG and 293).
Cells were seeded into 35 mm petri dishes at approximate densities of 2x105 (Vero,
or BHK 21 C13), 4xl05 (293 or CV-1) or 6xl05 (HFFF2, HFL1 or U-373 MG) cells in 2
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ml growth medium (DC 10 or EC 10) to be approximately 80 - 90% confluent at the time of 
transfection or infection. Cells were incubated for approximately 16-24 hours prior to use.
Cells for use in immunofluorescence were seeded into 35 mm petri dishes 
containing sterile coverslips (13 mm diameter). Cells were routinely screened for the 
presence of mycoplasma by J Mitchell, and were never found to contain any mycoplasma.
Cell storage and recovery
Cells were harvested at 85-90% confluency, as described above. Cells were 
resuspended in 10 ml of storage medium and aliquoted in 1.5 ml amounts into cryo-storage 
vials and frozen slowly at -70°C before being transferred to liquid nitrogen for long term 
storage.
Cells were recovered from liquid nitrogen by warming to room temperature and 
seeding into a 25 ml flask containing 10 ml of growth medium and incubated as described.
2.2.2 Growth and maintenance of virus stocks
Growth, titration and storage of cytomegalovirus strains AD 169. Towne and Colburn
Growth medium from flasks of HFFF2 cells at 80-90% confluency was replaced 
with 50 ml fresh growth medium containing approximately 1x10s p.f.u. of the appropriate 
strain of cytomegalovirus and incubation was continued. At three days post infection, the 
inoculum was discarded and 30 ml of fresh medium was added. Medium containing virus 
was collected at 9, 11, 13 and 15 days post infection by decanting into sterile tubes. Fresh 
medium was added to each flask. Cell debris was pelleted by centrifugation at 2000 rpm 
(Beckman GPR centrifuge) for 10 minutes at room temperature. Virus was aliquoted and 
stored at -70°C in glass vials.
High titre stocks of AD 169 were obtained by pelleting virus for 2 hours at 12000 
rpm in a GSA rotor (Sorvall) and resuspending the pellet in 1/3 0th the original volume 
DC10.
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Stocks of AD 169 and Towne were not obviously unstable over several cycles of 
freeze/thawing. Colburn stocks were less stable and once thawed were not refrozen.
Cytomegaloviruses were titrated on 90% confluent HFFF2 monolayers in 35 mm 
dishes. Cells were infected with 100 ql of virus serially diluted in DPS. Adsorption was 
for 45 minutes at 37°C. Following adsorption, cells were overlayed with 2 ml growth 
medium and incubation was continued for 5-7 days. When cytopathic effect was first 
observed in cells infected at the highest multiplicity, growth medium was replaced with 2 ml 
of HF methyl-cellulose overlay and incubation was continued for a further 5-7 days. Cells 
were stained by direct addition of 1.5 ml Giemsa stain containing methanol to the 
methyl-cellulose overlay followed by incubation for 48 hours at 4°C. Plaques were counted 
on a dissecting microscope following removal of Giemsa stain and inactivated virus by 
washing with water.
Growth, titration and storage of HSV-1
Medium from BHK 21 C13 cells at approximately 80% confluency in 175 cm2
flasks was replaced with 4 ml of DC5 containing approximately 4x106 pfu of HSV-1 strain
17+. Virus was adsorbed to the monolayer for 45 minutes at 37°C. 40 ml medium was
added per flask and incubation was continued for approximately four days at 31°C.
Cells were harvested by gently tapping the flask then decanting the medium into a
sterile falcon tube. Cell debris was pelleted by centrifugation at 2000 rpm (Beckman GPR
centrifuge). Supernatant was decanted into a sterile GSA bottle. Virus was pelleted from
the supernatant by centrifugation at 12000 rpm (Sorvall GSA rotor) for 2 hours at 4°C.
The pellet was resuspended by sonication in 1/10th volume of DC5. Aliquots were frozen
and stored at -70°C in glass vials as cell released virus (CRV).
The cell pellet was resuspended in l/5th volume of EC5. The resuspended cells
were extensively sonicated to release cell associated virus (CAV). CAV was cleared by
centrifugation for 2 minutes at 2000 rpm (Beckman GPR centrifuge), supernatant was
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aliquoted and stored in glass vials at -70°C.
Monolayers of BHK 21 C13 cells were infected with 100 pi of virus serially diluted 
in wash. Adsorption was for 45 minutes at 37°C and 5% CO2 . Following adsorption, cells 
were overlayed with 2 ml BHK methyl-cellulose overlay and incubation was continued for a 
further 2-3 days. Overlay was removed and cells were stained by addition of Giemsa stain 
to the plates for 48 hours at 4°C. Plaques were counted on a dissecting microscope 
following removal of Giemsa stain by washing with water.
2.2.3 Growth, maintenance and manipulation of prokaryotic cells
Growth and storage of E. coli
Starter cultures of E. coli strain DH5a or SCSI 10 were grown overnight at 37°C 
by inoculation of 5 ml L-broth, containing appropriate antibiotic, with approximately 5 pi 
of a DMSO stock. DMSO stocks were prepared by freezing 900 pi saturated bacterial 
culture with 100 pi DMSO. DMSO stocks were stored at -70°C.
Preparation and transformation of competent E. coli (Chung et al., 1988)
An overnight culture of bacteria grown in the absence of antibiotic was used to 
inoculate 50 ml of L-broth. The culture was grown at 37°C with shaking until the 
exponential growth phase was reached. Bacteria were pelleted in sterile falcon tubes at 
2500 rpm (Beckman GPR centrifuge) for 10 minutes at 4°C. Supernatant was discarded 
and the bacterial pellet was resuspended in 1/10th volume of ice-cold TSB:DMSO and 
incubated at 4°C for 10 minutes. Competent bacteria were immediately aliquoted (100 pi) 
into sterile vials and flash-frozen in dry ice with ethanol. Aliquots were stored at -70°C 
until required.
Competent bacteria were thawed by hand. Plasmid DNA was added to the cells (no
more than 1 pg per aliquot) and cells were incubated at 4°C for 30 minutes. 900 pi of
TSB:DMSO:glucose was added to the cells which were subsequently incubated at 37°C
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with shaking for one hour. Bacteria were plated onto LB agar plates containing an 
appropriate antibiotic, and transformants were selected.
Storage and transformation of commercially available cells
Competent E. coli strain SCSI 10 cells were used to produce unmethylated plasmid 
DNA. These cells were stored at -70°C until required. Cells were transformed according 
to the manufacturer’s (Stratagene) protocol, and transformants were selected.
Selection of transformed bacteria
Transformed bacteria were plated onto solid LB agar plates containing an 
appropriate antibiotic and incubated overnight at 37°C. Overnight cultures were then set 
up by ‘picking’ colonies into L-broth containing an appropriate antibiotic. DNA was 
prepared by the STET method (as described in section 2.2.6), then screened by restriction 
endonuclease analysis.
2.2.4 Manipulation of plasmid DNA
The following is an outline of the techniques used to produce the novel plasmids 
described in this thesis. The origin-containing plasmids, pCMVori, pCMVoriAXhoI, 
pADori, and pADoriAXhoI, are based on pCMVIO and pAT153 and contain HCMV DNA 
fragments subcloned from the Hindlll D fragment of HCMV strain AD 169 obtained from 
D Dargan. These origin-containing plasmids are described in figure 2.1.
Restriction enzyme digestion for cloning DNA fragments
Approximately 20 pg of plasmid DNA was incubated for 3 hours with 50 units of 
the desired restriction enzyme in 100 pi of the appropriate restriction buffer (lx) and at the 
optimum temperature for the enzyme. The digest was extracted once with phenol, once 
with chloroform:isoamyl alcohol, then finally ethanol precipitated and resuspended in TE 
pH 7.5.
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Figure 2.1 HCMV origin containing plasmids.
A) The HCMV HindXW D fragment spans nt 84864 - 107677. The location o f recognition 
sequences for 4^^ /11 (A) and ZN/EII (B) are shown.
B) The 2.8 kby AatW-BstEW fragment (nt 91321-94168) was inserted into HindlU digested 
pCMV 10 to generate plasmid pCMVori.
C) pCMVori was digested withATwI to remove a 1.2 kbp fragment (nt 92636-93799), 
generating plasmid pCMVoriAXho
D) The 2.8 kbp of HCMV DNA spanning oriLyt were subcloned from pCMVori into Himilll 
digested pGEM7, creating plasmid pADori.
E) The 1.4 kbp o f HCMV DNA spanning the deleted oriLyt were subcloned from 
pCMVoriAXho into HindlU digested pGEM7, creating plasmid pADoriAXho.
The orientation o f the HCMV major immediate early promoter in pCMVl 0 based plasmids is 
denoted by a blue arrow. .
Blunt ending
Digested DNA was incubated for 30 minutes at 37°C with 3 units of T4 DNA 
polymerase in 50 pi of lx  T4 DNA polymerase buffer containing 100 pg/ml BSA and 0.2 
mM each of dATP, dTTP, dCTP, and dGTP. The digest was extracted once with phenol, 
once with chloroformrisoamyl alcohol, and finally ethanol precipitated and resuspended in 
TE pH 7.5.
Linker ligation
Approximately 5 pg of blunt ended DNA was incubated overnight at room 
temperature with 2 units of T4 DNA ligase in lx T4 DNA ligase buffer with approximately 
0.5 pg of linker DNA. The reaction volume was increased to 130 pi with distilled water 
and the ligase was inactivated by heating to 70°C for 10 minutes.
Preparation of required enzyme fragment
DNA was digested for three hours at the appropriate temperature with 50 units of 
restriction enzyme in 150 pi of the appropriate restriction enzyme buffer.
DNA fragments were then separated on 1% agarose gel in TAE (as described in 
section 2.2.7). The gel was examined under long wave ultra violet (UV) fight and a block 
of the gel containing the desired fragment was cut out and transferred to clean dialysis 
tubing with 1 ml of fresh TAE. The DNA fragment was electroeluted from the agarose 
slice at 200 V for 2 hours.
The DNA was purified on a 0.4 ml DEAE-Sephacel column. The DEAE-Sephacel 
was washed with 3 ml TE (pH 7.5) containing 0.1 M NaCl. Electroeluted DNA in TAE 
was loaded onto the column, washed with 5 ml TE (pH 7.5) containing 0.1 M NaCl, and 
eluted with two 0.4 ml aliquots of TE (pH 7.5) containing 1 M NaCl. DNA was 
concentrated by ethanol precipitation and resuspension in a small volume of TE pH 7.5
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Preparation o f vector
5 pg of plasmid vector was digested for 3 hours at 37°C with 30 units of restriction 
enzyme and 1 unit of calf intestinal phosphatase in 50 pi of lx restriction enzyme buffer. 
EGTA was added to a final concentration of 20 mM and the digest was extracted once with 
phenol, once with chloroformiisoamyl alcohol, then ethanol precipitated and the DNA 
resuspended in TE pH 7.5.
Ligation of fragment and vector
Approximately 1 pg of vector and 1 pg of fragment were incubated overnight at 
4°C with 1 unit of T4 DNA ligase in 20 pi of lx NEB ligase buffer. The ligation was 
extracted once with phenol, once with chloroformiisoamyl alcohol, ethanol precipitated and 
the DNA was resuspended in TE pH 7.5.
2.2.5 Preparation of mutant pSVH and pZP8 plasmids
pSVH was used in the generation of pSVHAXhoI, pSVHABglll, pSVHASexAI and 
pSVHABglHASexAI. pZP8 was used in the generation of pZP8ABstEII, pZP8AEcoNI 
and pZP8ARsrII. Plasmid pZP8ARsrII was generated by digesting pZP8 to completion 
with ifarll, then religating. The plasmid was transformed into competent bacteria as 
described above. The pSVH mutants and the remaining pZP8 mutants were generated by 
inserting ‘amber’ Xbal linkers at the named restriction enzyme site. The ‘amber’ Xbal 
linkers used in this thesis have the sequence CTAGTCTAGAGACTAG. The linkers 
contain an Xbal restriction site (TCTAGA) and the UAG ‘amber’ stop codon in each of the 
three forward (and three reverse) reading frames, thus forcing the termination of protein 
synthesis. The insertion of these linkers was confirmed by Xbal digestion of the mutant 
plasmids produced. The pZP8 and pSVH mutants are described in figure 4.10 and 4.13.
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Insertion o f ‘amber’ linkers
Approximately 5 pg of plasmid DNA was digested with the appropriate restriction 
enzyme, blunt ended and phosphatased as described. 1 pg of digested DNA was incubated 
overnight at room temperature with 2 units of T4 DNA ligase and 0.5 pg of 
phosphorylated Xbal amber linkers in 50 pi of lx  T4 DNA ligase buffer. The ligation was 
extracted once with phenol, once with chloroformiisoamyl alcohol, ethanol precipitated and 
resuspended in TE pH 7.5. Bacteria were transformed with plasmid DNA as described 
above (section 2.2.3).
2.2.6 Preparation of plasmid DNA
STET method for DNA extraction from bacterial cultures (Sambrook et al., 1989)
Bacteria were pelleted from 1 ml of an overnight culture by centrifugation for 2 
minutes at 13000 rpm (MSE micro fuge). Supernatant was discarded and bacteria were 
resuspended in 100 pi STET buffer. Bacterial suspensions were digested for approximately 
30 seconds at room temperature with approximately 1.4 pg/ml of lysozyme. Samples were 
boiled for 1 minute. Cell debris was pelleted by centrifugation for 10 minutes at 13000 rpm 
(MSE microfiige). Cell debris was removed and DNA was precipitated with 100 pi 
isopropanol then resuspended at 37°C for 30 minutes in 2x RNase in TE pH 8.0.
Large-scale preparation of plasmid DNA
An overnight culture (4 ml) of bacteria grown at 37°C in L-broth containing a 
suitable antibiotic was inoculated into 350 ml of LB plus antibiotic in a 2 1 conical flask. 
The culture was incubated at 37°C overnight with shaking. Bacteria were pelleted at 8000 
rpm for 10 minutes (Beckman GSA rotor). The bacterial pellet was washed in TE pH 8.0 
and repelleted at 5000 rpm for 5 minutes (Beckman SS34 rotor). The pellet was 
resuspended in 2 ml sucrose reagent then digested with approximately 2.5 mg ml"1 lysozyme 
for 30 minutes at 4°C. Triton reagent (3.2 ml) plus 0.25 M EDTA pH 8.0 (0.8 ml) was
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added to lysed cells and incubation was continued at 4°C for 15 minutes.
Cellular debris was removed by pelleting at 35000 rpm (Sorvall T865 rotor) for 30 
minutes at 4°C. The supernatant was decanted into a clean 15 ml tube, 200 pi of ethidium 
bromide (10 mg m l1 in water) was added and the volume made up to 7.5 ml with sterile 
water. Caesium chloride (7.5 g) was added to give a final density of 1.55-1.60 g ml'1. The 
DNA solution was transferred to a T1270 tube and the tube was filled with liquid paraffin 
and sealed. Gradients were centrifuged at 44000 rpm (Sorvall T1270 rotor) at 16°C for at 
least 36 hours.
After centrifugation, two bands were clearly visible on the gradient; the upper band 
consisted of open circle and nicked DNA, the lower band was supercoiled plasmid DNA. 
The supercoiled plasmid DNA was extracted with an 18 gauge needle and 2 ml syringe and 
was transferred to a clean 5 ml tube. Ethidium bromide was removed from the plasmid 
DNA by four extractions with 1.5 ml isoamyl alcohol. Caesium chloride was removed by 
two rounds of dialysis against 3 litres of TE pH 7.5. The concentration of plasmid DNA 
was determined on a spectrophotometer by measuring absorbance at 260 nm, using the fact 
that an absorbance of 1.0 at 260 nm corresponds to a concentration of 50 pg/ml of 
double-stranded DNA. The identity of the purified plasmid DNA was confirmed by 
restriction enzyme analysis.
2.2.7 Agarose gel electrophoresis
Agarose was dissolved by boiling in the appropriate buffer. The dissolved agarose 
was cooled to hand hot then ethidium bromide was added to a final concentration o f 0.5 
pg/ml. The gel was poured into a mould with a comb and allowed to set. The comb was 
removed from the gel and the gel was placed in a gel tank containing the appropriate buffer. 
DNA samples were mixed with loading buffers to give the samples the same composition as 
the gel running buffer and samples were loaded into wells. Gels were run at 10 to 50V for 
3 hours to overnight.
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2.2.8 Calcium phosphate transfection of mammalian cells
Calcium phosphate transfection with hepes-buffered saline (adapted from Stow & Wilkie, 
1976)
Cells for transfection were set up as previously described. In a sterile 15 ml tube, 
26 pg DNA (plasmid with calf thymus carrier DNA) was mixed with 1 ml of 
hepes-buffered saline (HeBS). 56 pi of 2.5M CaCl2 was added per ml of HeBS, and a 
precipitate was allowed to form for five minutes at room temperature while medium was 
removed from cell monolayers. When multiple plates were to receive the same precipitate, 
the reaction was scaled up appropriately. 0.4 ml of precipitate was added to each 
monolayer and incubation was continued for 40 minutes. 2 ml of DC5 was added to each 
monolayer and incubation was continued. Four hours after transfection (h p.t.), cells were 
washed and ‘boosted’ as described below.
Medium was removed from 293 cells, the monolayers were washed twice with 2 ml 
of DPS, and incubation was continued in DC5. U-373 MG cells were boosted by removing 
medium, washing with DPS, incubating with 1 ml of 15% v/v glycerol in HeBS for 2 
minutes at room temperature. Glycerol was removed and the cells were washed.
All other cells were ‘boosted’ by removing medium, washing with DPS, incubating 
for 5 minutes at room temperature with 25% (v/v) DMSO in HeBS, followed by washing 
once with DPS. DC5 was added to boosted monolayers (2 ml per dish) and incubation was 
continued.
Preparation of calf thymus DNA for transfection
Calf thymus DNA was dissolved in TE pH 8.0 at 3 mg ml"1. Proteinase K was 
added to a final concentration of 100 pg/ml and SDS was added to a final concentration of 
5 % (w/v). Proteinase digestion was at 55°C for one hour. After digestion, NaCl and 
EDTA were added (to final concentrations of 0.3 M and 5 mM respectively), then the DNA
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was extracted with equal volumes of phenol, phenol:chloroform:isoamyl alcohol (25:24:1), 
chloroform:isoamyl alcohol. DNA was finally precipitated with 2.5 volumes of ethanol 
overnight at -20°C, then pelleted by centrifugation at 8000 rpm and 4°C for 30 minutes in a 
Beckman SM24 rotor. The DNA pellet was washed with 70 % ethanol:30 % 0.3 M 
sodium acetate (pH 7.0) then vacuum dried and resuspended in lx  RNase in TE (pH 7.5) at 
a final concentration of 3 mg ml'1.
Optimisation of conditions bv P-galactosidase assay
The optimum pH of HeBS used in transfection was determined for each batch of 
buffer prepared. Generally, five 200 ml samples in the pH range 6.95 - 7.15 were removed 
as the pH of a batch of HeBS was adjusted with NaOH. Transfection efficiency of the 
samples was compared by transfection of pElacZ into cells followed by staining for 
p-galactosidase activity. The buffer which gave the best transfection efficiency was used in 
subsequent experiments. The optimum DNA concentration in the precipitate was similarly 
determined by staining for p-galactosidase activity.
In situ /I-galactosidase assay
Medium was removed from monolayers and the cells were washed with 2 ml PBS. 
Cells were fixed at room temperature for 5 minutes with 1 ml of lacZ fix. Fix was removed 
and cells were washed with PBS. 1 ml of lacZ stain was added to each 35 mm dish and 
plates were incubated overnight at 37°C. Cells were examined by light microscopy and the 
number of positive cells (blue cells) per field of view was counted. Five fields of view 
(approximately 3 mm2) were counted for each 35 mm dish, and the average number of 
positive cells was determined. Transfection efficiencies were typically in the range of 1-2% 
for HFFF2, HFL1 and CV-1 cells, in the range of 2-5% in Vero, BHK 21 C13 and U-373 
MG cells, and in the range of 25-30% in 293 cells.
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2.2.9 Transient replication assay
Cells were transfected as described above. Infection was done at 6 hours post 
transfection. Medium was removed from monolayers and virus was added in a final volume 
of 100 pi. 293 cells were infected in a final volume of 500 pi. Mock infected plates were 
treated with wash without virus. Following adsorption of virus for 45 minutes, 2 ml of 
DC5 was added to each monolayer and incubation was continued as required.
Total-cellular DNA preparation
Medium was removed and cells were washed with 2 ml TS. Protease digestion was 
carried out at 37°C with 0.5 mg/ml protease XIV in lx CLB for 3-6 hours. NaCl was 
added to 0.3 M and EDTA was added to 3.6 mM. Lysates were sequentially extracted 
with an equal volume of phenol then chloroformiisoamyl alcohol and precipitated overnight
4»
with 2.5 volumes of ethanol at -20°C. DNA was pelleted by centrifugation at 8000 rpm 
and 4°C for 20 minutes in a Beckman SM24 rotor. The DNA pellet was washed with 70 % 
ethanol:30 % 0.3 M sodium acetate (pH 7.0) then vacuum dried and resuspended in lx 
RNase in TE (pH 7.5). Approximately 25% of the DNA from a 35 mm plate was digested 
for analysis by Southern blot.
Preparation of cell nuclei
Cells were scraped into the supernatant medium then transferred to a clean 10 ml 
tube and pelleted for 2 minutes at 1000 rpm (Beckman GPR centrifuge) at room 
temperature. Cells were resuspended by vortexing in RSB containing 0.5% (v/v) NP40. 
Nuclei were pelleted for 3 minutes at 1000 rpm at room temperature. Cytoplasmic 
supernatant was discarded and the nuclear pellet was resuspended in 2 ml RSB, repelleted 
and the supernatant discarded. Nuclei were resuspended in 1 ml TE (pH 7.5) and digested 
in lx  CLB with 0.5 mg/ml protease XIV at 37°C for 3 - 6 hours. DNA was extracted as 
described above.
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2.2.10 Preparation of radio>labelled probe (Rigby et al., 1977)
250 ng of plasmid DNA was incubated with 10 pCi each of a  32 P dCTP and a  32 P 
dGTP, 2 units of DNA polymerase I and lx l O'7 mg DNasel at 16°C for 90 minutes in a 
final volume of 30 pi of lx  NTB (containing ‘cold’ dATP and dTTP).
The reaction mixture was extracted once with an equal volume of phenol. The 
radiolabelled probe was separated from unincorporated nucleotides by column 
chromatography over G50 Sephadex. Plasmid was denatured by incubation in 0.16 M 
NaOH at room temperature for 10 minutes, neutralised with HC1 and the probe was added 
to 8.6 ml of hybridisation buffer heated to 68°C and used immediately.
2.2.11 Southern blotting (Southern, 1975)
Suitably digested DNA samples were separated by electrophoresis at 20-40 V for 
16-24 hours through a 0.8% (w/v) agarose slab gel in Loening's buffer containing 0.5 pg/ml 
ethidium bromide. The gel was photographed under long wave UV light.
DNA was denatured by shaking the gel for 45 minutes in gel soak I. The alkali was 
neutralised by shaking the gel for 45 minutes in gel soak II. DNA was transferred 
overnight onto nitrocellulose membrane by capillary blotting with 6x SSC at room 
temperature.
The membrane was marked, rinsed with 6x SSC then crosslinked by exposure to 
120 mJ/cm UV light Blocking of the membrane was with 100 ml pre-hybridisation buffer 
in a sealed hybridisation bag at 68°C with shaking for at least 2 hours.
The pre-hybridisation fluid was discarded, the hybridisation mix was added using an 
18 gauge needle and 10 ml syringe. The bag was resealed and hybridisation was carried out 
for 16-24 hours at 68°C with shaking.
The hybridisation fluid was discarded and the blot was washed three times at 68°C 
with shaking for 20 minutes each with 300 ml blot wash. The blot was rinsed with water
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then blotted dry.
The blot was then exposed to a BioRad FluorS phosphoimaging screen. The image 
was developed and manipulated on a BioRad Personal FX FluorS Multilmager and the 
associated software.
2.2.12 Quantitation of DNA in bands from Southern blotting
A selection box was drawn around a marker band on a blot to be quantified. The 
box was then copied over different areas of the blot to be quantified, including an area of 
background. The software calculated the ‘counts’ in each boxed region and a report was 
printed. For data presentation, the background was subtracted from the signal for each 
boxed region. The number of counts generated by the marker bands (corresponding to a 
known amount of DNA) was used to calculate the amount of DNA in a test area. 
Measurements were only taken from exposures where no saturation of pixels had occurred.
2.2.13 Western blotting to detect HCMV major immediate early proteins
Protein samples were mixed with 1/5 volume of boiling mix then boiled for 2-3 
minutes prior to separation by SDS-PAGE (Marsden et al., 1978). Gels with a 10% 
running gel (39:1 acrylamide to bisacrylamide) and a 5% stacking gel (19:1 acrylamide to 
biacrylamide) were run in tank buffer at 150 V using a BioRad ‘Mini-protean’ kit.
Prior to blotting, the gel, blotting pads, filter paper and membrane were soaked for 
10 minutes in chilled Towbin buffer (Towbin et al., 1979). Gels were blotted using a 
BioRad transfer kit in chilled Towbin buffer at 150V for 45 minutes. The membrane was 
subsequently blocked, probed and exposed.
The blotted membrane was blocked in IE1/IE2 block for 2 hours at 37°C with 
gentle agitation. The blocked membrane was washed five times with 50 ml of IE1/IE2 
wash at room temperature for a total of 15 minutes.
The membrane was incubated for 2 hours at 37°C with gentle agitation in diluted 
IE1/IE2 polyclonal antibody. The blot was washed as before.
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The membrane was finally incubated in protein-A peroxidase in IE1/IE2 wash with 
1% (w/v) BSA for one hour at 37°C. The blot was washed as before with a final wash in 
PBS followed by deionised water. The membrane was reacted with ECL reagent according 
to the manufacturers protocols. The blot was exposed to X-Omat film and developed.
2.2.14 Indirect immunofluorescence to detect UL84
Medium was removed from cells and monolayers were washed with 2 ml PBS. 
Cells were fixed by incubation in IF fix for 10 minutes at room temperature, then washed 
three times with PBS and permeabilised by incubation in IF permeabilisation buffer for 10 
minutes at room temperature. Cells were washed three times for 5 minutes each with 
PBSiFCS, then incubated for 90 minutes at room temperature with antibody D42 diluted in 
PBS:FCS. Cells were washed three times for 5 minutes each with PBS:FCS then incubated 
for 90 minutes at room temperature in the dark with Cy3 conjugated goat anti-mouse 
antibody diluted in PBSrFCS. After antibody incubation, cells were rinsed with PBSrFCS 
then washed five times for 5 minutes each with PBSrFCS. Prior to mounting, samples were 
rinsed twice with PBS then once with deionised water. Coverslips were mounted onto 
slides with a drop of CitiFluor and then sealed using clear nail varnish.
Samples were examined at 543 nm on a Nikon Microphot fluorescent microscope 
and images were captured and processed using a ‘CCD’ camera and the associated IPLab 
software.
2.2.15 Preparation of samples for electron microscopy (E.M.)
HCMV infected or mock infected cells in petri dishes were scraped into the
supernatant media then transferred to clean 10 ml tubes and pelleted for 2 minutes at 1000
rpm (Beckman GPR centrifuge). Supernatant was discarded, the cell pellet transferred, in a
small amount of PBS, to a clean BEEM capsule and spun for 3 minutes at 1000 rpm to seat
the pellet. Supernatant was discarded and 0.5 ml of E.M. grade glutaraldehyde (2.5% v/v
in PBS) was carefully added to each sample. Samples were stored at 4°C until required,
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then processed and examined by Jim Aitken on a JEOL 100S microscope.
Chapter 3: HCMV replication in epithelial and non-human fibroblast
cells
3.1 Introduction
Human cytomegalovirus growth in vitro is almost completely restricted to cell lines 
of human origin, although low yields of infectious progeny virus have reportedly been 
obtained from primary chimpanzee skin fibroblasts (Perot et al., 1992). Cell lines fully 
permissive for HCMV growth in vitro can be difficult to culture or manipulate.
Table 1.3 summarised the results of an extensive investigation into the blocks to 
immediate early gene expression and DNA replication by human (Towne) cytomegalovirus 
in cells of human, murine and simian origin (LaFemina & Hayward, 1988). Only three cell 
lines (all human) of the nineteen additional different lines examined supported HCMV 
Towne DNA replication to a level greater than 3% of the level in fully permissive human 
fibroblast (HF) cells.
3.2 Results
3.2.1 Replication of an HCMV origin-containing plasmid in HCMV strain AD169 
infected Vero cells
Studies into human cytomegalovirus DNA replication might be facilitated if easily
manipulated cell lines could be used for experimentation. Sarisky and Hayward (1996)
showed that Vero cells transfected with plasmids expressing the HCMV replication
proteins, UL44, UL54, UL57, UL70, UL102, UL105, UL84, UL112-113 and IRS1/TRS1,
from the SV40 early promoter, and with plasmids expressing IE1/2 and UL36-38 from the
HCMV major immediate early promoter, were able to support replication of an HCMV
origin-containing plasmid. I therefore re-examined the ability of Vero cells to support
HCMV origin-dependent DNA synthesis, initially by testing for their ability to support the
replication of a transfected HCMV origin-containing plasmid (pSP50) following
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superinfection with HCMV strain AD 169.
Duplicate monolayers of Vero cells were set up in 35 mm dishes and transfected 
with 1.6 pg/dish of pSP50. One dish of cells was infected with 0.25 p.f.u./cell of HCMV, 
the other dish was mock infected. Total cellular DNA was prepared 116 h p.i. and digested 
with Xbal (which linearises pSP50) and Dpnl (which cuts at dam methylated GATC sites). 
The input plasmid DNA used here had dam methylated GATC sites as it was prepared from 
the dam+ E. coli strain DH5a. DNA which has been synthesised in eukaryotic cells is not 
dam methylated. Dpnl digestion is therefore a useful tool, digesting only DNA synthesised 
in bacteria, thus allowing a distinction to be made between unreplicated, input plasmid 
(which is degraded by Dpnl) and plasmid replicated in eukaryotic cells (which is Dpnl 
resistant).
Fragments were separated by electrophoresis, blotted and hybridised to 32P-labelled 
pAT153. The blot was exposed to a phosphorimager screen and a phosphorimage (figure 
3.1) was acquired using a Bio-Rad Personal Molecular Imager and Quantity One software.
A band resistant to Dpnl cleavage, of the same size as linearised input plasmid was 
detected in DNA from infected cells, demonstrating that Vero cells support the replication 
of a transfected HCMV origin-containing plasmid upon superinfection with HCMV strain 
AD 169. No replicated pSP50 was detected in mock infected cells. The bands at the 
bottom of the blot are the result of hybridisation of the probe to the unreplicated, Dpnl 
digested input plasmid.
3.2.2 Time-courses of DNA replication
(a) HCMV strain AD 169 time-courses
Following the observation that AD 169 infected Vero cells could support the 
replication of an HCMV origin-containing plasmid, the replication of helper virus genomes 
was examined. Vero, CV-1, 293, BHK 21 C l3, and U-373 MG cells were investigated for
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Figure 3.1 Replication o f pSP50 in HCMV infected Vero cells.
Vero cells were transfected with 1.6 pg/dish of pSP50. Cells were infected with 0.25 
p.f.u./cell of HCMV (AD) or mock infected (MI). DNA was prepared 116 h p.i.. 25% of 
the DNA from a 35 mm dish was digested with EcoKl and Dpnl. Fragments were 
separated by electrophoresis through a 0.8% agarose gel which was blotted as described 
and the blot hybridised to 32P labeled pAT153. 'Dpnl bands' were produced by Dpnl 
degradation of the unreplicated, dam methylated input plasmid DNA.
4 ng of EcoRl digested pSP50 was loaded (M).
their ability to support replication of a transfected HCMV origin-containing plasmid and the 
replication of the superinfecting HCMV strain AD 169 genomes. Fully permissive HFFF2 
and HFL1 cell lines were also examined.
Vero, CV-1, 293, BHK 21 C13, U-373 MG, HFFF2 and HFL1 monolayers were 
set up and transfected as described. Cells were transfected with 1.6 pg/dish of pSP50 and 
five dishes for each cell line were superinfected with 1 p.f.u./cell of HCMV. Infected cells 
were harvested at 0, 24, 72, 124 and 168 h p.i.. One dish for each cell line was mock 
infected and harvested at 168 h p.i..
Total cellular DNA was prepared and digested with £<%>RI and Dpnl. Fragments 
were separated by electrophoresis and ethidium bromide stained gels were examined by 
long wave ultraviolet light before blotting to confirm efficient recovery and digestion of 
DNA. Gels were blotted and the DNA was hybridised to 32P-labelled pSP50. Figure 3.2 
shows that 32P-labelled pSP50 should detect 10.8 and 4.2 kbp fragments of EcoRl digested 
HCMV DNA and 5.6 and 2.4 kbp in fragments of EcciKL digested pSP50. Phosphorimages 
(figures 3.3 - 3.6) were generated as previously described.
Figures 3.3a. shows an example of an ethidium bromide stained gel, the blot 
produced from this gel is shown in figure 3.3b. In HFFF2 cells (figure 3.3b) the amount of 
HCMV genomic DNA increased from 24 h p.i. to 168 h p.i.. Replicated pSP50 was 
detected by 72 h p.i., and reached a maximum level at 124 h p.i.. Similarly, 293 cells 
(figure 3.3b) supported the replication of both pSP50 and AD 169 genomic DNA. Input 
HCMV genomic DNA was detectable at 0 h p.i. but the signal had decreased by 24 h p.i.. 
Accumulation of replicated genomic DNA was observed from 24 to 168 h p.i.. pSP50 was 
replicated by 72 h p.i., and increased in amount from 124 to 168 h p.i.. In HFFF2 and 293 
cells, as in all the cell lines examined, the mock infected samples showed no bands 
corresponding to either replicated pSP50 or to HCMV genomic DNA.
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Figure 3.2 EcoR\ restriction maps o f the HCMV origin region in the HCMV genome, pSP50 and 
pZP37.
A) The HCMV genome digested with £coRI and hybridised to pSP50 (B) produces bands o f 4.2 
kbp and 10.8 kbp.
B) pSP50 digested with EcoR\ yields fragments o f 2.4 kbp and 5.6 kbp. When hybridised to 
pSP50, both bands are detected. When hybridised to pAT153, only the 5.6 kbp fragment, 
containing the vector sequences, is detected.
C) pZP37 digested with EcoR\ yields fragments of2 .7  kbp, 6.6 kbp, 4.2 kbp and 3.3 kbp. When 
hybridised to pATl 53, only the 3.3 kbp fragment, containing the vector sequences, is detected.
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Figure 3.3 Time-course of infection of HFFF2 and 293 cells with FICMV strain AD 169.
Cells were transfected with 1.6 gig/dish pSP50 plasmid and infected with 1 p.f.u./cell o f HCMV strain 
AD 169. Infected cells were collected at various times after infection and total cellular DNA was 
prepared. 25% of the DNA from a 35 mm dish of cells was digested with EcoK\ and Dpn\. Fragments 
were separated by electrophoresis through a 0.8% agarose gel which was blotted as described and 
hybridised to 32P-labelled pSP50.
Panel (a) shows the ethidium bromide stained gel corresponding to the Southern blot in panel (b).
150 ng o f EcoK\ digested HCMV genomic DNA (G) and 4 ng ofZscoRI digested pSP50 (P) were loaded 
as markers. A mock infected sample for each cell type is included (MI).
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Figure 3.4 Time-courses of infection of HFL1 (a) and U-373MG cells (b) with HCMV strain 
AD169.
Cells were transfected with 1.6 fig/dish pSP50 plasmid and infected and processed as described in 
the legend to figure 3.3.
Markers for EcoR\ digested HCMV genomic DNA (G) and pSP50 (P) and a mock infected sample 
tor each cell type (Ml) are included.
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Figure 3.5 Time-courses of infection of BF1K 21 C l3 (a) and CV-1 cells (b) with HCMV strain 
AD169.
Cells were transfected with 1.6 gg/dish pSP50 plasmid and infected and processed as described in the 
legend to figure 3.3.
Markers for EcoK\ digested HCMV genomic DNA (G) and pSP50 (P) and a mock infected sample for 
each cell type (MI) are included.
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Figure 3.6 Time-course o f infection of Vero cells with HCMV strain AD169.
Cells were transfected with 1.6 jug/dish pSP50 and infected and processed as described in the 
legend to figure 3.3.
Markers for EcoK\ digested HCMV genomic DNA (G) and pSP50 (P) and a mock infected lane 
(MI) are included.
The replication of HCMV and pSP50 in HFL1 (a) and U-373 MG (b) cells is shown 
in figure 3.4. In both cell lines, the amount of HCMV genomic DNA increased from 24 h 
p.i. to 168 h p.i.. Replicated pSP50 was observed by 72 h p.i. and increased in amount at 
124 h p.i.. A further increase in replicated pSP50 was observed in U-373 MG cells by 168 
hp.i.. In contrast to the above, BHK 21 C13 (a) and CV-1 (b) cells (figure 3.5) showed 
no detectable accumulation of HCMV genomic DNA and no replication of the 
origin-containing plasmid DNA.
A third phenotype was exhibited by Vero cells (figure 3.6) which supported the 
replication of transfected pSP50 in the absence of detectable genomic DNA replication. 
HCMV genomic DNA was detectable at decreasing levels from 0 to 168 h p.i.. In contrast, 
replicated pSP50 was readily detectable from 72 h p.i. to 168 h p.i..
Summary
Three phenotypes were observed. In 293, U-373 MG, HFFF2 and HFL1 cells, 
HCMV strain AD 169 genomic DNA and a transfected origin-containing plasmid both 
replicated. In CV-1 and BHK 21 C13 cells, there was no detectable replication of either 
the origin-containing plasmid or the infecting helper virus genomes. Finally, in Vero cells, 
HCMV directed the replication of the origin-containing plasmid in the absence of 
detectable genomic DNA synthesis.
These findings agree with those of LaFemina and Hayward (1988) for the 
replication of HCMV genomic DNA in all the cell lines except 293 cells which were 
previously described as being negative. The ability of Vero cells to support replication of 
the origin-containing plasmid, in the apparent absence of genomic DNA synthesis, was a 
novel, unexpected result.
fb) HCMV strain Towne time-courses
LaFemina and Hayward (1988) used HCMV strain Towne in their investigations.
Since different strains of HCMV may have only 95% identity at the nucleotide sequence
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level, it is possible that their behaviour in different cell lines might vary. The replication of 
HCMV strain Towne was examined to determine whether interstrain differences could 
account for the apparent discrepant result in 293 cells, and whether replication of pSP50 in 
Vero cells was peculiar to HCMV strain AD 169.
Time-courses of replication of pSP50 and HCMV strain Towne in HFFF2, 293, 
Vero, and U-373 MG cells were carried out as described for AD 169 time-course 
experiments, except that infections were with 1 p.f.u./cell of HCMV strain Towne.
Samples were collected at 0, 24, 72, 119 and 166 h p.i.. One dish for each cell line was
mock infected and harvested at 166 h p.i.. Total cellular DNA was prepared and processed 
as previously described for HCMV strain AD 169 time-courses, phosphorimages are shown 
in figures 3.7 and 3.8.
Replication of both HCMV Towne genomic DNA and pSP50 DNA was clearly 
detectable in HFFF2 cells (figure 3.7a), 293 cells (figure 3.7b) and U-373 MG cells (figure 
3.8a). In Vero cells, (figure 3.8b) replicated pSP50 was detected from 72 h p.i., and in this 
case, plasmid replication was accompanied by a small accumulation of genomic DNA.
Summary
HCMV strain Towne directed replication of both its own genomic DNA and a 
transfected HCMV origin-containing plasmid in HFFF2, Vero, 293 and U-373 MG cells. 
These results differ from LaFemina and Hayward (1988) in that replication of HCMV strain 
Towne genomic DNA was previously not detected in 293 or Vero cells.
(c) Comparison of AD 169 and Towne replication
HFFF2, U-373 MG, 293 and Vero cells all support HCMV origin-dependent DNA
synthesis directed by HCMV infection. HCMV strain AD 169 and Towne behaved similarly
with regard to both genomic and plasmid DNA replication in all cell lines tested, except
that Vero cells appeared to support a very low level of HCMV strain Towne genomic DNA
synthesis, but no synthesis of strain AD 169 DNA. The behaviour of the two strains of
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Figure 3.7 Time-courses of infection of HFFF2 (a) and 293 cells (b) with HCMV strain Towne.
Cells were transfected with 1.6 gg/dish pSP50 and infected with I p.f.u./cell of HCMV strain Towne. 
Infected cells were collected at various times after infection and total cellular DNA was prepared. 25% 
of the DNA obtained from a 35 mm dish of cells was digested with EcoRl and Dpnl. Fragments were 
separated by electrophoresis through a 0.8% agarose gel which was blotted as described and hybridised 
to 32P-labelled pSP50.
Markers for EcoRl digested HCMV genomic DNA (G) and pSP50 (P) and a mock infected sample for 
each cell type (MI) are included. The white line at the centre o f the larger pSP50 marker band (panel a), 
and throughout this thesis, is indicative of saturated pixels.
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(hours)
0 24 72 119 166 MI P G 0 24 72 119 166 MI G P
b
C
*
Figure 3.8 Time-courses of infection of U-373 MG (a) and Vero cells (b) with HCMV strain 
Towne.
Cells were transfected with 1.6 pg/dish pSP50 and infected and processed as described in the legend 
to figure 3.7.
Markers for £coRI digested HCMV genomic DNA (G) and pSP50 (P) and a mock infected sample 
for each cell type (MI) are included.
virus in the different cell lines was compared by using the Quantity One software (as 
described in section 2.2.12) to quantify the signals corresponding to genomic DNA in these 
‘positive’ cell lines.
Figure 3.9 shows the accumulation in infected cells of (a) AD 169 genomic DNA 
and (b) Towne genomic DNA. 293 and U-373 MG cells support both AD 169 and Towne 
genomic DNA replication to levels comparable to those seen in the normally used 
permissive HFFF2 cell line. In these experiments, Vero cells supported HCMV strain 
Towne DNA replication to approximately 30% of the level accumulated in infected HFFF2 
cells.
While the data presented in figure 3.9 are derived only from the images presented in 
this thesis, the trends described are typical o f repeat experiments. The one exception to this 
is that the replication of HCMV strain Towne DNA in HFFF2 cells shown in figure 3.7a is 
lower than usually observed.
3.2.3 Specificity of replication
As Vero cells infected with AD 169 supported the replication of a transfected 
plasmid but not detectable replication of helper virus genomes, it was considered important 
to confirm that the DNA synthesis observed required the HCMV DNA polymerase and the 
intact HCMV origin sequences in the plasmid.
fa) Sensitivity to DNA polymerase inhibitors
The HCMV DNA polymerase is inhibited by phosphonoformic acid (PFA) and 
phosphonoacetic acid (PAA) (Nishiyama et al., 1983; Oberg, 1983). In order to confirm 
that the plasmid DNA replication in HCMV infected Vero cells was directed by the viral 
DNA polymerase, the replication of pSP50 in HCMV infected cells treated with PFA and 
PAA was examined.
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Figure 3.9 Graphic representation ofthe amount of genomic DNA accumulated in (a) AD 169 or (b) 
Towne infected Vero, HFFF2, 293 and U-373 MG cells.
The data were obtained from the scans in figures 3.3b, 3.4b and 3.6-3.8. The amount of HCMV 
genomic DNA markers loaded on each gel is consistent and was therefore used to calculate the 
amount of DNA accumulated. The amount of replicated genomic DNA is calculated in 
micrograms.
Effect o f  PFA and PAA on pSP50 replication
HFFF2, 293 and Vero cells were transfected with pSP50; three dishes of cells for 
each cell line were superinfected with HCMV and one dish of each was mock infected. 
After virus adsorption, the mock infected dish and one infected dish for each cell line were 
given 2 ml DC5. One dish of infected cells for each line was given DC5 supplemented with 
200 pg/ml PAA and one dish of infected cells was given DC5 supplemented with 250 
pg/ml PFA. Samples were harvested at 112 h p.i.. Total cellular DNA was prepared and 
digested with EcoKL and Dpnl. Fragments were separated by electrophoresis, blotted and 
hybridised to 32P-labelled pATl 53. A phosphorimage was produced as described.
Figure 3.10 shows that in the absence of inhibitor, pSP50 was replicated in all three 
cell lines following HCMV infection. Replication of pSP50 in infected cells was prevented 
in the presence of the DNA polymerase inhibitors PAA and PFA.
Effect o f  PFA and PAA on SV40 origin-dependent DNA synthesis
While the herpesvirus DNA polymerases have been reported to be up to one 
hundred times more sensitive to PAA and PFA than the cellular DNA polymerases, the 
sensitivity of the cellular enzymes to these phosphonic acids is reportedly cell and tissue 
type dependent (Nishiyama et al., 1983; Komberg & Baker, 1992). To confirm that the 
concentration of the inhibitors used was not affecting the major cellular replicative DNA 
polymerases in 293 and Vero cells, these cells were investigated for their ability to support 
non-herpesviral DNA synthesis in the presence of the viral DNA polymerase inhibitors, 
PAA and PFA.
pSV3-neo contains an SV40 origin of replication and constitutively expresses SV40 
T-antigen. pSV3-neo can be replicated in human and simian cells by the cellular 
polymerases a  and 5 when T-antigen is expressed in a suitably phosphorylated state to 
interact with and unwind the SV40 origin (Kelly, 1988).
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Figure 3.10 Effect of PFA and PAA on pSP50 replication.
Vero, HFFF and 293 cells were transfected with 1.6 pg/dish pSP50 and infected with 0.25 p.f.u./cell of 
HCMV. Cells were incubated in medium containing either 250 pg/ml of PFA (PFA) or 200 pg/ml of 
PAA (PAA). DNA from mock infected plates (MI) and from infected cells incubated in medium 
without inhibitor (U) was also prepared. Total cellular DNA was prepared 112hp.i.. 25% ofthe DNA 
from a 35 mm dish was digested with EcoK\ and Dpn\. Fragments were separated by electrophoresis 
through a 0.8% agarose gel which was blotted as described and the blot hybridised to 32P-labelled 
pAT153.
4 ng of EcoK\ digested pSP50 was loaded as a marker (pSP50).
Monolayers of Vero and 293 cells were transfected with 1.6 jag/dish pSV3-neo. 
Cells were mock infected and replicate dishes for each cell line were given either 2 ml DC5, 
or DC5 supplemented with 200 pg/ml PAA, or DC5 supplemented with 250 pg/ml PFA. 
Samples were collected after 112 hours and processed as described for the previous 
experiment, the result is shown in figure 3.11.
The effect of PFA on DNA synthesis driven by the cellular DNA polymerases was 
minimal. The presence of PAA had a slight inhibitory effect on the replication of pSV3-neo 
although this was much less than its effect on the replication of pSP50 (figure 3.10).
Summary
The replication of pSP50 in Vero and 293 cells superinfected with HCMV was 
sensitive to viral DNA polymerase inhibitors at concentrations which did not abrogate the 
activity of the cellular DNA polymerases a  and 8, indicating that the replication is most 
likely carried out by the viral DNA polymerase.
flf) Dependence on the HCMV origin sequences
pSP50 contains approximately 5 kbp of AD 169 DNA which includes the HCMV 
origin of lytic-phase DNA replication (oriLyt). In order to demonstrate that the plasmid 
replication observed in HCMV infected Vero cells was dependent on the HCMV origin, 
other plasmids containing complete or partial origins, and the vectors into which the origin 
sequences are cloned, were tested for their ability to be replicated following AD 169 
superinfection.
pSP50 and pGEM7 replication
pSP50 contains an HCMV oriLyt fragment cloned into the vector pGEM7. In 
order to show that the vector sequences of pSP50 were not responsible for its replication, 
the replication of pSP50 and pGEM7 were compared.
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Figure 3.11 Effect of PAA and PFA on SV40 origin-dependent DNA synthesis.
Vero and 293 cells were transfected with 1.6 pg/dish pSV3-neo. Cells were incubated in 
medium containing either 250 pg/ml ofPFA(PFA)or200 pg/ml of PAA (PAA) or in medium 
without inhibitor (U). Total cellular DNA was harvested 112 h p.t.. 25% of the DNA from a 
35 mm dish was digested with EcoR\ and Dpnl. Fragments were separated by 
electrophoresis through a 0.8% agarose gel which was blotted as described and the blot 
hybridised to '2P-labelled pAT153.
4 ng of EcoK\ digested pSV3-neo was loaded as a marker (pSV3).
Vero and HFFF2 cells were cotransfected with pSP50 and pGEM7. One dish of 
cells for each line was superinfected with HCMV, the other dish was mock infected. Total 
cellular DNA was prepared 112 h p.i. and digested with EcoPA and Dpnl. EcoRI digestion 
linearises pGEM7 so that a single band of 3 kbp is produced which is clearly distinguishable 
from the 5.6 kbp EcoPA fragment of pSP50 containing the vector sequences (see figure 
3.2b). Fragments were separated by electrophoresis, blotted and hybridised to 32P-labelled 
pAT153.
Figure 3.12 shows that pSP50 replicates in HCMV infected HFFF2 and Vero cells 
but that pGEM7 was not replicated.
pSP50 and pZP37 replication
pZP37 contains approximately 14 kbp of AD 169 DNA sequences in the same 
vector (pGEM7) as pSP50. The sequences in pZP37 overlap HCMV oriLyt so that pZP37 
contains only approximately 40 % of the essential minimal origin as defined by Anders et 
al. (1992).
Duplicate Vero and U-373 MG monolayers were cotransfected with pSP50 and 
pZP37. One dish of cells for each cell line was infected with HCMV, the other dish was 
mock infected. Samples were collected 112 h p.i.. Total cellular DNA was prepared and 
digested with EcoPA and Dpnl, and processed as previously described. Figure 3.2c shows 
that the vector sequences of EcoPA digested pZP37 are within a 3.3 kbp fragment detected 
in the marker lane in figure 3.13
Figure 3.13 shows that pSP50 was replicated in both AD 169 infected Vero and 
U-373 MG cells, but that pZP37 was not replicated. 
pCMVori replication
pCMVori is an HCMV origin-containing plasmid with HCMV sequences 
(nucleotides 91321-94168) subcloned from a Hindlll D containing plasmid into pCMVlO. 
The construction of pCMVori and its derivatives was described in figure 2.1.
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Figure 3.12 Specificity o f replication to origin sequences - pGEM7.
HFFF and Vero cells were cotransfected with 1.6 pg/dish each o f pGEM7 and pSP50. 
Cells were infected with 0.25 p.f.u./cell of HCMV (AD) or mock infected (MI). 
Total cellular DNA was prepared 112 h p.i.. 25%ofthe DNA from a 35 mm dish was 
digested with EcoK\ and Dpn\. Fragments were separated through a 0.8% agarose 
gel which was blotted as described and the blot hybridised to 32P-labelled pAT153. 
4 ng of EcoK\ digested pGEM7 was loaded as a marker (M).
Position of EcoK\ digested pSP50 marker band.
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Figure 3.13 Specificity of replication to intact origin sequences - pZP37.
U373MG and Vero cells were cotransfected with 1.6 pig/dish each of pZP37 and 
pSP50. Cells were infected with 0.25 p.f.u./cell HCMV. DNA from infected (AD) 
and mock infected (MI) cells was harvested 112 h p.i.. 25% ofthe DNA from a 35 mm 
dish was digested with EcoKl and Dpn\. Fragments were separated by electrophoresis 
through a 0.8% agarose gel which was blotted as described and the blot hybridised to 
32P-labelled pAT153.
4 ng each of£coRI digested pZP37 (pZP37) and pSP50 (pSP50) were loaded as 
markers.
HFFF2 and Vero cells were transfected with either pCMVori or pCMVlO. One 
dish of each duplicate transfection was infected with HCMV, the other dish was mock 
infected. Total cellular DNA was prepared 90 h p.i. and digested with Xbal and Dpnl. 
Xbal digestion linearises both plasmids so that the size difference is based on the insert. 
pCMVIO (lacking an insert) is 3.8 kbp, and pCMVori is 6.6 kbp.
Figure 3.14 shows that pCMVori was replicated in AD 169 infected HFFF2 and 
Vero cells and not in mock infected cells. No replication of pCMVIO was detected.
pADori and pM Al replication
pADori contains the origin sequences from pCMVori subcloned into pGEM7, 
pADoriAXho contains the mutated origin from pCMVoriAXho cloned into pGEM7. Xhol 
deletion removes 1160 bp of oriLyt spanning ‘essential region IF as defined by Zhu et al. 
(1998). pMAl contains an HCMV oriLyt derived from HCMV strain Towne.
Duplicate monolayers of Vero cells were either cotransfected with pADori and 
pADoriAXho or transfected with pMAl. One of the duplicate plates was infected with 
HCMV, the other was mock infected and incubation was continued for 112 h. Total 
cellular DNA was prepared and digested with Xbal and Dpnl. Fragments were separated 
by electrophoresis, blotted, and hybridised to 32P-labelled pAT153. Xbal digestion 
linearises all three plasmids, generating fragments of 9.4 kbp (pMAl), 5.8 kbp (pADori) 
and 4.7 kbp (pADoriAXho). The blot was exposed to a phosphorimager screen and an 
image (figure 3.15) was produced.
pADori and pMAl were replicated in HCMV infected Vero cells. The deleted 
origin-containing plasmid, pADoriAXho, was not replicated.
Summary
The replication of transfected plasmids by HCMV superinfection in Vero cells was 
dependent on an intact HCMV origin.
70
pCMVori pCMVIO
ori AD MI AD MI 10 AD MI AD MI
HFFF Vero HFFF Vero
Figure 3.14 Replication of an independent origin containing plasmid - pCMVori.
HFFF and Vero cells were transfected with 1.6 pg/dish of either pCMVori orpCMVlO. Cells 
were infected with 0.25 p.f.u./cell of HCMV (AD) or mock infected (MI). Total cellular 
DNA was prepared at 90 h p.i.. 25% of the DNA from a 35 mm dish was digested with Xbal 
and Dpnl. Fragments were separated by electrophoresis through a 0.8% agarose gel which 
was blotted as described and the blot hybridised to 32P-labeIled pATI 53.
4 ng each o f Xbal digested pCMVori (ori) and pCMVIO (10) were loaded as markers.
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Figure 3.15 Replication of two independent origin containing plasmids and a mutated 
origin containing plasmid.
Vero cells were either cotransfected with 1.6 (Lxg/dish of each o f pADori and 
pADoriAXho (A), or transfected with 1.6pg/dish pMAl (B). Cells were infected with 
0.25 p.f.u./cell o f HCMV (AD) or were mock infected (MI). Total cellular DNA was 
prepared 112 h p.i.. 25% of the DNA from a 35 mm dish was digested with Xbal and 
Dpnl. Fragments were separated by electrophoresis through a 0.8% agarose gel which 
was blotted as described and the blot hybridised to 32P-labelled pATl 53.
4ng of Xbal digested pADori (ori), pADoriAXho (Xho) and pMAl (MAI) were loaded 
as markers.
(c) Effect o f bacterial DNA methvlation
Plasmid DNA purified from E. coli DH5a bacteria has been methylated by DNA 
adenine and DNA cytosine methylases (dam and dcm) at the A residue in GATC sequences 
and at both C residues in CCa /tGG sequences respectively. Dam methylation is used by
bacteria to differentiate replicated from non-replicated DNA for purposes of DNA repair, 
and in the control of replication. The function of dcm methylation is unknown.
Eukaryotic DNA is methylated at the cytosine of some CG sequences- a process 
involved in the control of gene transcription. Methylation or undermethylation of DNA can 
alter the way DNA binding proteins interact with DNA.
The presence of bacterial methylation on the transfected origin-containing plasmid 
DNA, but not the superinfecting HCMV genomes, might provide an explanation for the 
different behaviours of the two DNAs in transient replication assays in Vero cells.
Preparation o f  unmethylatedplasmid DNA
pSP50 was purified from a bacterial strain (SCSI 10) lacking both dam and dcm 
methylases. The unmethylated state of the DNA was confirmed by restriction analysis. 
Figure 3.16 compares the restriction profiles of methylated and unmethylated pSP50 DNA 
digested with Dpnll (cleaves only when its restriction site, GATC, is not dam methylated) 
or with ScrFl (cleaves only when its restriction site, CCNGG, is not dcm methylated). 
Figure 3.16 shows that DNA prepared from E. coli strain SCSI 10 is cleaved by Dpnll, 
while DNA prepared from strain DH5a is uncleaved. ScrFl cleaved DNA prepared from 
strain SCSI 10 at more sites than it cleaved DNA prepared from strain DH5a. DNA 
prepared from E. coli strain DH5a was dam and dcm methylated, while, as expected, DNA 
prepared from strain SCSI 10 was not methylated.
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Figure 3.16 Digestion to confirm methylation state o f plasmid DNA
A) The restriction profile of unmethylated (U) and methylated (M) pSP50 when 
digested with DpnW.
B) The restriction profile of unmethylated (U) and methylated (M) pSP50 when 
digested with ScrFl.
1 jig of each plasmid was digested for 1 hour at 37°C with 10 units of enzyme. 0.5 pg 
of each plasmid digest was subjected to electrophoresis through a 1 % agarose gel. The 
gel was photographed under UV light.
Replication o f  unmethylated origin-containing plasmid DNA
Two dishes each of Vero and 293 cells were transfected with unmethylated pSP50 
{dam-1dcm-). One dish for each was infected with HCMV, the other was mock infected. 
Dpnl digestion could not be used to differentiate between input plasmid and replicated 
plasmid, so to remove some of the background from unreplicated input DNA, nuclear DNA 
was prepared instead of total cellular DNA. Nuclei were collected 160 h p.i., DNA was 
prepared, digested with fscoRI, and analysed by Southern blot as previously described.
In figure 3.17, the pSP50 detected in mock infected cells is the unmethylated input 
plasmid. Less unmethylated input plasmid was detectable in Vero cells than in 293 cells. 
The relative amounts of pSP50 observed in mock infected 293 and Vero cells corresponds 
with the relative amounts of Dpnl bands seen in the two cell lines in previous experiments 
{e.g. figure 3.10), and probably reflects differences in the uptake and stability of transfected 
DNA in the two cell lines.
The increase in intensity of the pSP50 band in AD 169 infected cells compared with 
mock infected cells confirms that unmethylated pSP50 was replicated in infected Vero and 
293 cells. Origin-containing plasmid DNA replication in Vero cells is therefore not a 
consequence of the plasmid DNA being dam or dcm methylated.
3.2.4 Production of virus progeny and electron microscopic examination of infected 
cells
293 cells clearly support the replication of infecting genomic DNA of HCMV 
strains AD 169 and Towne. In order to investigate how far the replication cycle proceeds, 
cells were examined for the production of progeny virus by virus yield assay and electron 
microscopic examination of infected cell pellets.
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Figure 3.17 Replication o f unmethylated pSP50.
Vero and 293 cells were transfected with 1.6 pg/dish of unmethylated pSP50. Cells 
were infected with 0.25 p.f.u./cell of HCMV (AD) or mock infected (Ml). Nuclear DNA 
was prepared 160 h p.i.. 25% of the DNA from a 35 mm dish was digested with £coRI. 
Fragments were separated by electrophoresis through a 0.8% agarose gel which was 
blotted as described and the blot hybridised to32P-labelled pATl 53.
------------- Position of £coRI digested pSP50.
(a) Production o f viral progeny
HCMV strain AD 169
HFFF2, Vero and 293 cells were infected with 1 p.f.u./cell of HCMV strain AD 169. 
Virus was adsorbed to the cells for 45 minutes at 37°C. After virus adsorption, the 
inoculum was removed and monolayers were washed twice with 2 ml of DPS per dish, then 
fed 2 ml of DC5 and the incubation was continued. Samples were collected by scraping 
cells into the supernatant medium then extensively sonicating the cell suspension. Samples 
were collected at 0, 26 and 110 h p.i., stored at -70°C until required, then sonicated and 
titrated on HFFF2 monolayers as described. Virus yields from a single experiment are 
plotted in figure 3.18.
In all three cell lines, an initial drop in virus titre corresponding to the eclipse phase 
was observed. At 110 h p.i., progeny virus was detected from HFFF2 cells while a further 
decrease in titre was observed from both 293 and Vero cells.
HCMV strain Towne
Monolayers of Vero and 293 cells infected with 1 p.f.u./cell of HCMV strain 
Towne, were incubated, harvested and titrated as described above. Results from a single 
experiment are plotted in figure 3.19.
In both cell lines, an initial drop in titre was observed at 26 h p.i.. By 110 h p.i., the 
titre from Vero cells had dropped further while the titre from 293 cells increased slightly. 
Although this experiment does not include HCMV strain Towne growth in HFFF2 cells, 
these were used for the production of the viral stocks and would be expected to yield a 
curve similar to that obtained for HCMV strain AD 169 infection.
Summary
Vero cells do not support the growth of either HCMV strain AD 169 or Towne as 
determined by virus yield assay. Although strain AD 169 did not grow in 293 cells, the
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Figure 3.18 Production of infectious HCMV strain AD 169.
Vero. 293 and HFFF2 cells were infected with 0.5 p.f.u./cell o f HCMV strain AD 169. Cell 
sonicates were collected at various times after infection and titrated on HFFF2 cells.
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Figure 3.19 Production of infectious HCMV strain Towne.
Vero and 293 cells were infected with 1 p.f.u./cell of HCMV strain Towne. Cell sonicates 
were collected at various times after infection and titrated on HFFF2 cells.
small increase in the titre obtained from strain Towne infected 293 cells between 26 and 
110 h p.i. suggests that limited growth of this virus may have occurred, even though the 
final yield obtained was less than the input. Before concluding that 293 cells support 
limited growth of HCMV strain Towne, these virus yield assays must clearly be repeated.
(b) Examination of infected cells by electron microscopy (EM)
To further investigate how far the growth cycle o f HCMV proceeds in 293 cells, 
infected cell sections were examined by transmission electron microscopy (EM).
50 mm dishes of HFFF2, Vero and 293 cells were set up overnight to be 
approximately 80 % confluent when infected. Monolayers were infected with 2 p.fiu./cell 
of HCMV strain AD 169, or Towne, or mock infected. Cells were fed 5 ml of DC5 per dish 
and incubation was continued at 37°C.
Cell pellets were prepared 140 h p.i. and stored under 2.5 % glutaraldehyde in PBS 
(v/v) at 4°C until the pellets were processed for examination by transmission electron 
microscopy. The preparation, examination and photography of cell sections was performed 
by Mr. Jim Aitken. At least fifty nuclei were examined for each section. Negatives from 
the electron microscope were scanned by D Bhella. Images of infected cell sections are 
shown in figures 3.20 - 3.22. The data presented here are the result of one experiment 
taken at one time point and should be repeated and expanded to confirm that the results are 
not an aberration.
Figure 3.20 shows HCMV strain AD 169 (a) and Towne (b) infected HFFF2 cells. 
In the mock infected sample, no virus was detected. All the nuclei examined from the 
AD 169 and Towne infected cell pellets contained virus particles.
Figure 3.21 shows HCMV strain ADI69 (a) and Towne (b) infected Vero cells. 
No virus particles were seen in any AD 169, Towne or mock infected Vero cells.
Figure 3.22 shows HCMV strain Towne infected 293 cells. Approximately 10 % of 
nuclei examined contained virus particles and two or three extracellular virus particles were
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Figure 3.20 Electron micrographs o f cytomegalovirus infected HFFF2 cells.
HFFF cells were infected with 2.5 p.f.u. per cell of HCMV strain AD 169 (a) or with 2.5 p.f.u. per cell 
of HCMV strain Towne (b). Cell pellets were collected 140 h p.i.. Pellets were dehydrated, stained 
with uranyl acetate and counter-stained with lead citrate. 70 nm thick sections were examined at 
10,000 times magnification.
The bar in the bottom left-hand corner of each picture represents approximately 250 nm.
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Figure 3.21 Electron micrographs o f cytomegalovirus infected Vero cells.
Vero cells were infected with 2.5 p.f.u. per cell o f HCMV strain AD 169 (a) or with 2.5 p.f.u. per 
cell o f  HCMV strain Towne (b). Cell pellets were collected 140 h p.i.. Pellets were dehydrated, 
stained with uranyl acetate and counter-stained with lead citrate. 70 nm thick sections were 
examined at 10,000 times magnification.
The bar in the bottom left-hand comer o f each picture represents approximately 250 nm.
Figure 3.22 Electron micrographs o f cytomegalovirus infected 293 cells.
293 cells were infected with 2.5 p.f.u. per cell o f HCMV strain Towne. Cell pellets were 
collected 140 h p.i.. Pellets were dehydrated, stained with uranyl acetate and 
counter-stained with lead citrate. 70 nm thick sections were examined at (a) 10,000 or (b) 
20,000 times magnification.
The bar in the bottom left-hand corner o f each picture represents approximately 250 nm.
seen. Cells which contained virus particles seemed to be clumped together in the block.
During the examination of HCMV strain AD 169 infected 293 cells, only one 
nucleus (of >100 nuclei examined) was found containing capsids. No virus was seen in 
mock infected 293 cells.
Summary
No virus was observed in any mock infected sample. HCMV particles were not 
observed in any sample of infected Vero cells, but all the nuclei in the infected HFFF2 
samples contained virus particles. 293 cells contained HCMV strain Towne particles in 
approximately 10 % of cells examined by electron microscopy, but only one nucleus from 
over one hundred AD 169 infected 293 cells examined contained any particles.
3.3 Discussion
3.3.1 Replication of an HCMV origin-containing plasmid in HCMV strain AD 169 
infected Vero cells
An HCMV origin-containing plasmid was shown to be replicated in Vero cells in 
the absence of detectable accumulation of helper virus genomes (figure 3.6). The data 
presented in section 3.2.3 confirmed that plasmid replication was dependent on the HCMV 
DNA polymerase and intact HCMV origin sequences, but independent of the presence of 
bacterial DNA methylation.
The most simple explanation for the apparently different behaviour of plasmid and 
genomic DNA is that because of the high background signal from input genomes, a low 
level of replication may have been missed. The use of Southern blot analysis means that an 
unambiguous increase in the signal from genomic DNA is necessary in order to conclude 
that replication has taken place.
In CV-1 cells, a very marked decrease in the amount of HCMV genomic DNA was 
observed, presumably as non-infectious input viral DNA was degraded. The decrease in
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HCMV genomes detected in Vero cells was slower than the decrease in CV-1 cells, 
suggesting that a low level of DNA synthesis may have been occurring in Vero cells. The 
almost constant level of genomic DNA detected between 2 and 6 days post infection might 
represent a balance between genome replication and degradation. To analyse this further, 
time-course experiments could be done in HCMV strain AD 169 infected Vero cells in the 
presence and absence of PFA. If higher levels of HCMV DNA accumulated at late times in 
the absence of inhibitor, this would suggest that DNA synthesis was occurring at a low 
level.
Other possible explanations for the replication of an HCMV origin-containing 
plasmid but apparently not HCMV strain AD 169 genomes in Vero cells, are discussed 
below.
(a) Relative copy numbers
Genomic DNA was supplied by infection with 1 p.f.u./cell of HCMV (one 
infectious genome per cell). Since the particle:p.f.u. ratios of my virus stocks were in the 
range of 100-300:1, this may mean that more than one genome actually reached the nucleus 
of each infected cell. Nevertheless, as 1 pg of pSP50 corresponds to approximately lx l 0n 
plasmid molecules, it is probable that many more copies of the HCMV origin-containing 
plasmid than HCMV genomes were delivered. If the HCMV replication proteins in 
transfected and superinfected cells are present in limiting amounts, it is possible that 
preferential replication of the plasmid sequence might occur. However, this postulated 
inhibition of genomic replication by origin-containing plasmids would only be expected to 
be observed in these time-course experiments if the plasmid were taken up by the majority 
of cells.
A time-course for HCMV DNA replication in Vero cells which had not been
transfected was essentially identical to that presented in figure 3.6, showing that the lack of
detectable HCMV DNA accumulation in transfected cells was not solely due to inhibition
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by the origin-containing plasmid (N. Stow, unpublished observation).
(b) DNA methylation
As previously discussed, methylation of DNA in prokaryotic and eukaryotic cells 
may be used to regulate the replication or transcription of DNA. The plasmid DNA used 
has bacterial dam and dcm methylation which is absent from viral genomes, but lacks the 
CpG methylation which is found on eukaryotic DNA. The presence of bacterial DNA 
methylation was not responsible for HCMV origin-containing plasmid replication in HCMV 
infected Vero cells since unmethylated plasmid DNA was replicated (figure 3.17). The 
absence of CpG methylation from the origin-containing plasmid DNA is unlikely to have 
any effect on replication since it was reported that CpG methylation of HCMV genomes in 
infected cells did not occur (LaFemina & Hayward, 1986). However, the effect of CpG 
methylation on pSP50 replication could be tested by examining the replication of plasmid 
DNA which has been methylated by the bacterial CpG methylase, Sssl.
(c) Circularisation
Transfected plasmid molecules are circular, while infecting HCMV genomes are 
linear and are circularised prior to DNA replication (McVoy & Adler, 1994). 
Circularisation of infecting HCMV genomes is one of the earliest steps in DNA replication, 
first detectable at about 4 h p.i. (McVoy & Adler, 1994), and reaching a maximum by 16 h 
p.i.. The failure of HCMV genomic DNA to circularise has previously been observed 
following infection of non-permissive Balb/c-3T3 cells (LaFemina & Hayward, 1983) when 
four HCMV early polypeptides were synthesised, indicating that at least in this case, linear 
HCMV genomes are available as a template for RNA transcription. It is possible that a 
protein required for efficient circularisation of HCMV genomic DNA is absent from, or not 
synthesised in, some ‘non-permissive’ cells such as Vero cells. Thus the HCMV replication 
proteins may be expressed from linear DNA and be able to replicate the circular plasmid 
molecules but not linear HCMV genomes.
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I used field inversion gel electrophoresis (FIGE) followed by Southern blotting in an 
attempt to separate and detect circular and linear HCMV genomes (McVoy & Adler,
1994), but these experiments were unsuccessful and the above hypothesis was not tested.
3.3.2 HCMV strain Towne DNA replicates more efficiently in the cell lines tested 
than strain AD 169
In contrast to strain AD 169, HCMV strain Towne genomic DNA synthesis was 
detected following infection of Vero cells, (figure 3.8b). Also, although the data were not 
the result of a direct comparison of replication efficiencies, more HCMV strain Towne 
genomic DNA than AD 169 DNA accumulated in infected 293 and U-373 MG cells. An 
investigation into the replication of human cytomegalovirus in SCID-hu mice (Brown et al.,
1995) also revealed differences in the replicative abilities of HCMV strain AD 169 and 
Towne. HCMV strain Towne and strain AD 169 from one source were able to replicate in 
the mice, while AD 169 from a second source could not. The observed difference in DNA 
replication of the two HCMV strains studied here in Vero cells, may be due to interstrain 
sequence differences.
Because both HCMV strains are able to replicate an HCMV origin-containing 
plasmid in Vero cells, reported differences in the origin sequences of HCMV strain AD 169 
and Towne (Chen et al., 1996), in immediate early gene expression (Gibson, 1981), or 
possible differences in expression of the DNA replicative machinery of the two viruses, are 
unlikely to account for their different behaviours in Vero cells. However, HCMV strain 
Towne has at least one sequence block which is absent from the AD 169 sequence (Cha et 
al., 1996), and the presence of additional genes in the Towne strain might allow the virus to 
be less host-cell restricted.
Sequence variation between the two strains is particularly pronounced at the 
‘a’-sequence (Mocarski et al., 1987). As well as having roles in cleavage/packaging of 
replicated concatemeric DNA at the L-S junction, the ‘a’-sequence has been implicated in
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the circularisation of infecting linear genomes, and it would therefore be of interest to 
determine whether strain AD 169 and Towne differ in their ability to circularise following 
infection of Vero cells.
3.3.3 HCMV strain Towne DNA replicates in cells which have previously been 
reported to not support HCMV DNA synthesis
The results presented in section 3.2.2, showing that Vero and 293 cells can support 
the replication of HCMV strain Towne genomic DNA to a level greater than 3% of the 
level detected in a fully permissive infection of human fibroblast (HF) cells, differ from 
previously reported findings, (LaFemina & Hayward, 1986; 1988).
To exclude the possibility that my cell lines were not actually Vero or 293 cells, I 
checked my 293 cells by immunofluorescence using a commercially available antibody, to 
confirm that they expressed Adenovirus El A. In addition, I used Vero cells from two 
sources in the early experiments and these gave identical results. The possibility that 
HCMV driven replication was confined to a small number of HF cells contaminating the 
293 and Vero cultures can be excluded because of the high levels of replication of the 
origin-containing plasmid observed in these cells.
In this thesis, DNA replication was examined following superinfection of cells 
which had been transfected, while LaFemina and Hayward (1986; 1988) infected 
untransfected cells. Transfection itself is unlikely to have caused the differences seen, and 
indeed, similar analysis of strain AD 169 replication in untransfected Vero and 293 cells 
yielded essentially the same results as I observed in transfected cells (N Stow, personal 
communication).
Altered tropisms of clinical HCMV isolates, associated with changes in the viral 
genomes, have been reported to occur following tissue culture adaptation of the viruses 
(Sinzger et al., 1999), and laboratory strains of HCMV have been reported to have lost up 
to 19 genes found in recent clinical isolates (Cha et al., 1996). It is therefore conceivable
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that my HCMV strain Towne stocks differ from those used by LaFemina and Hayward 
(1986; 1988). Resolution of the differences in behaviour reported here might be achieved 
by exchange of virus and cell stocks
3.3.4 Production of virus progeny and electron microscopic examination of infected 
cells
The data presented here (figures 3.18 - 3.22) as growth curves and electron 
micrographs were from preliminary experiments which need to be repeated in order to 
confirm the results, especially those concerning the replication of HCMV strain Towne in 
293 cells.
Neither Vero cells infected with HCMV strain ADI69 or Towne, nor 293 cells 
infected with HCMV strain AD 169, supported the production of HCMV progeny as 
measured by plaque assay or by electron microscopy (EM).
HCMV particles were, however, observed by EM at 140 h p.i. in 10% of 293 cells 
infected with HCMV strain Towne. The observation of HCMV particles in only one 
nucleus of over one hundred HCMV strain AD 169 infected 293 cells examined suggests 
that the particles in Towne infected cells are unlikely to be input virus. This data would 
seem to indicate another clear difference between the behaviour of HCMV strains AD 169 
and Towne in tissue culture. However, to confirm that de novo synthesis of proteins and 
DNA is required for HCMV strain Towne particle formation, infected cells should be 
incubated both with and without cycloheximide or phosphonoformic acid and analysed by 
electron microscopy.
It would be interesting to further investigate the block to the replication cycle in
HCMV Towne and AD 169 infected Vero and 293 cells, and to determine whether all the
cells in the population behave similarly, or if DNA synthesis occurs in only a minority of
cells in a population. Western blotting or indirect immunofluorescence against infected
Vero and 293 cells could be done with a panel of antibodies to HCMV early and late
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proteins. In order to verify that the proteins are synthesised de novo and are not 
components of the inoculum, proteins from infected cells incubated in cycloheximide or 
phosphonoformic acid should be screened in parallel.
»
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Chapter 4; Transient replication assay
4.1 Introduction
The cis-acting signals and trans-acting proteins required for viral DNA synthesis 
have now been identified for representative members of the Alpha-, Beta-, and 
Gammaherpesviruses.
A lytic origin for HSV-1 DNA replication was identified by transfecting plasmids 
containing fragments of HSV-1 DNA into cells which were infected with HSV-1. 
Subsequently, the cotransfection method developed by Challberg (Challberg, 1986) was 
used to identify seven HSV-1 proteins directly involved in HSV-1 origin-dependent DNA 
synthesis (Wu et al., 1988)
Epstein-Barr virus is the prototype human Gammaherpesvirus. An EBV origin of 
lytic phase DNA replication (oriLyt) was identified, as were EBV encoded homologues of 
the six HSV-1 replication fork proteins (Hammerschmidt & Sugden, 1988; Fixman et al., 
1992). The replication fork proteins are the helicase-primase complex, the DNA 
polymerase holoenzyme and the single-stranded DNA binding protein. In addition to the 
EBV replication fork proteins, Zta, Mta and Rta are required for EBV oriLyt dependent 
DNA synthesis in a cotransfection assay. The functional conservation of the six replication 
fork proteins between HSV-1 and EBV is such that in a cotransfection assay, the HSV-1 
proteins, supplemented with Zta and Rta, directed EBV oriLyt dependent DNA synthesis, 
(Fixman et al., 1995).
An origin of HCMV lytic-phase DNA replication (oriLyt) has been identified,
(Anders et al., 1992) and a transient replication assay was used to identify eleven HCMV
loci required for origin-dependent DNA synthesis (Pari & Anders, 1993). The eleven loci
identified included homologues of the six herpesviral replication fork proteins. The
remaining five HCMV loci identified were termed auxiliary loci. Four of the auxiliary loci
were shown to cooperate in the activation of expression from the HCMV DNA polymerase
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accessory protein promoter (Iskenderian et al., 1996). The effect of the fifth auxiliary locus 
(UL84) on gene expression was small.
Sarisky and Hayward (1996) reported that the six EBV replication fork proteins 
together with HCMV UL84 were able to activate the HCMV origin in transfected Vero 
cells, suggesting that of the HCMV auxiliary loci, only UL84 provided an essential 
origin-specific function.
4.2 Results
4.2.1 Replication of an HCMV origin-containing plasmid by the HCMV replicative 
machinery
The HCMV transient replication assay (Pari & Anders, 1993) requires the 
transfection of twelve plasmids into human foetal foreskin fibroblasts. I endeavoured to 
use this assay to further investigate HCMV origin-dependent DNA synthesis, but, despite 
numerous attempts, was unable to achieve replication of the HCMV origin-containing 
plasmid by cotransfection of HF cells with the set of plasmids used by Pari and Anders 
(1993).
As 293 and Vero cells were shown to be permissive for HCMV origin-dependent 
DNA synthesis (section 3.2.2 of this thesis), and because of their relatively high efficiency 
of transfection, the HCMV transient replication assay was attempted in these cells. Again, 
no replication of an HCMV origin-containing plasmid was detected following 
cotransfection with plasmids encoding the eleven essential replication loci.
4.2.2 Replication of an HCMV origin-containing plasmid by the HSV-1 core 
replication machinery
As it had previously been demonstrated that the EBV replication fork proteins were 
functionally interchangeable with the replication fork proteins of both HSV-1 and HCMV 
(Fixman et al., 1995; Sarisky & Hayward, 1996), the ability of the HSV-1 replication fork
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proteins to replicate an HCMV origin-containing plasmid in the presence of the HCMV 
auxiliary loci was investigated.
fa) Replication of pSP50 by the HSV-1 core replication machinery
The six open reading frames encoding the HSV-1 replication fork proteins UL5, 
UL8, UL29, UL30, UL42 and UL52 are contained in plasmids pE5, pE8, pE29, pE30, 
pE42 and pE52. Plasmid pE9 expresses the HSV-1 origin-binding protein (UL9) and a 
functional copy of oriS is contained within pSl. The HSV-1 plasmids were used in 
combination with the HCMV origin-containing plasmid (pSP50) and plasmids encoding the 
HCMV auxiliary proteins (pZP3 encoding IRS1/TRS1, pZP8 encoding UL36-38, pZP13 
encoding UL84, pZP24 encoding UL112-113, pSVH encoding IE1/IE2, pCV84 
constructed to constitutively express UL84).
Expression o f  UL84 in transfected cells
To confirm that pCV84 expresses UL84, immunofluorescent labelling was used to 
detect UL84 in transfected cells. pZP13 was transfected with the remaining ten replication 
plasmids to ensure expression from the UL84 promoter. Expression of UL84 from the 
HCMV major immediate early promoter (in pCV84) did not require addition of any other 
HCMV loci.
293 cells were set up and transfected as previously described. One dish of cells (a) 
was transfected with 0.4 pg/dish each of pZP3, pZP7, pZP8, pZP13, pZP18, pZP20, 
pZP24, pZP29, pZP33 and pZP37 and with 1.6 pg/dish each of pSVH and pSP50. The 
cells were fixed 120 h p.t.. One dish of cells (b) was transfected with 0.8 pg/dish of pCV84 
and fixed 48 h p.t.. Cells were permeabilised then probed with the UL84 monoclonal 
antibody, D42, followed by Cy™3 conjugated goat anti-mouse IgG.
Cells were examined by fluorescent microscopy at 543 nm. Images were captured 
in black and white with a CCD camera system and were converted to pseudocolour using
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the associated software. The fluorescent images shown in figure 4.1 indicate that in both 
instances UL84 could be detected with the monoclonal antibody. In cells transfected with 
either pZP13 or pCV84, the staining is predominantly nuclear, but is not in clearly defined 
replication compartments. Cells transfected with a plasmid containing the UL84 open 
reading frame in reverse orientation (pCV84(-)) did not stain red (data not shown). 
Non-expressing cells in the fields of view shown in figure 4.1, which are not stained red, 
also confirm the specificity of antibody binding.
pSP50 is replicated by the HSV-1 replication fork proteins and the HCMV auxiliary 
proteins
Vero cells were transfected with a mixture containing the six HSV-1 replication 
fork plasmids supplemented with either (a) 0.4 pg/dish each of pE9 and pSl, (b) 0.4 
pg/dish of pCV84 and 1.6 pg/dish of pSP50, or (c) 0.4 pg/dish each of pZP3, pZP8, 
pZP13 and pZP24 and 1.6 pg/dish each of pSVH and pSP50. Total cellular DNA was 
prepared at 46 h p.t.. DNA was processed as previously described, hybridised to 
32P-labelled pAT153, and an image obtained (figure 4.2).
As expected, pSl was replicated by the HSV-1 replication machinery and the 
HSV-1 origin-binding protein. Similarly, pSP50 was replicated after cotransfection of the 
six HSV-1 plasmids with the full set of five HCMV auxiliary loci with UL84 supplied by 
pZP13. pSP50 was not, however, replicated by cotransfection of the HSV-1 core 
replication plasmids with a plasmid that constitutively expresses UL84.
The HSV-1 replication fork proteins, like their EBV homologues, are therefore able 
to replicate an HCMV origin-containing plasmid in the presence of the HCMV auxiliary 
proteins. In contrast to the findings with EBV, UL84 alone does not appear to be able to 
mediate replication in the presence of the HSV-1 replication fork proteins.
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Figure 4.1 Expression of IJL84 in transfected 293 cells.
293 cells were transfected with (a) 0.4 pg/dish each of pZP3, pZP7, pZP8, pZP13, pZP18. 
pZP20, pZP24, pZP29. pZP33 and pZP37 and 1.6 pg/dish each of pSVH and pSP50 or with 
(b) 0.8 pg/dish o f pCV84.
Cells were fixed 120 (a) or 48 (b) h post transfection. Cells were permeabilised and probed 
with D42 (monoclonal UL84 antibody) then Cy™3 conjugated goat anti-mouse IgG. Slides 
were examined by fluorescent microscopy at 543 nm. Digital images were captured and 
processed as described.
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Figure 4.2 Replication o f pSP50 by the HSV-1 replicative machinery.
Vero cells transfected with 0.4 pg/dish each of the HSV-1 replication fork plasmids 
(pE5, pE8, pE29, pE30, pE42 and pE52) with the addition of: (a) 0.4 pg/dish each of pS 1 
and pE9, (b) 1.6 pg/dish pSP50 and 0.4 pg/dish pCV84, (c) 1.6 pg/dish pSP50 and 0.4 
pg/dish each ofthe HCMV auxiliary plasmids (pZP3, pZP8„ pZP13 and pZP24) and 1.6 
pg/dish o f pSVH.
25% o f the DNA from a 35 mm dish was digested with EcoRl and Dpnl. Fragments 
were separated by electrophoresis through a 0.8% agarose gel and blotted as described. 
The blot was hybridised to 32P-labelled pATl 53.
4 ng o f EcoRl digested pSl was loaded as a marker (pS l).
^ ----------  Shows the position of an £coRI digested pSP50 marker band.
(b) Sensitivity o f replication to PAA
To confirm that the replication of pSP50 (figure 4.2) was due to the HSV-1 DNA 
polymerase, the sensitivity of replication to PAA was determined.
Vero monolayers were transfected with pCMVori, the six HSV-1 replication 
plasmids, and the HCMV auxiliary plasmids. After the DMSO boost, cells were fed with 
unsupplemented medium or with medium supplemented with 200 pg/ml of PAA. At 46 h 
p.t., total cellular DNA was prepared and processed as described previously.
Figure 4.3 shows that in the absence of polymerase inhibitor, pCMVori was 
replicated. Cells treated with PAA failed to support the replication of pCMVori, 
confirming that the replication observed was due to the HSV-1 DNA polymerase.
tel Replication is specific to HCMV origin sequences
To confirm that the replication observed was due to the HCMV origin sequences, 
three origin-containing plasmids and one deleted origin-containing plasmid were tested in 
the cotransfection assay.
Vero cells were transfected with the six HSV-1 replication fork plasmids and the 
HCMV auxiliary plasmids together with 0.8 pg/dish of pSP50, pADori, pADoriAXhoI or 
pMAl.
Total cellular DNA was prepared 46 h p.t. and digested with Xbal (linearises each 
of the test plasmids), and Dpnl. Fragments were separated by electrophoresis, blotted and 
hybridised as before. The blot was exposed to a phosphorimager screen and a 
phosphorimage was produced (figure 4.4).
As observed following HCMV superinfection in transfected Vero cells (figures 3.1 
and 3.15), in this experiment pSP50, pADori and pMAl were all replicated, the deleted 
origin-containing plasmid, pADoriAXhoI, was not. Replication of an HCMV 
origin-containing plasmid by the HSV-1 replication fork proteins is therefore not peculiar
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Figure 4.3 Sensitivity of replication to PAA.
Vero cells transfected with 0.4 pg/dish each of the HSV-1 replication fork plasmids, 1.6 
pg/dish of pCMVori and 0.4 pg/dish of each o f the five HCMV auxiliary plasmids. Cells 
were incubated in unsupplemented media (U) or media containing 200 pg/ml PAA (P).
25% of the DNA from a 35 mm dish was digested with Xba\ and Dpn\. Fragments were 
separated by electrophoresis through a 0.8% agarose gel and blotted as described. The blot 
was hybridised to 32P-labelled pAT153.
4 ng ofXba\ digested pCMVori was loaded as a marker (CMVori)
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Figure 4.4 Replication is specific to HCMV origin sequences.
Vero cells transfected with 0.4 pig/dish each of the HSV-1 replication fork plasmids and 0.4 qg/dish of 
each o f the five HCMV auxiliary plasmids.
0.8 p.g/dish of the appropriate origin containing plasmid was added; (a) pSP50, (b) pADori, (c) 
pADoriAXho, or (d) pM Al.
25% of the DNA from a 35 mm dish was digested with Xba\ and Dpn\. Fragments were separated through 
a 0.8% agarose gel and blotted as described. The blot was hybridised to 32P-!abelled pATl 53.
4 ng each oiXba\ digested pSP50 (pSP50), pADori (ADori), pADoriAXho (ADoriAX) and pMAl 
(pM Al) were loaded as markers.
to pSP50 and is, furthermore, dependent on an intact HCMV lytic origin sequence.
4.2.3 HCMV functions required for replication of an HCMV origin-containing 
plasmid by the HSV-1 replication fork proteins
The results presented in section 4.2.2 demonstrated that the HSV-1 replication fork 
proteins are able to replicate an HCMV origin-containing plasmid in the presence of the 
five HCMV auxiliary loci. Further work was therefore done to define which of the HCMV 
auxiliary loci are essential in the HSV-1 driven transient replication assay.
(a) Replication is not dependent on UL84 or IRS1/TRS1
An omission assay was done to determine whether UL36-38, UL84, or IRS1/TRS1 
were important for the replication of pSP50 by the HSV-1 replication fork proteins.
Vero cells were transfected with the HSV-1 replication fork plasmids, pSP50, and 
the five HCMV auxiliary plasmids (a), (b) pZP3, (c) pZP8 or (d) pZP13 were individually 
omitted from the transfection mix. At 46 h p.t., total cellular DNA was prepared and 
processed for analysis by Southern blotting as previously described, and an image was 
produced.
Figure 4.5 shows that omission of pZP8 significantly inhibited the replication of 
pSP50. Omission of pZP13 or pZP3 did not reduce the amount of plasmid replicated.
(b) pSVH provides functions for replication of pSP50 by the HSV-1 replication proteins
Vero cells were set up and transfected with the HSV-1 replication fork plasmids, 
pSP50, and all five possible combinations of four HCMV auxiliary plasmids (0.4 pg/dish of 
each) i.e., each of the five HCMV auxiliary plasmids was omitted in turn from the 
transfected plates. Total cellular DNA was prepared, digested with EcoKl and Dpnl, and 
processed as previously described to produce the image in figure 4.6.
It was previously shown (figure 4.5) that there was no decrease in the amount of 
pSP50 replication when either UL84 or ISR1/TRS1 were omitted from the transient
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MFigure 4.5 Replication is not dependent on UL84 or IRS1/TRS1.
Vero cells were transfected with 0.4 pg/dish of each o f the HSV-1 replication fork 
plasmids, 1.6 pg/dish of pSP50 and pS VH and 0.4 pg/ dish of each of pZP3, pZP8, pZP 13 
and pZP24 with the following omissions; (a) no omission, (b) pZP3, (c) pZP8 and (d) 
pZP13.
25% ofthe DNA from a 35 mm dish was digested with EcoK\ and Dpn\. Fragments were 
separated by electrophoresis through a 0.8% agarose gel and blotted as described. The 
blot was hybridised to 32P-labelled pAT153.
4 ng of EcoRl digested pSP50 was loaded as a marker (M).
Figure 4. 6  Repl icat ion is dependent on pSVH.
Vero cells transfected with 0.4 pg/dish of each of the HSV-1 replication fork 
plasmids, 1.6 pg/dish of pSP50 and 0.4 pg/dish of each o f pZP3, pZP8, pZPl 3, 
pZP24 and pSVH with the following omissions; (a) pZP13, (b) pZP3, (c) pZP8, 
(d) pZP24 and (e) pSVH.
25% of the DNA from a 35 mm dish was digested with EcoRX and Dpn\. 
Fragments were separated by electrophoresis through a 0.8% agarose gel and 
blotted as described. The blot was hybridised to 32P-labelled pATl 53.
4 ng o f EcoRl digested pSP50 was loaded as a marker (pSP50)
replication assay. The level of replication in the absence of either pZP3 or pZP13 can 
therefore be taken as the positive control level. Figure 4.6 shows that omission of pZP24,
(d), did not reduce the replication of pSP50 by the HSV-1 replication fork proteins. 
Omission of pSVH (e) abrogated replication of pSP50, and although the effect was less 
marked, omission of pZP8 (c) also caused a large drop in replication efficiency.
The UL112-113 products (expressed from plasmid pZP24) are, like UL84 and 
IRS1/TRS1, dispensable in this assay, whereas one or more of the proteins encoded by 
pSVH and pZP8 appear to play more important roles.
(c) pSVH is sufficient to complement replication of pSP50 by the HSV-1 core replication 
proteins
Vero cells were set up and transfected as previously described with a mix containing 
the HSV-1 replication fork plasmids and pSP50 in the presence or absence of pSVH. At 
48 h p.t., total cellular DNA was prepared and analysed as previously described.
Figure 4.7 shows that although pSP50 was not replicated by the HSV-1 replication 
machinery alone (a), replication was observed on addition of pSVH (b).
One (or more) of the protein products of pSVH is therefore both necessary and 
sufficient to mediate replication of an HCMV origin-containing plasmid by the HSV-1 
replication fork proteins.
fd) Replication efficiency is significantly increased bv pZP8
Vero monolayers were transfected with a mix containing pCMVori, the HSV-1 
replication fork plasmids and pSVH. Plates were additionally transfected with individual 
plasmids pZP3, pZP8, pZP13 or pZP24, or with pZP8 in combination with pZP3, pZP13 or 
pZP24.
Total cellular DNA was prepared 46 h p.t., digested with Xbal and Dpnl, and 
analysed by Southern blot hybridised to 32P-labelled pAT153. The blot was exposed to a 
phosphorimager screen, the image generated is shown in figure 4.8.
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Figure 4.7 pSVH is sufficient to complement the HSV-1 replication fork proteins 
for replication o f pSP50.
Vero cells were transfected with 0.4 pg/dish o f each of the six HSV-1 core 
replication plasmids, 1.6 pg/dish of pSP50 and either (a) no addition, or (b) 0.4 
pg/dish o f pSVH.
25% of the DNA from a 35 mm dish was digested with EcoK\ and Dpn\. 
Fragments were separated by electrophoresis through a 0.8% agarose gel and 
blotted as described. The blot was hybridised to 32P-labelled pATl 53.
4 ng of EcoRl digested pSP50 was loaded as a marker (pSP50)
CMVori a b c d e f  g h
Figure 4.8 Replication efficiency is significantly increased by pZP8.
Vero cells transfected with 0.4 pg/dish o f each of the HSV-1 replication fork plasmids 
and pSVH, and 1.6 pg/dish each of pCMVori and 0.4 pg/dish of each of (a) pZP3, (b) 
pZP13, (c) pZP24, (d) pZP8, (e) pZP3 and pZP8, (f) pZP13 and pZP8, (g) pZP24 and 
pZP8 or (h) no additional plasmids.
25% of the DNA from a 35 mm dish was digested with Xba\ and Dpn\. Fragments were 
separated through a 0.8% agarose gel and blotted as described. The blot was hybridised 
to 32P-labelled pAT153.
4 ng oiXba\ digested pCMVori (CMVori) was loaded as a marker.
As before, the HCMV origin-containing plasmid, pCMVori, was replicated by the 
HSV-1 replication machinery supplemented with pSVH (h). Addition of pZP3 (a), pZP13
(b), or pZP24 (c) did not increase the amount of pCMVori replicated, in contrast, addition 
of pZP8 (d) did significantly increase the amount of replicated plasmid observed. Addition 
of pZP3, pZP13 or pZP24 (lanes e, f, or g respectively) to a mix containing both pSVH and 
pZP8 did not further increase the amount of plasmid replicated.
Thus one or more of the products of pZP8 can significantly enhance the replication 
of an HCMV origin-containing plasmid by the HSV-1 replication fork proteins and pSVH.
(e) Replication fork functions could not be provided bv HSV-1
In order to simplify this assay, HSV-1 virus was tested for its ability to replicate 
pSP50 in the presence of the HCMV auxiliary loci.
Vero cells were transfected with pSP50, pZP8 and pSVH. Replication fork 
proteins were provided by infection with 20 p.f.u./cell of HSV-1 (X) or by cotransfection 
of the six HSV-1 replication fork plasmids (P).
Total cellular DNA was prepared 46 h p.t. and digested with EcoRl and Dpnl. 
Fragments were separated by electrophoresis, blotted and hybridised to 32P-labelled 
pAT153. The blot was exposed to a phosphorimager screen and scanned (figure 4.9).
As before, the HSV-1 replication fork plasmids in the presence of pZP8 and pSVH 
were able to replicate an HCMV origin-containing plasmid. Remarkably, HSV-1 virus was 
unable to function in this assay.
(f) The replicative function of pSVH is attributable to IE2
The major immediate early locus contained in pSVH is a complex region reported 
to specify at least five transcripts. To elucidate which of the major immediate early 
proteins activate the replication of an HCMV origin-containing plasmid in conjunction with 
the HSV-1 replication fork proteins, mutants in pSVH were made and tested. The 
construction of pSVH amber mutants is described in figure 4.10.
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Figure 4.9 HSV-1 virus does not provide replicative machinery to replicate pSP50.
Vero cells were transfected with 1.6 gg/dish of pSP50 and 0.4 jig/dish o f each of pSVH and 
pZP8. Replicative machinery was provided by transfection of 0.4 gg/dish of each of the six 
HSV-1 replication fork plasmids (P) or by infection with 20 p.f.u./cell o f HSV-1 (X).
25% of the DNA from a 35 mm dish was digested with EcoK\ and Dpn\. Fragments were 
separated by electrophoresis through a 0.8% agarose gel and blotted as described. The blot 
was hybridised to 32P-labelled pAT153.
4 ng o f EcoR\ digested pSP50 was loaded as a marker (M).
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Figure 4.10 pSVH mutants.
A) The pSVH plasmid contains two overlapping fragments o f DNA from HCMV strain 
Towne which span the IE 1/2 locus (Stenberg et al., 1990).
B) The coding region for IE 1/2 is shown along with the restriction enzymes used in the 
construction of pSVH mutants. The single and double mutants were made by inserting 
an Xba\ amber linker at the site named. The colored blocks show the regions o f the 
spliced mRNAs which are translated for each protein.
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Expression o f  IE1 and IE2 from pSVH derived plasmids
To confirm that plasmids pSVHABglll (intact IE2 locus) and pSVHAXhoI (intact 
IE1 locus) produce the appropriate proteins, samples of HCMV infected or transfected 
cells were reacted with an IE1/IE2 polyclonal antibody in a Western blot.
293 cells were set up and transfected with 1.6 pg/dish of pSVH, pSVHABglll or 
pSVHAXhoI, or infected with 1 p.f.u./cell of HCMV strain AD 169 or Towne, or mock 
infected.
Cells were harvested 24 h p.i.. Proteins were separated by electrophoresis through 
a 10% SDS-polyacrylamide gel. 10 % of the cells from a 35 mm dish were loaded per lane. 
Duplicate gels were run, one gel was stained to check that similar amounts of protein were 
loaded in each lane (data not shown), the other gel was electroblotted as described. The 
blot was reacted with anti-IE 1/IE2 followed by peroxidase conjugated protein-A. The blot 
was developed using ECL reagent and exposed to X-Omat film. The film was scanned and 
its image is shown in figure 4.11.
Both IE1 and IE2 were detected in cells infected with AD 169 or Towne, or 
transfected with pSVH. The pSVH transfected cells showed proteins which co-migrated 
with those in HCMV strain Towne infected cells. This was expected since the HCMV 
DNA sequences in pSVH were cloned from HCMV strain Towne. The electrophoretic 
mobilities of IE1 and IE2 in cells infected with strain AD 169 were slightly different from 
those in cells infected with strain Towne, in agreement with previous results (Gibson, 
1981).
pSVHABglll expressed IE2-86 but not IE 1-72, while pSVHAXhoI expressed 
IE 1-72 but not IE2-86. The two pSVH mutant plasmids therefore express the expected 
proteins.
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Figure 4.11 Expression of IE1/1E2 from HCMV and pSVH plasmids.
293 cells were either infected with 1 p.f.u/cell of HCMV strain Towne (a), strain ADI 69 (b) or mock 
infected (c), or transfected with either 1.6 pg/dish ofpSVH (d), pSVHABglll (e), or pSVHAXhoI
(f).
Cells were harvested 24 h p.i. and 10% of the cells from a 35 mm dish were subjected to 
electrophoresis through a 10% SDS-polyacrylamide gel which was electroblotted and hybridised to 
polyclonal IE1/IE2 followed by horseradish peroxidase conjugated protein-A. The blot was 
developed with ECL reagent and exposed to X-Omat film.
Replicative function ofpSVH  resides within the IE2 locus
The pSVH mutants were tested for function in the transient replication assay.
Vero cells were set up and transfected with a mix containing the HSV-1 replication 
fork plasmids, pSP50 and pZP8 with (a) no addition, (b) pSVH, (c) pSVHAXhoI, (d) 
pSVHABglll, or (e) pSVHAXhoI and pSVHABglll. Total cellular DNA was prepared 46 
h p.t., analysed by Southern blot as described, and a phosphorimage was produced, figure 
4.12.
As before, replication of pSP50 was directed by the HSV-1 replication fork proteins 
with pSVH and pZP8 (b); pZP8 alone was insufficient to promote HCMV origin-dependent 
DNA synthesis by the HSV-1 replication fork proteins (a). Addition of pSVHABglll (d) to 
the transfection mix allowed transactivation of pSP50, while addition of pSVHAXhoI (c) 
did not support transactivation. Transactivation was observed when both IE mutants were 
transfected together (e).
These results indicate that the products o f pZP8 alone are insufficient to mediate 
replication of an HCMV origin-containing plasmid by the HSV-1 replication fork proteins. 
Furthermore, in the presence of pZP8, replication of pSP50 was observed when a plasmid 
expressing IE2 but not IE1 was used, demonstrating that IE1 is not required for activation 
of the HCMV origin. Transactivation in the presence of both IE mutants confirmed that 
neither deleted protein had a dominant inhibitory effect. It can therefore be concluded that 
the IE2 locus plays an important role in activating the HCMV origin in this assay.
(q) pSVH and pZP8 functions responsible for transactivating replication
IE2 mutants
The IE2 locus generates at least four transcripts, the most abundantly expressed of 
these (at immediate early times, in HF cells) is IE2-86. To determine whether IE2-86 is 
responsible for the replicative function of pSVH, a mutant was made (pSVHASexAI) that
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Figure 4.12 Replicative function o f pSVH resides within the IE2 locus.
Vero cells were transfected with 0.8 pg/dish of pSP50, with 0.4 pg/dish of each o f the six 
HSV-1 replication fork plasmids and pZP8 with the addition of 0.4 pg/dish of the 
following; (a) no addition, (b) pSVH, (c) pSVHAXhoI, (d) pSVHABglll and (e) 
pSVHAXhol and pSVHABglll.
25 % of the DNA from a 35 mm dish was digested with EcoK\ and Dpn\. Fragments were 
separated by electrophoresis through a 0.8% agarose gel and blotted as described. The blot 
was hybridised to 32P-label led pAT153.
4 ng o f EcoK\ digested pSP50 was loaded as a marker (M).
was predicted to abrogate IE2-86 and L40 (a late transcript) and maintain intact IE2-55 
and IE2-18 transcripts. This mutant was tested for function in the cotransfection assay. To 
ensure that any effect seen using the IE2-86 mutant was not due overexpression of IE1, a 
double mutant lacking both IE1 and IE2-86 (pSVHABglHASexAI) was also made (figure 
4.10) and tested (see below).
UL36-38 mutants
The UL36-38 locus in pZP8 expresses at least four known proteins. To determine 
which of the products of the UL36-38 locus were necessary for stimulating replication of 
pSP50 by the HSV-1 replication fork proteins and IE2, pZP8 mutants were made and 
tested.
The construction of pZP8 amber mutants, and an Tfarll deletion mutant, is described 
in figure 4.13.
Vero cells were transfected with the six HSV-1 replication fork plasmids and pSP50 
alone (a) or with the addition of HCMV auxiliary plasmids in combinations outlined in table 
4.1.
LAIVE
a b c d e f g h i j locus or mutation
pSVH X X X X X X IE1/IE2
pSVHASexAI X IE2-86 (L40) mutant
pSVHASexAIABglll X IE1 and IE2-86 (L40) mutant
pZP8 X X X X UL36-38
pZP8ABstEII X X UL36 mutant
pZP8AEcoNI X X UL37 and UL37xl mutant
pZP8ARsrII X X UL37, UL37xl and UL38 mutant
Table 4.1 The plasmids added (X) to the transfection mix containing 0.4 pg/dish of each of the six HSV-1 
core replication plasmids and 1.6 pg/dish of the HCMV origin-containing plasmid. The column labels 
correspond to the lanes of the phosphorimage shown in figure 4.14. The proteins expressed by, or the 
mutations in, the pSVH and pZP8 derived plasmids are described.
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Figure 4.13 pZP8 mutants.
A) The pZP8 plasmid contains 11.0 kbp o f HCMV DNA spanning the UL36-38 locus (Pari et a/., 1993).
B) 1 he UL36-38 coding region contained in pZP8, showing the restriction enzymes used in the 
construction o f the pZP8 mutants. The colored blocks show the translated regions o f the spliced mRNAs 
from UL36-38. Two o f the mutant pZP8 plasmids (to abrogate UL36 and U L37/UL37xl) were made by 
inserting an Xba\ amber linker at the appropriate site within pZP8. The UL38 mutant plasmid was made by 
deleting the sequences o f pZP8 between the two ftsrll sites shown.
Total cellular DNA was prepared 46 h p.t. and digested with EcoRl and Dpnl. 
Fragments were separated by electrophoresis, blotted and hybridised to 32P-labelled 
pAT153. The blot was exposed to a phosphorimager screen and a phosphorimage was 
acquired as previously described. The image is shown in figure 4.14.
The HSV-1 core replication proteins alone, as before, were insufficient to replicate 
pSP50 (a), replication was observed when pSVH (b), but not pZP8 (h), was individually 
present. A combination of pSVH and pZP8 (c) resulted in the highest level of replication.
A level of replication similar to the level of replication with pSVH alone was 
observed when pZP8ARsrII (f) was transfected. Replication was, however, stimulated 
when pZP8ABstEII (d) or pZP8AEcoNI (e) were transfected. Replication was also 
stimulated when all three pZP8 mutants were added to pSVH and the HSV-1 core 
replication plasmids (g), demonstrating that the products of pZP8ARsrII do not have a 
dominant inhibitory effect.
Co transfection of the six HSV-1 replication fork plasmids and pZP8 with either 
pSVHASexAI (i) or pSVHABgUIASexAI (j) failed to complement replication of pSP50.
These results show that the important protein contributed by pSVH is IE2-86 (or 
possibly L40). The fact that the pZP8 derivative plasmids affecting the UL36 or 
UL37/UL37xl proteins supported stimulated levels of DNA replication, whereas the 
plasmid affecting UL37/UL37xl and UL38 did not, suggests that UL38 is the only function 
supplied by pZP8 which is required for enhanced levels of replication.
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Figure 4.14 IE2-86 and UL38 function in mediating replication of pSP50 by the HSV-1 
replication fork proteins.
Vero cells were transfected with 0.4 pg/dish of each o f the six HSV-1 replication fork plasmids.
1.6 pg/dish o f pSP50 and 0.4 pg/dish of the following plasmids: (a) no addition, (b) pSVH, (c) 
pSVFl and pZP8, (d) pSVH and pZP8ABstEII, (e) pSVH and pZP8AEcoNl, (f) pSVH and 
pZP8ARsrII, (g) pSVH and pZP8ABstEII, pZP8AEcoNI and pZP8ARsrII, (h) pZP8, (i) pZP8 and 
pSVHASexAI and (j) pZP8 and pSVHABglllASexAI.
25% of the DNA from a 35 mm dish was digested with EcoK\ and Dpnl. Fragments were 
separated by electrophoresis through a 0.8% agarose gel and blotted as described. The blot was 
hybridised to 32P-labelled pAT153.
4 ng o f £coRI digested pSP50 was loaded as a marker (pSP50)
4.3 Discussion
As I was unable to achieve replication of an HCMV origin-containing plasmid in a 
transient replication assay using plasmids obtained from David Anders, I decided to 
investigate the ability of the HSV-1 replication fork proteins to replicate an HCMV 
origin-containing plasmid when cotransfected with the HCMV auxiliary proteins. In an 
omission assay using the six HSV-1 replication fork proteins, only IE 1/2 was absolutely 
essential for replication, although omission of UL36-38 resulted in a very large drop in 
replication efficiency. The other auxiliary loci were dispensable.
IE 1/2 alone was able to mediate replication by the HSV-1 replication fork proteins 
(figure 4.7). Individual addition of UL84 or UL36-38 to the replication fork proteins was 
also tested but neither was able to mediate replication (figure 4.1 and 4.11). In an addition 
assay with the HSV-1 replication fork proteins and IE 1/2, addition of UL36-38 greatly 
enhanced the replication efficiency. Individual addition of the other auxiliary loci did not 
result in a significant increase in replication efficiency (figure 4.8).
4.3.1 Requirements for replication of an HCMV origin-containing plasmid by the 
HSV-1 replication fork proteins
Whilst my results have demonstrated that there is not an absolute requirement for 
UL84, it should be noted that this is in the context of the replication of an HCMV 
origin-containing plasmid by the HSV-1 replication fork proteins, and that there may be 
differences in HCMV DNA replication during a normal virus infection.
My failure to reproduce the work of Pari and Anders (1993) may have been due to 
a low transfection efficiency in HFFF2 and HFL1 cells. However, when the assay was 
performed in 293 cells, which transfect with much greater efficiency and have been shown 
to be permissive for HCMV DNA replication (figure 3.3), no replication of the 
origin-containing plasmid was ever detected. A mutation in one (or more) of the
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replication plasmids would prevent the assay working, but while none of the plasmids was 
sequenced, a mutation seems unlikely as the plasmids were obtained directly from D Anders 
in whose hands they were functional. A third possible reason for failure to achieve plasmid 
replication in the transient replication assay might have been in my use of well-established 
cell lines instead of the newly cultured foetal foreskin fibroblasts used by Pari and Anders 
(1993).
When tested for its ability to substitute for the HSV-1 replication fork plasmids, 
HSV-1 superinfection failed to direct HCMV DNA replication. One possible explanation 
for this is that the HCMV auxiliary proteins may be significantly less adept than UL9 at 
recruiting the HSV-1 replication fork proteins, so that HSV-1 viral DNA would be 
preferentially replicated in this assay. It would be interesting to determine whether in the 
presence of UL36-38 and IE 1/2, an HSV-1 UL9 null mutant could activate an HCMV 
oriLyt. Another possible explanation for the failure of HSV-1 to activate HCMV oriLyt is 
that virus infection might prevent expression of, or sequester, host cell proteins required for 
the initiation of HCMV DNA synthesis.
Both IE 1/2 and UL36-38 produce spliced transcripts. IE 1/2 produces one late and 
four immediate-early transcripts, and U36-38 produces one early and three immediate early 
transcripts (reviewed by Fortunato & Spector, 1999, also see figures 4.10 and 4.13). 
Derivatives of the pSVH (IE 1/2) and pZP8 (UL36-38) plasmids containing amber 
mutations, and a deletion mutant, were constructed to abrogate expression of certain of the 
IE 1/2 or UL36-38 proteins. Because some of the characterised protein products of IE 1/2 
and UL36-38 are involved in the regulation of gene expression, double mutants and 
combinations of mutant plasmids were tested to ensure that the effects seen were due to the 
mutation of the individual protein rather than due to a secondary effect on gene expression. 
The mutant plasmids enabled the identification of IE2-86 (or L40) and UL38 as the gene 
products which were most active in this HSV-1/HCMV transient replication assay.
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IE2-86 is the major product of the HCMV major immediate early region two (IE2). 
It is a promiscuous, non-sequence specific trans-activator of gene expression capable of 
autoregulation (Pizzomo et al., 1988; Stenberg et al., 1990; Gebert et al., 1997). IE2-86 
can modulate transcriptional activation, and hence gene expression, by direct binding to 
promoter sequences or by interaction with one of a plethora of cellular proteins (reviewed 
by Fortunato & Spector, 1999). No function has yet been attributed to the UL38 protein. 
To confirm the requirement for the two HCMV proteins, plasmids expressing only IE2-86 
and UL38 should be constructed and tested in this assay.
4.3.2 Possible mechanisms of initiation of HCMV DNA replication
The requirement for IE2-86 in this assay is most interesting in the light of the 
observation that a small RNA molecule, termed the smallest replicator transcript (SRT), is 
transcribed from the HCMV oriLyt region (Huang et al., 1996). The candidate promoter 
for the SRT contains putative IE2-86 binding sites, deletion of some of which have been 
reported at a recent International Herpesvirus Workshop to abrogate origin function (Kiehl 
et al., 2000). It has been proposed that the initiation of HCMV DNA replication, like 
mitochondrial heavy strand DNA replication, may require an origin derived transcript 
(Prichard et al., 1998). IE2-86 may be responsible for directing transcription through the 
origin, and UL38 might possibly activate this function or stabilise the RNA:DNA hybrid. 
Since UL84 seems absolutely essential for HCMV origin-dependent DNA synthesis in the 
presence of either the HCMV or EBV replication fork proteins, it may provide some 
function that is required by the HCMV and EBV replication fork proteins but not the 
HSV-1 proteins. The HSV-1 replication fork proteins may encode some enzyme function 
not encoded by the HCMV or EBV proteins, e.g., the HSV-1 DNA polymerase has an 
RNase H activity (Marcy et al., 1990) while no such activity has been confirmed for the 
HCMV DNA polymerase. Alternatively, the HSV-1 proteins may allow initiation of DNA 
replication by a mechanism which does not require UL84.
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Similarly, the HSV-1 replication fork proteins were used to substitute for the EBV 
replication fork proteins to drive replication of an EBV oriLyt containing plasmid. In this 
assay, addition of the Zta and Rta transactivators allowed replication of the EBV 
origin-containing plasmid (Fixman et al., 1995). Zta has subsequently been shown to 
interact with the EBV helicase/primase complex (Gao et al., 1998) and is now accepted as 
being the origin-specific function encoded by EBV. Interestingly, in a transient replication 
omission assay using the EBV replication fork proteins, the EBV uracil-DNA glycosylase 
and the three lytic cycle transactivators, neither Zta nor Rta was absolutely essential to 
direct replication of an EBV origin-containing plasmid, while omission of Mta almost 
completely abrogated replication (Fixman et al., 1995). Thus, while transient replication 
assays have proven extremely useful in the initial identification of virus encoded functions 
required for DNA replication, in complex systems such as HCMV and EBV, careful 
consideration should be given to the interpretation of all available data before any final 
conclusions are reached.
My results contrast with those obtained in transient replication assays using either 
the EBV or HCMV replication fork proteins expressed from constitutive promoters to 
activate HCMV oriLyt (Sarisky & Hayward, 1996 and summarised in table 1.2). The data 
presented by Sarisky and Hayward (1996) led to the conclusion that UL84 was the only 
HCMV encoded auxiliary protein with an absolutely essential role in HCMV oriLyt 
dependent DNA replication. However, the authors also demonstrated that in an omission 
assay in HF cells transfected with the HCMV replication fork proteins, three HCMV 
auxiliary loci, UL36-38, UL84 and IE1/IE2, were essential for HCMV origin-containing 
plasmid replication.
The HCMV lytic cycle in tissue culture is more protracted than that of HSV-1, and 
seems to be intimately associated with the cell cycle and cell type infected, thus HCMV 
may have developed multiple mechanisms to initiate or control the initiation of DNA
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replication. It is easy to imagine that when taken out of the context of a virus infection, a 
control mechanism could be deregulated, leading to less strictly controlled initiation of 
DNA replication, and possibly to less stringent protein requirements. One example of the 
association of HCMV lytic replication with intracellular conditions, is the ability of HCMV 
infected stem cells in tissue culture to support HCMV replication only when the cells are 
differentiated (Minton et al., 1994). If HCMV is able to initiate DNA replication by more 
than one mechanism, it may be difficult to determine which, if any, is the preferred one 
without studying the cell types infected in vivo.
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Chapter 5: Replication of an HCMV origin-containing plasmid by a 
simian cytomegalovirus
5.1 Introduction
Several cytomegaloviruses of non-human mammals have been identified, including 
viruses which infect monkeys, mice, rats and guinea pigs (reviewed in Plummer, 1973; 
Staczek, 1990). The lytic origins of DNA replication of simian cytomegalovirus (SCMV) 
strain Colburn (Anders & Punturieri, 1991) and murine cytomegalovirus (MCMV) strain 
K181 (Masse et al., 1997) have been identified and sequenced. The cytomegalovirus 
origins which have been studied are large, complex, and share little sequence identity. 
There are, however, several blocks within the origins whose features are conserved 
throughout the cytomegaloviruses.
It has been reported (Masse et al., 1997) that plasmids containing cytomegalovirus 
lytic origins are only replicated in vitro in cells infected with the virus type from which the 
origin sequences were obtained. A plasmid containing an HCMV oriLyt was thus only 
replicated in HCMV infected human fibroblasts, not in Colburn or K181 infected human, 
murine or simian fibroblasts.
HCMV is more closely related to SCMV than to EBV or HSV-1 (McGeoch et al., 
2000). Therefore, the failure of SCMV to support the replication of pSP50 in transfected 
human fibroblasts is in surprising contrast to the ability of transfected EBV or HSV-1 
replication fork proteins to support HCMV origin-dependent DNA synthesis in the 
presence of the HCMV auxiliary factors (Sarisky & Hayward, 1996; section 4.2 of this 
thesis). Thus, while the replication fork proteins of HCMV and SCMV are likely to be very 
similar, it seems that the origin-specific proteins may be quite different. The ability of 
SCMV infection to replicate an HCMV origin-containing plasmid was therefore 
re-examined.
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5.2 Results
5.2.1 pSP50 is replicated in Colburn infected HFFF2 cells
As it had previously been reported that UL84 was the only HCMV encoded factor 
required to mediate replication of an HCMV origin-containing plasmid by the EBV 
replication fork proteins (Sarisky & Hayward, 1996), the ability of SCMV to direct 
replication of pSP50 in the presence of UL84, expressed from its own promoter (pZP13) or 
from the HCMV major immediate early promoter (pCV84), was examined.
Triplicate dishes of HFFF2 cells were transfected with 1.6 pg/dish of pSP50 (a), 1.6 
pg/dish of pSP50 and 1.6 pg/dish of pZP13 (b), or 1.6 pg/dish pSP50 and 1.6 pg/dish of 
pCV84 (c). One dish of each triplicate transfection was infected with 0.25 p.f.u./cell of 
HCMV (A), one dish was infected with 0.25 p.f.u./cell of Colburn strain cytomegalovirus 
(C), the third dish was mock infected (M).
Total cellular DNA was prepared 96 h p.i., digested with EcoRl and Dpnl, and 
processed as previously described. The phosphorimage is shown in figure 5.1.
Colburn cytomegalovirus infection directed the replication of transfected pSP50 in 
the absence of any HCMV encoded transactivator (C:a). The level of replication in 
Colburn infected cells was much lower than the level achieved by HCMV infection (A:a). 
When pSP50 was cotransfected with a plasmid expressing UL84 (either from pZP13 (C:b) 
or pCV84(C:c)), there was no significant change to the amount of pSP50 replicated 
following superinfection with Colburn.
Cotransfection of pSP50 with pZP13 (A:b) did not significantly alter the amount of 
pSP50 replicated by HCMV infection, but cotransfection with pCV84 (A:c) resulted in 
lower levels of replication. No pSP50 replication was detected in the mock infected 
samples.
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Figure 5.1 Replication o f an HCMV origin-containing plasmid (pSP50) by Colburn 
cytomegalovirus.
HFFF2 cells were transfected with 1.6 pg/dish o f pSP50 either (a) unsupplemented or with the 
addition of (b) 1.6 pg/dish of pZPl 3 or (c) 1.6 pg/dish of pCV84.
Cells were either infected with 0.25 p.f.u./cell o f Colburn (C), infected with 0.25 p.f.u./cell of 
HCMV (A) or mock infected (M).
Total cellular DNA was prepared 96 h p.i. digested with EcoK\ and Dpn\ and fragments were 
separated by electrophoresis through a 0.8% agarose gel, blotted and hybridised to 32P-labelled 
pAT153.
The position of EcoK\ digested pSP50 marker band is shown ------
Colburn cytomegalovirus infection can therefore supply all the functions necessary 
to replicate an HCMV origin-containing plasmid, and the amount of DNA replicated is not 
increased on addition of UL84.
5.2.2 Replication of a VZV origin-containing plasmid by HSV-1
SCMV infection activated an HCMV origin-containing plasmid in the absence of 
any HCMV encoded auxiliary factor, suggesting that SCMV encodes a protein capable of 
activating an HCMV origin. SCMV superinfection resulted in a lower level of replication 
than was obtained following superinfection with HCMV, so the origin-specific proteins 
may be functionally interchangeable but preferentially specify their cognate origins. 
Addition of the putative HCMV origin-specific protein (UL84) to the transient replication 
assay did not increase the amount of plasmid DNA replicated by SCMV.
In a similar “cross-complementation” assay, HSV-1 infection of cells transfected 
with a plasmid containing an origin of VZV DNA replication (pV02) results in 
amplification of the VZV origin-containing plasmid (Stow & Davison, 1986). To 
determine the effect of the addition of a defined cognate origin-binding protein in a 
heterologous assay system, the effect of the VZV origin-binding protein (expressed from 
plasmid pEV51) on the efficiency of replication of a VZV origin-containing plasmid 
(pV02) following HSV-1 superinfection was investigated. A plasmid containing the open 
reading frame for the VZV origin-binding protein in reverse orientation (pEV51R) was 
used as a control.
Duplicate monolayers of 293 cells were transfected with 0.4 pg/dish of pV02 (a), 
0.4 pg/dish each of pV02 and pEV51 (b), or 0.4 pg/dish each of pV02 and pEV51R (c). 
One dish of each duplicate transfection was infected with 10 p.f.u./cell of HSV-1, the other 
was mock infected. One dish of cells was transfected with 0.4 pg of pV02 and 1.6 pg of 
pEV51 and infected with 10 p.f.u./cell of HSV-1 (d).
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Total cellular DNA was prepared at 20 h p.i. and digested with EcoRl and Dpnl. 
Fragments were separated by electrophoresis, blotted and hybridised to 32P-labelled 
pAT153. The blot was exposed to X-Omat film, and the film was developed and scanned 
to produce the image shown in figure 5.2.
HSV-1 infection directed replication of a transfected VZV origin-containing 
plasmid (a). Cotransfection of pV02 with pEV51 increased the efficiency of replication in 
a dose dependent manner (b,d). Addition of pEV51R slightly decreased the amount of 
pV02 replicated (c).
Thus, while HSV-1 infection alone replicated a VZV origin-containing plasmid, 
addition of increasing amounts of the cognate origin-binding protein to the assay resulted in 
an increased replication efficiency.
5.2.3 Stimulation of pSP50 replication by Colburn cytomegalovirus
The increase in the amount of replication of a VZV origin-containing plasmid by 
HSV-1 in the presence of increasing amounts of the VZV origin-binding protein suggested 
that the transactivation of the HCMV origin-containing plasmid by Colburn 
cytomegalovirus might be enhanced by addition of an HCMV origin-specific function. The 
data presented in section 4.2 demonstrated a direct role for some of the proteins encoded 
by pSVH and pZP8, but not UL84, in HCMV lytic origin-dependent DNA synthesis in the 
presence of the HSV-1 replication fork proteins. The ability of pSVH and pZP8 to enhance 
replication of pSP50 in Colburn cytomegalovirus infected cells was therefore examined.
A single experiment in which similar levels of replicated pSP50 were detected in all
HCMV infected samples showed that replicated pSP50 was only detected in the Colburn
infected samples which received pZP8 and pSVH (data not shown). While the level of
pSP50 replication was lower in this experiment than in figure 5.1, (where detectable
replication of pSP50 by SCMV occurred in the absence of additional plasmids and in the
presence of pCV84), addition of pZP8 and pSVH had a stimulatory effect on the
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Figure 5.2 Replication o f a VZV origin-containing plasmid by HSV-1.
293 cells were transfected with 0.4 pig/dish of pV02 with either no addition (a) or with the 
addition of 0.4 p.g/dish of pEV51R (c), 0.4 pig/dish of pEV51 (b) or 1.6 p,g/dish of pEV51 
(d). Cells were either mock infected (MI) or infected with 10 p.f.u./cell of HSV-1 (X). 
Total cellular DNA was prepared 20 h p.i., digested with EcoK\ and Dpn\ and fragments 
were separated by electrophoresis through 0.8% agarose gel, blotted and hybridised to 
32P-labelled pAT153.
The position of the £coRI digested pV02 marker band is shown ------ ►
replication o f pSP50 by Colburn cytomegalovirus superinfection.
Had more time been available, this experiment using Colburn cytomegalovirus to 
replicate pSP50 would have been repeated and extended to include the pSVH and pZP8 
mutants described earlier in order to identify the individual proteins responsible.
5.3 Discussion
HSV-1 and VZV are both human Alphaherpesviruses, the origins, and 
origin-binding proteins of which, are so closely related that in a transient replication assay, 
a VZV origin-containing plasmid is replicated following superinfection with HSV-1 virus. 
Nevertheless, HSV-1 replicates an HSV-1 origin-containing plasmid 20-30 times more 
efficiently than it replicates a VZV origin-containing plasmid (Stow & Davison, 1986).
Cotransfection of a plasmid expressing the VZV origin-binding protein increased 
the amount of VZV origin-containing plasmid replicated following HSV-1 superinfection 
(figure 5.2), demonstrating that addition of the cognate origin-binding protein can increase 
replication efficiency in such a “cross-complementation” assay.
SCMV strain Colburn had previously been reported to be unable to direct 
replication of an HCMV origin-containing plasmid (Masse et al., 1997), but the data 
presented here show that low levels of activation can occur (figure 5.1).
Similar “cross-complementation” experiments to that done with the VZV/HSV-1 
model system were therefore carried out to determine whether any HCMV protein could be 
identified which enhanced replication from HCMV oriLyt following SCMV superinfection. 
SCMV driven replication of an HCMV origin-containing plasmid was not enhanced on 
addition of plasmids expressing UL84, as might have been expected if UL84 provided the 
HCMV origin-binding protein function.
In an experiment in which the level of replication of the HCMV origin-containing
plasmid by SCMV strain Colburn was below the limits of detection, addition of HCMV
IE1/IE2 and UL36-38 increased the efficiency of replication to a detectable level. Thus, as
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with the assays using the HSV-1 replication fork proteins, the IE 1/2 and UL36-38 loci 
appear to perform an HCMV oriLyt specific function. These studies should be extended 
using the pSVH and pZP8 derivatives previously described (figure 4.10 and 4.13).
The major immediate early regions from cytomegaloviruses of rhesus macaques 
(RhCMV), rats and mice have been sequenced and shown to have extensive amino acid 
homology to the major immediate early region 2 of human cytomegalovirus (Messerle et 
al., 1992; Sandford et al., 1993; Barry et al., 1996). In the case of RhCMV and HCMV, 
the IE2 proteins are 48% identical (Barry et al., 1996). All the cytomegalovirus origins 
described to date contain several repeated sequence motifs including possible binding sites 
for cellular transcription factors, which might act in conjunction with IE2-86 (or its 
homologues in the other cytomegaloviruses) in initiating cytomegalovirus DNA replication. 
In the light of these findings and the data presented in section 4.2 of this thesis, it would be 
interesting to re-examine the ability of the other cytomegaloviruses to transactivate each 
others origins in transient replication assays.
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Chapter 6: Conclusions
6.1 Replication of HCMV genomes in epithelial and non-human fibroblast 
cells
In chapter 3, I have shown that both 293 cells and Vero cells are capable of 
supporting HCMV DNA synthesis, and that 293 cells might support, to a very limited 
extent, the production of infectious HCMV strain Towne particles. Further investigations 
into the block to HCMV replication in these cell lines could yield important information 
about the HCMV life cycle and its requirements for interactions with the host cell.
Figure 3.8b shows that HCMV strain Towne genomic DNA accumulates in infected 
Vero cells. While there was no detectable accumulation of HCMV strain AD 169 genomes 
in Vero cells, it is unclear whether this is due to a failure to detect accumulation of DNA, 
or a failure of the virus to synthesise DNA. Further work could be undertaken to resolve 
this. In order to see a small amount of genomic DNA replication, unreplicated input 
genomes would need to be clearly distinguishable, or separated from newly synthesised 
DNA. This might be achieved by in vivo labelling of replicating DNA in infected cells. 
Labelled DNA could subsequently be hybridised to HCMV genomic DNA. If this was not 
sensitive enough, HCMV DNA synthesis might be confined to the origin region by 
incubating infected cells in medium containing ganciclovir.
Ganciclovir is an effective HCMV antiviral which acts on viral DNA replication, but 
does not inhibit the viral DNA polymerase, so a series of short DNA fragments from the 
origin region are produced in ganciclovir treated HCMV infected cells (Hamzeh et al., 
1990). Ganciclovir terminated DNAs could be separated from input genomes by 
electrophoresis of undigested DNA and detected directly with a radiolabelled probe, 
alternatively, in vivo labelled ganciclovir DNAs could be hybridised to a DNA fragment 
containing HCMV origin sequences, such as pSP50. Phosphonoformic acid inhibition
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would be used to confirm that incorporation of label was directed by the HCMV DNA 
polymerase. The detection of ganciclovir terminated DNA would confirm that 
origin-dependent DNA synthesis was occurring.
I have proposed that HCMV strain AD 169 DNA may fail to be replicated in Vero 
cells if the infecting genomic DNA is not circularised. Detection of ganciclovir terminated 
DNAs would not necessarily preclude this possibility as initiation and limited DNA 
synthesis might be possible on a linear template. The ability of HCMV strain AD 169 DNA 
to circularise should thus be tested by FIGE, which allows the separation of high molecular 
weight DNA molecules (McVoy & Adler, 1994).
The replication efficiency of different human cytomegalovirus strains in different cell 
lines could also be examined in greater detail. For example, combining Southern blot data 
with indirect immunofluorescence might make it possible to assess whether a small amount 
of virus replication takes place in the majority of Vero and 293 cells, or if a wild type level 
of DNA synthesis is achieved in a small minority of these cells. In cells which support 
HCMV DNA replication, but not infectious virus production, it would also be interesting to 
find out at what point the lytic cycle is blocked.
6.2 Initiation of HCMV origin-dependent DNA synthesis
Two novel transient replication assay systems have been described (section 4.2 and 
5.2) and used to identify HCMV encoded proteins with possible origin-specific functions 
during HCMV DNA synthesis.
Firstly, an assay using the HSV-1 replication fork proteins to replicate an HCMV
origin-containing plasmid was described. In this assay there was no absolute requirement
for UL84 to initiate DNA synthesis at an HCMV origin, in fact, omission of UL84 from an
assay in which the four remaining HCMV auxiliary loci were present did not significantly
reduce the replication of the origin-containing plasmid (figure 4.5). IE2-86 was able to link
the HSV-1 replication fork proteins to the HCMV origin (figure 4.7), and UL36-38 was
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the only one of the three remaining auxiliary loci which, individually, significantly increased 
the amount of replication observed (figure 4.8).
The second assay system used transfection followed by superinfection with Colburn 
cytomegalovirus (SCMV). SCMV was shown to be able to replicate an HCMV 
origin-containing plasmid (figure 5.1). In a model system used to investigate the action of a 
cognate origin-binding protein in the presence of heterologous replication fork proteins, i.e. 
the replication of a VZV origin-containing plasmid by HSV-1 virus, replication was shown 
to be enhanced on addition of the cognate origin-binding protein (figure 5.2). Addition of 
UL84 did not affect the amount of replication observed (figure 5.1). Data from a 
preliminary experiment suggested that addition of IE1/IE2 and UL36-38 to the Colburn 
‘superinfection assay’ does increased the amount of HCMV origin-containing plasmid 
replicated by Colburn cytomegalovirus infection (not shown).
The use of a simian cytomegalovirus to replicate an HCMV origin-containing
plasmid could provide a useful additional assay for the study of HCMV DNA replication as 
the two cytomegaloviruses are more closely related than HCMV is to either HSV-1 or 
EBV. However, infection with Colburn cytomegalovirus is a much more complex system 
than transfection with plasmids expressing the herpesviral replication fork proteins, and any 
results obtained must be carefully interpreted.
The fact that Colburn cytomegalovirus (SCMV) is able to replicate an HCMV 
origin-containing plasmid in the absence of any HCMV encoded proteins suggests that 
SCMV encodes at least one protein which can provide an HCMV origin-specific function, 
although this should be confirmed using plasmids containing mutant origin sequences or 
plasmids containing only vector sequences. It would also be interesting to determine which 
protein encoded by SCMV is specific for the HCMV origin in a transient replication assay, 
and, if appropriate, to identify the DNA sequences which are required. The ability of
HCMV infection to replicate an SCMV origin-containing plasmid could also be examined.
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In the two transient replication assay systems I have described, I found that there 
was no absolute requirement for UL84, but that one or more of the major immediate early 
proteins, probably IE2-86, displays some HCMV origin-specific properties. These results 
clearly contrast with those published by Sarisky and Hayward (1996), who reported that of 
the HCMV auxiliary loci, only UL84 was absolutely essential for origin-dependent DNA 
replication. UL84 has also been shown to be an inhibitor of HCMV replication (Gebert et 
al., 1997), a phenotype similar to the inhibition of HSV-1 DNA replication by UL9 (Stow 
et al., 1993). However, UL84 has been shown to interact with IE2-86, (Spector & 
Tevethia, 1994) and the inhibition of HCMV replication by UL84 may be due to the effects 
of UL84 on transcriptional transactivation by IE2-86, whereas the inhibition of HSV-1 
DNA replication by UL9 is thought more likely to be at the point of UL9 binding to the 
HSV-1 origin and its interactions with the HSV-1 replication fork proteins. The reported 
RNase H activity of UL84 (Sarisky & Hayward, 1996b) has not been published, and the 
data of Sarisky and Hayward (1996) have not been confirmed or extended.
At the recent International Herpesvirus Workshop it was reported (Kiehl et al., 
2000) that mutation of an IE2-86 binding site within a region flanking the core of HCMV 
oriLyt abrogated origin function. This flanking region could be functionally substituted 
with regions containing clusters of IE2-86 binding sites (e.g., the UL112-113 promoter), 
furthermore, there are reportedly several IE2-86 binding sites overlapping functionally 
important regions of the core of oriLyt. This recent report supports my data in suggesting 
an important role for IE2-86 in the initiation of HCMV oriLyt dependent DNA synthesis. 
Further evidence in support of my data comes from the fact that in a transient replication 
assay, UL84, UL112-113 and IE2 were the minimum set of auxiliary loci required for 
HCMV origin-dependent DNA synthesis in Vero cells in the presence of the HCMV 
replication fork proteins and UL69 (Sarisky & Hayward, 1996). The authors also reported 
that in HF cells in the presence of the frill set of eleven replication proteins, UL84,
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UL36-38 and IE 1/2 were absolutely essential for HCMV origin-dependent DNA synthesis. 
The full set of HCMV replication fork proteins and IE2-86, UL84 and TRS1 have been 
over-expressed using a semliki forest virus (SFV) expression system in mammalian cells 
(McCue and Anders, 1998). The UL38 protein should probably also be similarly 
overexpressed, purified, and its function examined. It would also be most interesting to 
characterise possible interactions of IE2-86 with the replication fork proteins, and with 
UL84 and UL38. The ability of IE2-86, UL84 and UL38 to bind independently or together 
to specific DNA sequences (or RNA:DNA hybrid regions) within HCMV oriLyt should be 
examined in detail.
In order to resolve the question of which proteins are required for initiation of 
HCMV origin-dependent DNA synthesis, much further investigation is needed. Plasmids 
expressing only UL38 and IE2-86 should be constructed and tested in the transient 
replication assays described here, and the specific protein domains of IE2-86 and UL38 
involved in DNA replication should be determined.
When considered together, previously published work showing an essential role for 
UL84 in HCMV DNA replication, and my data showing a direct role for IE2-86 in HCMV 
DNA replication, as well as the presence of RNA molecules within and transcribed from the 
origin, tend to suggest that the initiation of HCMV lytic-phase DNA synthesis may proceed 
by more than one mechanism. It is possible that different mechanisms for the initiation of 
DNA replication may be employed in different cell types, or at different stages in the cell 
cycle. However, testing such a hypothesis will probably require the construction of HCMV 
mutants and their examination in different cell lines that more closely resemble those 
infected in vivo. Construction of HCMV IE2 mutants has proven extremely difficult, and 
once constructed, a separation of the effects of the mutation on HCMV gene expression 
from any direct effect on origin-dependent DNA synthesis will be extremely difficult. Cell 
free systems for HCMV oriLyt dependent DNA synthesis should also assist in the
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identification of proteins that perform origin-specific functions. Such systems, when 
supplemented with extracts from various cell types, may also reveal the existence of 
different initiation mechanisms. Finally, cell free systems may allow detailed dissection of 
the molecular events during initiation of HCMV origin-dependent DNA synthesis.
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